
<html lang="en"     class="pb-page"  data-request-id="17fdb38f-177f-4a50-86ba-481ce6df7781"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b00489;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton" /></meta><meta name="dc.Creator" content="Hana  Kostrhunova" /></meta><meta name="dc.Creator" content="Juraj  Zajac" /></meta><meta name="dc.Creator" content="Vojtech  Novohradsky" /></meta><meta name="dc.Creator" content="Jana  Kasparkova" /></meta><meta name="dc.Creator" content="Jaroslav  Malina" /></meta><meta name="dc.Creator" content="Janice R.  Aldrich-Wright" /></meta><meta name="dc.Creator" content="Emanuele  Petruzzella" /></meta><meta name="dc.Creator" content="Roman  Sirota" /></meta><meta name="dc.Creator" content="Dan  Gibson" /></meta><meta name="dc.Creator" content="Viktor  Brabec" /></meta><meta name="dc.Description" content="The substitution inert platinum agent [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)]2+ (56MeSS, 5) is a potent cytotoxic metallodrug. In contrast to conventional cisplatin or oxal..." /></meta><meta name="Description" content="The substitution inert platinum agent [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)]2+ (56MeSS, 5) is a potent cytotoxic metallodrug. In contrast to conventional cisplatin or oxal..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 28, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00489" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00489" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00489" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00489" /></link>
        
    
    

<title>A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00489" /></meta><meta property="og:title" content="A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0002.jpeg" /></meta><meta property="og:description" content="The substitution inert platinum agent [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)]2+ (56MeSS, 5) is a potent cytotoxic metallodrug. In contrast to conventional cisplatin or oxaliplatin, the mechanism of action (MoA) of 5 is fundamentally different. However, details of the mechanism by which the 5,6-dimethyl-1,10-phenanthroline ligand contributes to the cytotoxicity of 5 and its derivatives have not been sufficiently clarified so far. Here, we show that 5 and its Pt(IV) derivatives exhibit an intriguing potency in the triple-negative breast cancer cells MDA-MB-231. Moreover, we show that the Pt(IV) derivatives of 5 act by multimodal MoA resulting in the global biological effects, that is, they damage nuclear DNA, reduce the mitochondrial membrane potential, induce the epigenetic processes, and last but not least, the data provide evidence that changes in the organization of cytoskeleton networks are functionally important for 5 and its derivatives, in contrast to clinically used platinum cytostatics, to kill cancer cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00489"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00489">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00489&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00489&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00489&amp;href=/doi/10.1021/acs.jmedchem.9b00489" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5176-5190</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00462" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00497" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hana Kostrhunova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hana Kostrhunova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hana++Kostrhunova">Hana Kostrhunova</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Juraj Zajac</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juraj Zajac</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juraj++Zajac">Juraj Zajac</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Vojtech Novohradsky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vojtech Novohradsky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vojtech++Novohradsky">Vojtech Novohradsky</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jana Kasparkova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jana Kasparkova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Kasparkova">Jana Kasparkova</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5279-5381" title="Orcid link">http://orcid.org/0000-0002-5279-5381</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jaroslav Malina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jaroslav Malina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jaroslav++Malina">Jaroslav Malina</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Janice R. Aldrich-Wright</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Janice R. Aldrich-Wright</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Science and Health, Western Sydney University, Penrith South DC 1797, NSW, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Janice+R.++Aldrich-Wright">Janice R. Aldrich-Wright</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Emanuele Petruzzella</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emanuele Petruzzella</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem 91120, Israel</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emanuele++Petruzzella">Emanuele Petruzzella</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Roman Sirota</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roman Sirota</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem 91120, Israel</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roman++Sirota">Roman Sirota</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Dan Gibson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dan Gibson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem 91120, Israel</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Gibson">Dan Gibson</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Viktor Brabec</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Viktor Brabec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#680a1a090a0d0b28010a18460b12"><span class="__cf_email__" data-cfemail="0d6f7f6c6f686e4d646f7d236e77">[emailÂ protected]</span></a>. Tel: 420 541517148.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Viktor++Brabec">Viktor Brabec</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8233-1393" title="Orcid link">http://orcid.org/0000-0002-8233-1393</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00489&amp;href=/doi/10.1021%2Facs.jmedchem.9b00489" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5176â5190</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 28, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 March 2019</li><li><span class="item_label"><b>Published</b> online</span>28 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00489" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00489</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5176%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHana%2BKostrhunova%252C%2BJuraj%2BZajac%252C%2BVojtech%2BNovohradsky%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b00489%26title%3DA%2BSubset%2Bof%2BNew%2BPlatinum%2BAntitumor%2BAgents%2BKills%2BCells%2Bby%2Ba%2BMultimodal%2BMechanism%2Bof%2BAction%2BAlso%2BInvolving%2BChanges%2Bin%2Bthe%2BOrganization%2Bof%2Bthe%2BMicrotubule%2BCytoskeleton%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5190%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00489"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1110</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00489" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hana&quot;,&quot;last_name&quot;:&quot;Kostrhunova&quot;},{&quot;first_name&quot;:&quot;Juraj&quot;,&quot;last_name&quot;:&quot;Zajac&quot;},{&quot;first_name&quot;:&quot;Vojtech&quot;,&quot;last_name&quot;:&quot;Novohradsky&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Kasparkova&quot;},{&quot;first_name&quot;:&quot;Jaroslav&quot;,&quot;last_name&quot;:&quot;Malina&quot;},{&quot;first_name&quot;:&quot;Janice&quot;,&quot;last_name&quot;:&quot;R. Aldrich-Wright&quot;},{&quot;first_name&quot;:&quot;Emanuele&quot;,&quot;last_name&quot;:&quot;Petruzzella&quot;},{&quot;first_name&quot;:&quot;Roman&quot;,&quot;last_name&quot;:&quot;Sirota&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Gibson&quot;},{&quot;first_name&quot;:&quot;Viktor&quot;,&quot;last_name&quot;:&quot;Brabec&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5176-5190&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00489&quot;},&quot;abstract&quot;:&quot;The substitution inert platinum agent [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)]2+ (56MeSS, 5) is a potent cytotoxic metallodrug. In contrast to conventional cisplatin or oxaliplatin, the mechanism of action (MoA) of 5 is fundamentally different. However, details of the mechanism by which the 5,6-dimethyl-1,10-phenanthroline ligand contributes to the cytotoxicity of 5 and its derivatives have not been sufficiently clarified so far. Here, we show that 5 and its Pt(IV) derivatives exhibit an intriguing potency in the triple-negative breast cancer cells MDA-MB-231. Moreover, we show that the Pt(IV) derivatives of 5 act by multimodal MoA resulting in the global biological effects, that is, they damage nuclear DNA, reduce the mitochondrial membrane potential, induce the epigenetic processes, and last but not least, the data provide evidence that changes in the organization of cytoskeleton networks are functionally important for 5 and its derivatives, in contrast to clinically used platinum cy&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00489&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00489" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00489&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00489" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00489&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00489" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00489&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00489&amp;href=/doi/10.1021/acs.jmedchem.9b00489" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00489" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00489" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00489%26sid%3Dliteratum%253Aachs%26pmid%3D31030506%26genre%3Darticle%26aulast%3DKostrhunova%26date%3D2019%26atitle%3DA%2BSubset%2Bof%2BNew%2BPlatinum%2BAntitumor%2BAgents%2BKills%2BCells%2Bby%2Ba%2BMultimodal%2BMechanism%2Bof%2BAction%2BAlso%2BInvolving%2BChanges%2Bin%2Bthe%2BOrganization%2Bof%2Bthe%2BMicrotubule%2BCytoskeleton%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D10%26spage%3D5176%26epage%3D5190%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292098" title="Platinum">Platinum</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/jmcmar.2019.62.issue-10/20190523/jmcmar.2019.62.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The substitution inert platinum agent [Pt(1<i>S</i>,2<i>S</i>-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)]<sup>2+</sup> (56MeSS, <b>5</b>) is a potent cytotoxic metallodrug. In contrast to conventional cisplatin or oxaliplatin, the mechanism of action (MoA) of <b>5</b> is fundamentally different. However, details of the mechanism by which the 5,6-dimethyl-1,10-phenanthroline ligand contributes to the cytotoxicity of <b>5</b> and its derivatives have not been sufficiently clarified so far. Here, we show that <b>5</b> and its Pt(IV) derivatives exhibit an intriguing potency in the triple-negative breast cancer cells MDA-MB-231. Moreover, we show that the Pt(IV) derivatives of <b>5</b> act by multimodal MoA resulting in the global biological effects, that is, they damage nuclear DNA, reduce the mitochondrial membrane potential, induce the epigenetic processes, and last but not least, the data provide evidence that changes in the organization of cytoskeleton networks are functionally important for <b>5</b> and its derivatives, in contrast to clinically used platinum cytostatics, to kill cancer cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Platinum coordination compounds, such as cisplatin, carboplatin, and oxaliplatin (<b>1</b>), are some of the most widely used chemotherapeutics for the treatment of human tumors. However, their clinical use is associated with several drawbacks<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> involving inherent and acquired resistance, adverse side effects, a narrow spectrum of activity, low bioavailability, and the fact that no single-platinum agent is equally effective against all cancer types. These disadvantages triggered a search for novel cytotoxic platinum coordination compounds resulting in the design and synthesis of a large number of platinum complexes that were tested for anticancer activity, and their mechanism of action (MoA) has been extensively investigated by laboratories worldwide.</div><div class="NLM_p">The most extensive research on the cellular and molecular MoAs that underlie efficacy were performed first on the approved drugs, cisplatin, carboplatin and <b>1</b>. The main steps of the MoA of cisplatin and its derivatives involve cellular accumulation, activation by aquation, the formation of DNA adducts (cross-links) that distort the DNA, and their cellular processing leading to cell death.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, one of the strategies for the design of new anticancer platinum drugs is to change the outcome of one or more of these steps, that is, to improve cellular accumulation and alter the DNA binding mode and, consequently, cellular processing of DNA adducts. In addition, attempts have been made to design complexes that bind to targets different from DNA. Clinicians try to overcome resistance to existing anticancer platinum drugs by combination chemotherapy, treating the patients with platinum drugs together with drugs that act by different mechanisms. For instance, the introduction of cisplatin or <b>1</b> in combination chemotherapy helped advance cure rates.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Thus, the current trend in clinical research has gradually shifted from a focus on monotherapy to combination therapy for enhanced treatment efficacy.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5â7)</a> In combining drugs, we face the problem that different drugs have different solubilities and pharmacokinetics.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Notwithstanding, the design and development of new single cytostatics that simultaneously affect more distinct oncogenic targets appears to be a promising strategy, which is more profitable in comparison with the development of a combination of two or more drugs.</div><div class="NLM_p">One approach to designing multiaction cytotoxic platinum agents is based on Pt(IV) prodrugs that simultaneously release, after their reduction inside the cancer cell, an active Pt(II) drug and bioactive moieties.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These six-coordinate octahedral complexes are derivatives of square planar Pt(II) complexes containing axial ligands that can enhance hydrophobicity and consequently cellular accumulation, increase solubility, modify rates of reduction, and affect cellular target(s) other than DNA.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> After they enter the tumor cell with the internal hypoxic environment, these inert Pt(IV) prodrugs are activated by reduction releasing the cytotoxic Pt(II) complex and the two axial bioactive ligands that can affect different intracellular targets and act by MoA(s) different from that of the Pt(II) complex.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Unquestionable advantages of these Pt(IV) prodrugs are as follows: (i) they contain the combination of different drugs, each acting by a different MoA, in a single molecule with a single pharmacokinetic profile; (ii) they are kinetically inert in comparison with their Pt(II) counterparts, minimizing undesirable interactions with nucleophiles in extracellular milieu, which may reduce side effects, and can enhance bioavailability; and (iii) they can be administered orally.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a></div><div class="NLM_p">A number of novel Pt(IV) prodrugs that simultaneously release, besides the active Pt(II) complex, one or more different bioactive moieties inside the cancer cell were introduced (for instance, see refs <a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25">(15â25)</a>). Their cytotoxicity against cancer cells in vitro and also, in some cases, in vivo was significantly better than that of cisplatin or its clinically used derivatives. Quite recently, a novel Pt(IV) dinuclear complex (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which acted as a âquadruple actionâ cytotoxic prodrug, was designed, and some aspects of its MoA were determined.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Quadruple-action platinum(IV) prodrug with an anticancer activity described in a recently published article.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This Pt(IV) prodrug released four different bioactive moieties in cancer cells: cisplatin, dichloroacetate (DCA), phenylbutyrate (PhB), and [Pt(1<i>S</i>,2<i>S</i>-diaminocyclohexane) (5,6-dimethyl-1,10-phenanthroline)]<sup>2+</sup> (56MeSS, <b>5</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The activity of the quadruple-action platinum(IV) prodrug shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> was attributed among others to its enhanced accumulation in cancer cells and synergism between DNA platination (cisplatin), histone deacetylase (HDAC) inhibition (PhB), action on the mitochondria (DCA), and the effects of <b>5</b>. Intriguingly, <b>5</b> is a very potent cytotoxic metallointercalator exhibiting submicromolar IC<sub>50</sub> values against a variety of cancer cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In contrast, the MoA of <b>5</b> is fundamentally different from cisplatin,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> but the details of the mechanism by which the 5,6-dimethyl-1,10-phenanthroline ligand (5,6-Me<sub>2</sub>phen) contributes to the cytotoxicity of the complexes containing this ligand have not been sufficiently clarified so far. Multiaction anticancer Pt(IV) prodrugs hitherto investigated, the working hypotheses, MoAs, the basic chemistry of these complexes, and the interpretations of the biological data were very recently reviewed.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Platinum complexes used in this study and their abbreviations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we describe, with the aim to contribute to understanding the role of the 5,6-Me<sub>2</sub>phen ligand in the mechanisms of cytotoxicity of Pt(IV) âmultiactionâ prodrugs, the synthesis and biochemical and antiproliferative properties of a series of multiaction Pt(IV) prodrugs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). These new Pt(IV) complexes release different bioactive agents in tumor cells, such as <b>5</b>, PhB, and octanoic acid (OA), that act on DNA and the mitochondria, are inhibitors of HDACs and act as a DNA hypermethylating agent<a onclick="showRef(event, 'ref18 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref21">(18,21)</a> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The properties of the latter series of Pt(IV) prodrugs were compared with the series of very similar compounds, Pt(IV) derivatives of <b>1</b>, which thus contained the leaving oxalate instead of the 5,6-Me<sub>2</sub>phen ligand.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Antiproliferative Activity Screening</h3><div class="NLM_p">The antiproliferative properties of the compounds evaluated in the present work were screened on the panel of malignant and nonmalignant cell lines using the colorimetric MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and 72 h of the drug incubation period. Results expressed as IC<sub>50</sub> values (concentration of the compound that causes death in 50% of cells calculated from doseâsurvival curves) are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Cytotoxicity Data [IC<sub>50</sub> Mean Values (Î¼M)] Obtained by MTT Test<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">platinum complex</th><th class="colsep0 rowsep0" align="center" char="Â±">HeLa</th><th class="colsep0 rowsep0" align="center" char="Â±">HCT-116</th><th class="colsep0 rowsep0" align="center" char="Â±">A2780</th><th class="colsep0 rowsep0" align="center" char="Â±">MDA-MB-231</th><th class="colsep0 rowsep0" align="center" char="Â±">MCF-7</th><th class="colsep0 rowsep0" align="center" char="Â±">MRC-5 pd30</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="Â±">36 Â± 2</td><td class="colsep0 rowsep0" align="char" char="Â±">1.1 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">0.89 Â± 0.06</td><td class="colsep0 rowsep0" align="char" char="Â±">4.2 Â± 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">10 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">31 Â± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="Â±">23.6 Â± 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">1.6 Â± 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">13 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">6.45 Â± 0.02</td><td class="colsep0 rowsep0" align="char" char="Â±">8 Â± 2</td><td class="colsep0 rowsep0" align="char" char="Â±">42 Â± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="Â±">18 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">1.1 Â± 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">12 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">4.4 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">3.0 Â± 0.7</td><td class="colsep0 rowsep0" align="char" char="Â±">42 Â± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="Â±">4.1 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">0.27 Â± 0.02</td><td class="colsep0 rowsep0" align="char" char="Â±">0.93 Â± 0.05</td><td class="colsep0 rowsep0" align="char" char="Â±">0.46 Â± 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3 Â± 0.4</td><td class="colsep0 rowsep0" align="char" char="Â±">5.0 Â± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.37 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.08 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.038 Â± 0.009</td><td class="colsep0 rowsep0" align="char" char="Â±">0.24 Â± 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">0.74 Â± 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">0.16 Â± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.32 Â± 0.06</td><td class="colsep0 rowsep0" align="char" char="Â±">0.07 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.23 Â± 0.06</td><td class="colsep0 rowsep0" align="char" char="Â±">0.08 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.78 Â± 0.09</td><td class="colsep0 rowsep0" align="char" char="Â±">0.467 Â± 0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.29 Â± 0.02</td><td class="colsep0 rowsep0" align="char" char="Â±">0.07 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.20 Â± 0.04</td><td class="colsep0 rowsep0" align="char" char="Â±">0.07 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.64 Â± 0.08</td><td class="colsep0 rowsep0" align="char" char="Â±">0.357 Â± 0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.29 Â± 0.02</td><td class="colsep0 rowsep0" align="char" char="Â±">0.064 Â± 0.006</td><td class="colsep0 rowsep0" align="char" char="Â±">0.17 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.06 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.6 Â± 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">0.122 Â± 0.008</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The drug-treatment period was 72 h. The results are expressed as mean values Â± SD from three independent experiments each performed in triplicate.</p></div></div></div><div class="NLM_p">Notably, significant differences exist in the antiproliferative activity of the Pt(IV) derivatives of <b>1</b> and corresponding derivatives of <b>5</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Interestingly, the Pt(IV) derivatives of <b>1</b> and <b>5</b> were established to have antiproliferative activity with few exceptions similar or markedly better than their Pt(II) counterparts. The Pt(IV) derivatives of <b>1</b> displayed low to moderate toxicity against all cell lines depending on the type of the axial ligands. While the dual-action Pt(IV) derivatives of <b>1</b> containing only one bioactive ligand (PhB or OA) exhibited relatively low antiproliferative activity, a marked increase was observed for triple-action <b>4</b> containing two different bioactive axial ligands.</div><div class="NLM_p">Conversely, the Pt(IV) derivatives of <b>5</b> exhibited impressive potency at markedly lower concentrations (submicromolar) than the analogous Pt(IV) derivatives of <b>1</b>. Moreover, the antiproliferative activity of the Pt(IV) derivatives of <b>5</b> does not depend on the type of axial ligand(s). The potency of the Pt(IV) derivatives of <b>5</b> appears to stem primarily from the Pt(II) precursor, [Pt(<i>SS</i>-DACH)(5,6-Me<sub>2</sub>phen)] (DACH = 1<i>S</i>,2<i>S</i>-diaminocyclohexane), that is common to all these compounds, rather than from the bioactive axial ligand(s). These observations emphasize the fact that, unlike the Pt(IV) derivatives of cisplatin and <b>1</b>, where bioactive axial ligands can significantly improve the cytotoxicity compared to the Pt(II) precursors, in the case of the Pt(IV) derivatives of <b>5</b>, the axial ligands have negligible effects on the antiproliferative activity.</div><div class="NLM_p">The markedly higher antiproliferative activity of <b>5</b> and its Pt(IV) derivatives in comparison with that of those based on <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) deserves further discussion. Both groups of compounds contain enantiomeric DACH ligand; the DACH ligand in the compounds based on <b>1</b> is <i>RR</i>-DACH, whereas <i>SS</i>-DACH is contained in the compounds based on <b>5</b>. Thus, it is possible to speculate that the considerable differences in antiproliferative activities observed for the compounds based on <b>1</b> and <b>5</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) might also be a consequence of different enantiomericity of their amine ligands. However, this eventuality is unlikely since it has been found<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29â31)</a> that the platinum(II)âoxalate complex with <i>RR</i>-DACH (<b>1</b>) was more active than the corresponding complexes with <i>SS</i>-DACH,<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29â31)</a> whereas platinum(II)âcomplex <b>5</b> with <i>RR</i>-DACH was less active than the corresponding complexes with <i>SS</i>-DACH.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">An intriguing potency of the compounds based on <b>5</b> was observed for breast cancer cells MDA-MB-231 and colon carcinoma cells HCT-116 [for instance, the IC<sub>50</sub> values found for the investigated Pt(IV) derivatives of <b>5</b> were as low as 0.06â0.07 Î¼M (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)], that is, by approximately two orders of magnitude lower than the IC<sub>50</sub> values found for clinically used anticancer platinum drugs. A common feature of these cancer cells is that both carry RAS mutation that can cause the tumor to become resistant to drugs usually used to treat these types of cancer cells. Thus, these results are also consistent with those reported recently for the treatment of other KRAS-mutated cancer cells with the dinuclear quadruple-action Pt(IV) prodrug (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) that also contained the portion of <b>5</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, studies aimed at revealing the reasons why the RAS-mutated cancer cells exhibit specific sensitivity to the treatment with the compounds based on <b>5</b> have not been carried out so far.</div><div class="NLM_p last">Interestingly, the triple-negative breast cancer cells MDA-MB-231 are highly aggressive cells that are resistant to a number of chemotherapeutics including cisplatin. Hence, it is important for the design and development of the chemotherapeutics efficient in treating this type of breast cancer to understand molecular mechanisms responsible for the response of these breast cancer cells to antitumor agents. Therefore, we also used here MDA-MB-231 cells to further investigate the role of the 5,6-Me<sub>2</sub>phen ligand in the mechanisms of cytotoxicity of Pt(IV) multiaction prodrugs.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Cellular Accumulation</h3><div class="NLM_p">Cellular accumulation of <b>1</b>, <b>5</b>, and their Pt(IV) derivatives in the triple-negative breast cancer MDA-MB-231 cell line was studied to investigate a possible relationship between the cellular uptake and in vitro cytotoxicity of the platinum complexes. Cellular concentrations of platinum from <b>1</b>, <b>5</b>, and their Pt(IV) derivatives were determined by inductively coupled plasma mass spectrometry (ICP-MS) after 6 h of exposure to the complexes at the concentrations of 0.8, 2, and 5 Î¼M. These concentrations were chosen as a compromise between the limit of quantitation of platinum in our biological samples by ICP-MS and the high toxicity of the Pt(IV) derivatives of <b>5</b>, which could compromise the results. As the investigated compounds exhibit a rather broad range of IC<sub>50</sub> values (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) to assess the ability of these compounds to enter the cells, short (6 h) incubation periods and equimolar concentrations were chosen. All compounds were tested with the MDA-MB-231 cells at concentrations of 2 Î¼M and either 800 nM or 5 Î¼M depending on their cytotoxicity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cellular Platinum Accumulation in MDA-MB-231 and log <i>P</i> (Octanol/Water) Values Obtained by the Shake Flask Method</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="Â±" /></col><col align="left" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="3" align="center">TotalÂ ngÂ Pt/10<sup>6</sup>Â cells<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="Â±">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">platinum complex</th><th class="colsep0 rowsep0" align="center">800Â nMÂ /Â 6Â h</th><th class="colsep0 rowsep0" align="center" char="Â±">2Â Î¼MÂ /Â 6Â h</th><th class="colsep0 rowsep0" align="center">5Â Î¼MÂ /Â 6Â h</th><th class="colsep0 rowsep0" align="center" char="Â±">logÂ <i>P</i><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">1.8 Â± 0.1</td><td class="colsep0 rowsep0" align="left">3.24 Â± 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">â1.89 Â± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">1.3 Â± 0.1</td><td class="colsep0 rowsep0" align="left">2.9 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">0.02 Â± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">1.5 Â± 0.1</td><td class="colsep0 rowsep0" align="left">2.94 Â± 0.05</td><td class="colsep0 rowsep0" align="char" char="Â±">0.30 Â± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">7 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">34 Â± 4</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">0.41 Â± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">4 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">13 Â± 2</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">â1.70 Â± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">5 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">16 Â± 1</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">â1.37 Â± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">7 Â± 2</td><td class="colsep0 rowsep0" align="char" char="Â±">24 Â± 3</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">â0.75 Â± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">41 Â± 6</td><td class="colsep0 rowsep0" align="char" char="Â±">190 Â± 30</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">0.010 Â± 0.003</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The table shows the cellular platinum accumulation into MDA-MB-231 cells after 6 h of exposure to 0.8, 2, or 5 Î¼M of the compounds.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">log P values obtained by the shake flask method at 25 Â°C.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Results are expressed as the mean Â± SD for three independent experiments in triplicate for each run.</p></div></div></div><div class="NLM_p">It was demonstrated that a higher accumulation of Pt drugs generally correlates with enhanced hydrophobicity, although the involvement of active and facilitated transport mechanisms in the cellular accumulation of the investigated Pt(IV) complexes and <b>1</b> can substantially affect their final cellular accumulation.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> A measure of hydrophobicity of the metallodrugs was determined using their partition coefficient (log <i>P</i>) values for 1-octanol/water partition<a onclick="showRef(event, 'ref17 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref17 ref35 ref36">(17,35,36)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">Despite the significant difference in their log <i>P</i> values, <b>1</b> (â1.89) and its Pt(IV) derivatives, <b>2</b> (0.02) and <b>3</b> (0.30), accumulated in a similar extent when the cells were treated for 6 h with the compounds at a concentration of 2 or 5 Î¼M. The presence of two bioactive axial ligands (PhB and OA) in <b>4</b> led to a significant increase in platinum taken up by the cells (19- to 26-fold) when the cells were treated for 6 h with the compounds at a concentration of 2 Î¼M. The bioactive axial ligands in <b>4</b> transformed this Pt(IV) derivative of <b>1</b> to the most hydrophobic compound of the group <b>1</b>â<b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). On the other hand, this enhancement of hydrophobicity of <b>4</b> was not so high as one would expect considering a marked enhancement of its cellular accumulation and cytotoxicity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Thus, the cellular accumulation and cytotoxicity of compounds of the <b>1</b>â<b>4</b> series do not appear to reflect their hydrophobicity.</div><div class="NLM_p">We also confirmed some correlation between the hydrophobicity (log <i>P</i>), cellular accumulation, and cytotoxicity for <b>5</b> and its Pt(IV) derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Interestingly, although <b>5</b>, <b>6</b>, and <b>7</b> are hydrophilic, they accumulate significantly more efficiently than <b>2</b>, <b>3</b>, and <b>4</b> that are all lipophilic, suggesting that structural factors other than lipophilicity might contribute to the cellular accumulation of <b>5</b> and its Pt(IV) derivatives. This may be due to the square planar [Pt(<i>SS</i>-DACH)(5,6-Me<sub>2</sub>phen)] moiety and/or to the positive charge (2+) of these complexes.</div><div class="NLM_p">Cellular accumulation of platinum was also investigated to evaluate the distribution of platinum species in different subcellular compartments. MDA-MB-231 cells were treated with <b>1</b>, <b>5</b>, and their Pt(IV) derivatives (2 Î¼M each) for 6 h, and the cells were fractionated into four pools: membrane, cytosol, nucleus, and cytoskeleton. The platinum levels in each pool were measured by ICP-MS. The results are presented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cellular accumulation of <b>1</b>, <b>5</b>, and its Pt(IV) derivatives in MDA-MB-231 cells. The amount of Pt in the cell membrane (green), cytosol (pink), nucleus (orange), and cytoskeleton (blue) is shown. The data represent the percentage of Pt in different fractions over total uptake. Cells were exposed to platinum compounds (2 Î¼M) for 6 h. All results are expressed as the mean Â± SD from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The extent of accumulation of <b>1</b> and its Pt(IV) derivatives into the cell membrane fraction was markedly greater than that of <b>5</b> and its Pt(IV) derivatives, accounting for 54 vs 13% (<b>1</b> vs <b>5</b>), 61 vs 14% (<b>2</b> vs <b>6</b>), 57 vs 14% (<b>3</b> vs <b>7</b>), and 71 vs 15% (<b>4</b> vs <b>8</b>) of the total Pt associated with the cell. In contrast, <b>5</b> and its Pt(IV) derivatives accumulated markedly more into the cytoskeleton fraction in comparison with <b>1</b> and its Pt(IV) derivatives, accounting for 76 vs 21% (<b>5</b> vs <b>1</b>), 76 vs 10% (<b>6</b> vs <b>2</b>), 76 vs 15% (<b>7</b> vs <b>3</b>), and 73 vs 7% (<b>8</b> vs <b>4</b>) of the total Pt associated with the cell. Thus, while <b>1</b> and its Pt(IV) derivatives were most abundant in the cell membrane fraction, <b>5</b> and its Pt(IV) derivatives accumulated with a marked preference into the cytoskeleton. These data, and particularly the fact that the most lipophilic compound (<b>8</b>) does not accumulate in the membrane, support the hypothesis that the hitherto unclear role of the 5,6-Me<sub>2</sub>phen ligand in the mechanisms of cytotoxicity of <b>5</b> and its Pt(IV) multiaction prodrugs consists in targeting these platinum complexes toward the cytoskeleton.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Impedance-Based Time-Dependent Cell Response Profiling</h3><div class="NLM_p">Given the above findings, we investigated the influence of <b>5</b> and its Pt(IV) derivatives on the cytoskeleton structure and function. First, we analyzed the cell growth profiles obtained by RTCA (real-time cell analyzer) and compared them with the profiles acquired for cells treated with cytoskeleton-modifying compounds. Impedance-based time-dependent cell response profiling has been used as the predictive method for the mechanism of biological action of bioactive compounds; compounds with similar biological activity often produce similar signature time-dependent cell response profiles (TCRPs) so that the TCRPs make it possible to recognize the MoA of the investigated agents.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> The TCRPs for MDA-MB-231 treated with <b>5</b> and its Pt(IV) derivatives (bottom row of panels in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) could be coclustered with those of another microtubule (MT)-modulating agents.<a onclick="showRef(event, 'ref37 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref39">(37,39)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Impedance-based time-dependent cell response profiling. The TCRPs of MDA-MB-231 cells treated with increasing concentrations of the investigated platinum complexes ranging from IC<sub>10</sub> to IC<sub>98</sub> (determined previously with MTT assay for the 72 h treatment). The trend of the concentrations growth was as follows: black (control) < orange < green < blue < purple < pink. Data were normalized to the time of the treatment and expressed as the normalized cell index.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Also of note is that the TCRPs for MDA-MB-231 treated with <b>5</b> and its Pt(IV) derivatives (bottom row of panels in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) were different from those for MDA-MB-231 treated with <b>1</b> and its Pt(IV) derivatives (upper row of panels in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>); the latter TCRPs were indicative of the compounds interfering with DNA synthesis or repair.<a onclick="showRef(event, 'ref37 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref39">(37,39)</a> Altogether, the TCRPs obtained for the investigated complexes based on <b>5</b> (bottom row in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) are consistent with the view and support the hypothesis that a possible MoA of these complexes involves alterations of the MT cytoskeleton. On the other hand, the results shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> also indicate that a small fraction of <b>5</b> and its Pt(IV) derivatives is also associated with the cell nucleus. This finding might indicate that the MoA of these complexes includes, in some extent, DNA damage by its modification by <b>5</b> and its Pt(IV) derivatives as well. The latter conclusion is supported by the results (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Table S1</a>) demonstrating that the treatment of MDA-MB-231 cells with the Pt(IV) derivatives of <b>5</b> resulted in DNA damage caused by its association with a platinum compound.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> The Role of DNA Modification and Reduction of Pt(IV) Complexes to Their Pt(II) Derivatives</h3><div class="NLM_p">A biological tool to establish whether DNA is the target of cytotoxic agents takes advantage of the fact that drugs exhibit higher toxicity in cells, which are deficient in DNA repair.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Mutant Chinese hamster ovary CHO-K1 cells MMC-2, carrying the ERCC3/XPB mutation, which are deficient in DNA nucleotide excision repair, were distinctly more sensitive to killing mainly by <b>1</b> and its Pt(IV) derivatives compared with the wild-type cells (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cytotoxicity Data [IC<sub>50</sub> Mean Values (Î¼M)] Obtained by MTT Test for Chinese Hamster Ovary CHO-K1 Cell Line (Wild Type) and Its Mutant Cell Line MMC-2 Deficient in DNA Repair<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">platinum complex</th><th class="colsep0 rowsep0" align="center" char="Â±">CHO-K1</th><th class="colsep0 rowsep0" align="center" char="Â±">MMC-2</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="Â±">19 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">1.9 Â± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="Â±">61 Â± 9</td><td class="colsep0 rowsep0" align="char" char="Â±">5.7 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="Â±">48 Â± 6</td><td class="colsep0 rowsep0" align="char" char="Â±">4.9 Â± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="Â±">12 Â± 2</td><td class="colsep0 rowsep0" align="char" char="Â±">1.1 Â± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">10.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="Â±">8 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">4.9 Â± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="Â±">11 Â± 2</td><td class="colsep0 rowsep0" align="char" char="Â±">8 Â± 1</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="Â±">11 Â± 2</td><td class="colsep0 rowsep0" align="char" char="Â±">7.1 Â± 0.9</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="Â±">9 Â± 1</td><td class="colsep0 rowsep0" align="char" char="Â±">6.1 Â± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The drug-treatment period was 72 h. The results are expressed as mean values Â± SD from three independent experiments each performed in triplicate.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last"><i>F</i> = factor defined as IC<sub>50</sub> (NER-efficient, CHO-K1)/IC<sub>50</sub> (NER-deficient, MMC-2).</p></div></div></div><div class="NLM_p">These results are consistent with the hypothesis that unrepaired DNA damage contributes to the cytotoxicity of <b>1</b> and its Pt(IV) derivatives. In contrast, we observed that there was a markedly lower difference in the sensitivity of mutant MMC-2 and wild-type CHO-K1 to killing by <b>5</b> and its Pt(IV) derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This result suggests that DNA damage by these compounds may play a less decisive role in the mechanism of their antiproliferative activity very likely due to their markedly lower accumulation in the cell nucleus in comparison with <b>1</b> and its Pt(IV) derivatives (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><div class="NLM_p">Designing multiaction antitumor platinum agents is based on the stability of the kinetically inert Pt(IV) prodrugs outside the cell and on their activation by reduction inside the cell, resulting in the simultaneous release of the active Pt(II) drug and axial bioactive moieties. Due to the very low intracellular concentrations of these cytotoxic prodrugs, there are no analytical or spectroscopic procedures that can directly monitor the oxidation state of the Pt inside cells. Therefore, a support for the view that Pt(IV) prodrugs, such as those investigated in our study, are activated by reduction inside the cell rests in on indirect evidence demonstrating that incubation in a cell-free medium of the kinetically inert Pt(IV) compounds based on <b>5</b> or <b>1</b> with isolated DNA did not result in its platination (shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S1</a>). In contrast, if these Pt(IV) compounds were incubated with DNA in the presence of a known reductant, such as ascorbic acid, then an extensive association of platinum with DNA was observed (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S1</a>). It implies that the Pt(IV) compounds based on both <b>5</b> and <b>1</b> can modify DNA only after their reduction or, in other words, that the reduction of the Pt(IV) compounds based on both <b>5</b> and <b>1</b> is a prerequisite for DNA modification. Next, we isolated DNA from MDA-MB-231 cells treated with the <b>5</b>-based Pt(IV) compounds and found that this DNA was modified by platinum (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Table S1</a>).</div><div class="NLM_p last">The importance of the reduction of Pt(IV) platinum compounds containing biologically active axial ligands also follows from the previously published results describing the MoA of closely related Pt(IV) prodrugs (for review, see a recently published work<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>) and those showing that Pt(IV) derivatives of <b>5</b> very similar to those investigated in the present study were stable in human serum for 40 h at 37 Â°C, attesting to their extracellular stability.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Also, importantly, the Pt(IV) derivatives of <b>5</b> containing HDAC inhibitors (valproate (VPA) or PhB) in the axial positions exhibited cellular downregulation of HDACs that was absent when there were innocent ligands in the axial positions. This attests to a cellular reduction of the Pt(IV) derivatives of <b>5</b> because a cell-free medium Pt(IV) prodrug containing VPA axial ligand(s) was unable to inhibit HDAC activity, whereas if this Pt(IV) prodrug was reduced by ascorbic acid, inhibition of HDAC activity was observed.<a onclick="showRef(event, 'ref17 ref42'); return false;" href="javascript:void(0);" class="ref ref17 ref42">(17,42)</a> Collectively, the only reasonable explanation of these observations is that the Pt(IV) compounds based on <b>5</b> and <b>1</b> investigated in the present study were intracellularly reduced to allow DNA damage by its modification by platinum, that is, one of the modes of action of these multimodal antitumor agents.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cell-Cycle Profiles of MDA-MB-231 Cells</h3><div class="NLM_p">To further investigate the hypothesis that a possible MoA of the investigated <b>5</b> and its Pt(IV) derivatives involves the disruption of the microtubule cytoskeleton, we investigated the cell-cycle profiles of MDA-MB-231 cells modified with the investigated platinum compounds. Several articles report that MT modification coincides with the induction of cell cycle G<sub>2</sub>/M arrest.<a onclick="showRef(event, 'ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46">(43â46)</a> Therefore, we investigated the cell-cycle profiles of MDA-MB-231 cells treated with the investigated platinum compounds. MDA-MB-231 cells were treated with the platinum compounds for 12, 24, and 48 h at the concentrations corresponding to their IC<sub>30</sub> values (found for these compounds in MDA-MB-231 cells treated for 72 h) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S2</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cell-cycle distribution of MDA-MB-231 cells after treatment with the investigated compounds at concentrations corresponding to IC<sub>30</sub> values (found for these compounds in MDA-MB-231 cells treated for 72 h) for 12, 24, and 48 h (first, second, and third column for each compound, respectively). Percentage of cells in (A) G<sub>2</sub>/M and (B) S phases. The data were acquired using ModFit software and represent the percentages as mean Â± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Longer treatment resulted in a significant reduction in the percentage of cells in the S phase (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B) and an increase in the percentage in the G<sub>2</sub>/M phase (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The number of cells in the G<sub>2</sub>/M region after 48 h of treatment increased significantly to 30 Â± 2% to 44 Â± 2%, in comparison with that of solvent-treated control (16 Â± 1%), indicating the disruption of the MT cytoskeleton in MDA-MB-231 cells by <b>5</b> and its Pt(IV) derivatives.</div><div class="NLM_p last">Subsequently, we examined, for comparative purposes, the cell-cycle profiles of MDA-MB-231 cells treated for 24 h with <b>1</b> and its Pt(IV) derivatives at their concentrations corresponding to their IC<sub>30</sub> values (found for these compounds in MDA-MB-231 cells treated for 72 h). In contrast to the cell-cycle profiles recorded for <b>5</b> and its Pt(IV) derivatives (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), the platinum compounds of the group <b>1</b>â<b>4</b> arrested cells mainly in the S phase (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S3</a>), similar to cisplatin,<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> and slightly in the G<sub>2</sub>/M phase as well. These results suggest that a mechanism of MDA-MB-231 cell death induced by complexes of the group <b>1</b>â<b>4</b> relies on DNA damage signaling consistent with the results of impedance-based time-dependent cell response profiling (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, top row) and cytotoxicity data obtained for the Chinese hamster ovary CHO-K1 cell line (wild type) and its mutant cell line MMC-2 deficient in DNA repair (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Conversely, these results also underscore the ability of complexes of <b>5</b> and its Pt(IV) derivatives to kill MDA-MB-231 cells by a fundamentally different mechanism.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> The Effect of Tubulin and Actin Inhibitors</h3><div class="NLM_p">The previous experiments suggested that <b>5</b> and its Pt(IV) derivatives can interfere with the components of the cytoskeleton. Among others, actin filaments and microtubules represent two major groups of cytoskeletal proteins. It has been reported previously<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> that simultaneous action of two agents results in superadditive or synergistic effects if the two drugs cooperate on the target(s) involved in the same process. Therefore, to find out which cytoskeleton component is targeted by <b>5</b> and its Pt(IV) derivatives, the antiproliferative effect of the simultaneous treatment of <b>5</b> with drugs affecting either actin (phalloidin and cytochalasin D) or tubulin (nocodazole and vinblastine) was examined. Phalloidin functions by stabilizing filamentous actin and inhibits its depolymerization, whereas cytochalasin D is an inhibitor of actin polymerization. Vinblastin and nocodazole inhibit the assembly of microtubules. The MDA-MB-231 cells were simultaneously treated with <b>5</b> and the particular inhibitor in their equimolar (1:1) or equitoxic (corresponding to the respective IC<sub>50</sub> values) concentrations. The antiproliferative effect was then evaluated by the MTT method. The combination index (CI) method developed by Chou and Talalay<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> was used to confirm and quantify the synergism observed for the co-treatment. CI < 1 is indicative of synergy, CI > 1 indicates antagonism, and a CI of â¼1 (0.9â1.1) is considered an additive response to the combination of drugs. The CI values for the activity of <b>5</b> and actin or tubulin affecting drug combinations were calculated using CompuSyn software (Combo Syn, Inc., USA), and these are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. At least six entries of doseâeffect relationships were employed for each drug combination.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Combination Index (CI) Values of Antiproliferative Activity after 72 h Treatment of MDA-MB-231 Cells with <b>5</b> and Actin/Tubulin Affecting Drug Combinations<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">inhibitor</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vinblastine</td><td class="colsep0 rowsep0" align="char" char=".">0.775 (1:1)</td><td class="colsep0 rowsep0" align="char" char=".">0.809 (100:1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nocodazole</td><td class="colsep0 rowsep0" align="char" char=".">0.510 (1:1)</td><td class="colsep0 rowsep0" align="char" char=".">0.662 (2:1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phalloidin</td><td class="colsep0 rowsep0" align="char" char=".">1.146 (1:1)</td><td class="colsep0 rowsep0" align="char" char=".">0.984 (1:10)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytochalasin D</td><td class="colsep0 rowsep0" align="char" char=".">0.979 (1:1)</td><td class="colsep0 rowsep0" align="char" char=".">1.035 (1:2)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The ratio (<b>5</b>:drug) is shown in brackets.</p></div></div></div><div class="NLM_p last">As indicated, <b>5</b> and tubulin inhibitors vinblastine and nocodazole were synergistic in MDA-MB-231 cells, with CI values ranging from 0.51 to 0.81. The CI somewhat increased for vinblastine as compared with the nocodazole but was still within the mathematical index of synergy. In contrast, the combination of actin targeting inhibitors phalloidin or cytochalasin D with <b>5</b> yielded CI values around 1, which is considered as an additive effect. Thus, the data implies that tubulin rather than actin is likely affected by <b>5</b> and its Pt(IV) derivatives. Therefore, in the next experiments, the effects of <b>5</b> and its Pt(IV) derivatives on tubulin were investigated in further detail.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Organization of the Structural Network within the Cytoplasm of MDA-MB-231 Cells</h3><div class="NLM_p last">As platinum from <b>5</b> and its Pt(IV) derivatives preferentially accumulated in the cytoskeleton fraction of MDA-MB-231 cells, we next sought to gain more insight into the influence that <b>5</b> and its Pt(IV) derivatives may exert on the organization of the structural network (cytoskeleton) within the cellâs cytoplasm. To do so, we treated the MDA-MB-231 cells with <b>5</b> and its Pt(IV) derivatives, stained with monoclonal antibodies directed against Î±-tubulin, and visualized by confocal microscopy (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S4</a>). In nontreated cells, MTs extended continuously through the cytoplasm and formed an extensive intracellular network. The treatment with <b>5</b> and its investigated Pt(IV) derivatives at the concentrations corresponding to the IC<sub>50</sub> values (72 h; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) for 16 h induced changes in the architecture of MT networks through retraction to the perinuclear region when compared with untreated cells. This specific distribution of irregular MT fragments in MDA-MB-231 cells is consistent with the observation that <b>5</b> and its Pt(IV) derivatives cause cell cycle G<sub>2</sub>/M arrest as previously demonstrated for other agents capable of disturbing tubulin assembly.<a onclick="showRef(event, 'ref44 ref53'); return false;" href="javascript:void(0);" class="ref ref44 ref53">(44,53)</a> Thus, the capability of <b>5</b> and its Pt(IV) derivatives to induce changes in the architecture of cytoskeleton networks presents new insights into their MoA. In this connection, it is relevant to mention that there is a class of anticancer drugs that alter MT dynamics, that is, MT stabilizers and depolymerizers, which bind to established tubulin-binding sites.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> However, it is difficult to ascribe the effects of <b>5</b> and its Pt(IV) derivatives to their ability to affect the MT dynamics since the MDA-MB-231 cells treated with <b>5</b> and its Pt(IV) derivatives showed no appreciable change in the MT size (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S4</a>). Moreover, drugs affecting MT dynamics are supposed to change the kinetics of MT polymerization and the polymerized steady-state level. Therefore, we investigated MT polymerization kinetics in a cell-free medium by turbidity measurements.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Tubulin Polymerization and Depolymerization Assay</h3><div class="NLM_p">Compounds that interact with tubulin often alter its polymerization by enhancing the growth of microtubules (such as paclitaxel)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> or by destabilizing and depolymerizing microtubules (such as nocodazole).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> To elucidate the effect of <b>5</b> and its Pt(IV) derivatives on tubulin polymerization in vitro (in cell-free media), the HTS-Tubulin Polymerization Assay Biochem Kit was employed. The assay is based on the fact that light is scattered by microtubules to the extent that is proportional to the concentration of microtubule polymer.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> Thus, the polymerization of porcine tubulin in the presence or absence of the Pt compounds was followed by turbidimetry as an increase in absorbance at 340 nm at 37 Â°C. The control assembly curve (tubulin in the absence of <b>5</b> or <b>8</b>) displayed typical patterns of microtubule polymerization (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A and B, solid curves) with a flat plateau in the last phase of polymerization, indicating the steady-state equilibrium of polymerization and depolymerization reactions. In the presence of <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, dashed and dotted curves) or <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, dashed and dotted curves), the slopes of the assembly curves dropped down, indicating a decrease in polymerization rate. Importantly, in a later reaction interval, the plateau was no longer stable, and the light was scattered to the extent higher than that for the control, thus indicating aggregation or bundling.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A, B) Tubulin assembly curves. Polymerization was followed in the absence (solid lines) or the presence of (A) 30 or 60 Î¼M concentration of <b>5</b> (dashed and dotted lines, respectively) and (B) 30 or 60 Î¼M concentration of <b>8</b> (dashed and dotted lines, respectively). (C) Microtubule disassembly induced by the decrease in temperature (0.5 Â°C/min) in the presence of 20, 40, and 80 Î¼M concentration of <b>5</b> (dashed, dash-dotted, and dotted lines, respectively). The absorbance at 37 Â°C (<i>t</i> = 0) was assessed as 1. (D) Whole cell analysis of microtubule by flow cytometry. MDA-MB-231 cells were treated with indicated concentrations of <b>5</b> (light gray) and <b>8</b> (dark gray) for 3 h. The cells were stained with anti-Î±-tubulin-FITC antibody. The value of fluorescence of untreated control was taken as 100%. The data represent a mean of three independent experiments. (*) indicates <i>P</i> < 0.05; (***) indicates <i>P</i> < 0.001 based on a two-tailed Studentâs <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The effect of <b>5</b> and its Pt(IV) derivatives on depolymerization was also assessed by turbidimetric measurement. The porcine brain tubulin was allowed to polymerize in the presence or absence of <b>5</b> and its Pt(IV) derivatives at 37 Â°C for 80 min. After that period, the temperature was regulated to slowly decrease (0.5 Â°C/min), and scattered light was measured at 340 nm. If microtubules are cooled, then they depolymerize into stable Î±Î²-tubulin dimers accompanied by a decrease in light scattering (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C, solid line). However, the microtubules formed in the presence of <b>5</b> and its Pt(IV) derivatives disassembled more slowly than the control, unaffected microtubules (shown for <b>5</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C, dashed, dash-dotted, and dotted lines). Thus, <b>5</b> and its Pt(IV) derivatives also interfered with tubulin depolymerization, thus affecting microtubule assembly/disassembly dynamics.</div><div class="NLM_p last">Interestingly, the results of the experiments performed in a cell-free medium (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) show that there was no substantial difference in the capability of platinum(II) complex <b>5</b> and its Pt(IV) derivative <b>8</b> to induce changes in the organization of tubulin cytoskeleton networks. Thus, this result is consistent with the view and supports the hypothesis that the reduction of the Pt(IV) derivatives of <b>5</b> does not have to take place to observe their effect on the MT dynamics.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Whole Cell Analysis of Microtubule by Flow Cytometry</h3><div class="NLM_p">The experiments performed using whole cell methods make it possible to examine the mechanism of action of the investigated compounds under conditions closer to the situation in vivo in comparison with the experiments performed in cell-free media. The experiments aimed at microtubule stabilization or destabilization in cells affected by the investigated agents can be performed by means of confocal microscopy<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> or flow cytometry<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> along with a fluorescently labeled antibody to Î±-tubulin. Thus, the flow cytometry-based technique was also used for the analysis of tubulin polymerization in the presence of <b>5</b> and its Pt(IV) derivatives. Flow cytometry can be used to quantitatively determine the polymerized tubulin, which makes it possible to easily detect compounds that affect tubulin polymerization.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Briefly, MDA-MB-231 cells were incubated with compounds for 3 h at the concentrations of 20, 40, or 80 Î¼M, tubulin monomers were washed out of the cells using a mild lysis buffer, and the microtubule network in cells was stabilized by treatment with glutaraldehyde. After quenching glutaraldehyde, samples were exposed to an FITC-labeled tubulin antibody and analyzed. Under this experimental approach, it is expected that compounds effective in the destabilization of tubulin polymerization decrease fluorescence compared to the control; in contrast, compounds that stabilize microtubules increase fluorescence, reflecting the change in the amount of tubulin in the polymerized microtubules.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><div class="NLM_p last">The treatment of MDA-MB-231 cells with <b>5</b> or <b>8</b> resulted in a significant dose-dependent increase in fluorescence, indicating an accrual of tubulin mass in the treated cells compared to untreated control cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D). The data plausibly correspond with the findings mentioned above in cell-free media and support the view that <b>5</b> and its Pt(IV) derivatives can act through the disruption of the tubulin/microtubule dynamics.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Atomic Force Microscopy</h3><div class="NLM_p">Atomic force microscopy (AFM) has been previously used to visualize the effect of small molecules on microtubule morphology. We, therefore, employed this method to reveal how <b>5</b> and its Pt(IV) derivatives can impact the shape and structure of polymeric microtubules. Porcine brain tubulin was polymerized in the absence or the presence of <b>5</b> or <b>8</b>, fixed on mica, and analyzed by AFM.</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, long narrow microtubules were yielded by tubulin polymerization in the absence of the platinum agents (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect on microtubule morphology. Tubulin purified from porcine brain (4 mg mL<sup>â1</sup>) was polymerized (A) without or (B) with 80 Î¼M <b>5</b> or (C) <b>8</b>. After 90 min polymerization, aliquots were withdrawn, fixed with glutaraldehyde solution, and diluted 40-fold. Four microliters of the sample was transferred onto mica, dried, and analyzed with AFM. The scale bars represent 1 Î¼m.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The presence of either <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B) or <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C) in the polymerization reaction influences the appearance of the final product. Nonfibrillar condensed structures such as bundles, knots, or coils were formed if the polymerization occurred in the presence of the tested compounds. Thus, it appears that <b>5</b> and its Pt(IV) derivatives do not stop the polymerization or disintegrate the arising microtubules but induce the structural changes of the final polymeric product. The bundling and/or aggregation could be responsible for slower depolymerization of microtubules as detected in both cell-free media and living cells (vide supra).</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Analysis of Mitochondrial Membrane Potential</h3><div class="NLM_p last">Treatment of cancer cells with numerous antitumor metallodrugs cause mitochondrial transmembrane potential disruption and activates the mitochondrial apoptotic pathway.<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63â65)</a> The previous investigation of the MoA of the Pt(IV) derivatives of <b>5</b> containing some nonbioactive, lipophilic, and bioactive axial ligands<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> showed that some of these compounds effectively induced the hypopolarization of the mitochondrial membrane of 2008 ovarian tumor cells. However, the role of the 5,6-Me<sub>2</sub>phen ligand in the mechanisms of the hypopolarization of the mitochondrial membrane remained elusive. It was, therefore, logical to evaluate the activities of the investigated platinum compounds at the mitochondrial level in MDA-MB-231 cells as well. We used the assay based on TMRE staining similarly as described in our previous articles.<a onclick="showRef(event, 'ref21 ref38 ref67'); return false;" href="javascript:void(0);" class="ref ref21 ref38 ref67">(21,38,67)</a> We found (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S5A</a>) that the hypopolarization of the mitochondrial membrane induced by the Pt(II) compounds <b>1</b> (16%) and <b>5</b> (11%) was similar. The derivatization of both <b>1</b> and <b>5</b> with the bioactive PhB and OA axial ligands resulted in a substantial reduction of the mitochondrial membrane potential, and this reduction induced by <b>5</b> and its Pt(IV) derivatives was similar or only slightly lower than that of the corresponding <b>1</b>-based compounds (the loss of the mitochondrial membrane potential of 21â35% or 24â37% was observed for the Pt(IV) derivatives of <b>5</b> or Pt(IV) derivatives of <b>1</b>, respectively). In addition, the extent of the alterations in the hypopolarization of the mitochondrial membrane induced by the investigated compounds in both series of platinum compounds (<b>1</b>â<b>4</b> and <b>5</b>â<b>8</b>) was mainly affected by the axial ligands. These results indicate that the mechanisms connected with the hypopolarization of the mitochondrial membrane of MDA-MB-231 cells by the Pt(IV) derivatives of <b>1</b> and <b>5</b> are mainly caused by the bioactive axial ligands (PhB, OA).</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Involvement of Epigenetic Processes</h3><div class="NLM_p">It was shown<a onclick="showRef(event, 'ref17 ref18 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref21">(17,18,21)</a> that, in the case of the Pt(IV) derivatives of cisplatin and <b>1</b>, having bioactive valproic acid, PhB, or OA axial ligands, their enhanced cytotoxicity is a consequence of several processes, which also involve other epigenetic processes. These processes consisted of the downregulation of HDACs (PhB)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> or global hypermethylation of DNA (OA).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Given that the Pt(IV) derivatives of <b>5</b> and <b>1</b> investigated in this work also had bioactive PhB and/or OA axial ligands, it was of interest to investigate whether <b>1</b> or <b>5</b> affect the inhibition of HDACs or DNA methylation.</div><div class="NLM_p">We found that the activity of HDACs in MDA-MB-231 was inhibited by <b>1</b> and <b>5</b> only very slightly; the â¼11% inhibition was observed for the inhibition by <b>1</b> and â¼5% by <b>5</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S5B</a>). A substantial decrease in the activity of HDACs was only observed upon treatment of the cells with Pt(IV) derivatives containing the PhB axial ligand (22% by <b>2</b> and 28% by <b>4</b>; 17% by <b>6</b> and 23% by <b>8</b>). The treatment of the cells with Pt(IV) derivatives of <b>1</b> or <b>5</b> containing only OA axial ligands resulted in a markedly lower inhibition of the activity of HDACs (16% by <b>3</b> or 10% by <b>7</b>). Hence, inhibition of the activity of HDACs in MDA-MB-231 cells by the investigated platinum complexes depends on the presence of the PhB axial ligand; <b>5</b>-based platinum complexes have diminished HDAC inhibitory activity.</div><div class="NLM_p">Another well-known epigenetic mechanism involved in the cytotoxic effects of Pt(IV) prodrugs is connected with DNA methylation,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> a mechanism that inactivates tumor suppressor genes by methylating their promoters.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The results of our very recent study<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> demonstrated that the markedly enhanced toxic effects of the Pt(IV) derivatives of cisplatin-containing axial OA ligands were also connected with significant global hypermethylation of DNA. Therefore, we went on to characterize the ability of the platinum compounds to modulate the level of DNA methylation in MDA-MB-231 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S5C</a>). Only a threshold change in DNA methylation was observed for the compounds lacking the OA ligand (<b>1</b>, <b>2</b>, <b>5</b>, and <b>6</b>). In contrast, the Pt(IV) derivatives of both <b>1</b> and <b>5</b> containing OA axial ligands induced considerable global DNA hypermethylation (enhancement of DNA methylation of 48â60% was observed for <b>3</b> and <b>4</b> and 20â24% for <b>7</b> and <b>8</b>; <a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S5C</a>). Thus, similar to the case of HDAC inhibition, DNA hypermethylation in MDA-MB-231 cells by the platinum complexes depends on the presence of an OA axial ligand; the platinum complexes based on <b>5</b> apparently do not affect DNA methylation.</div><div class="NLM_p">Collectively, triggering the epigenetic mechanisms in MDA-MB-231 cells, such as inhibition of HDAC activity or DNA hypermethylation, by the investigated platinum complexes was observed only in the case when the Pt(IV) complexes contained PhB or OA axial ligands, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S5B,C</a>). Moreover, the presence of the 5,6-Me<sub>2</sub>phen ligand in the investigated platinum complexes did not contribute to the hypopolarization of the mitochondrial membrane of MDA-MB-231 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">Figure S5A</a>). We reasoned that the role of the 5,6-Me<sub>2</sub>phen ligand in <b>5</b> and its Pt(IV) derivatives in both the hypopolarization of the mitochondrial membrane in the MDA-MB-231 cells and the epigenetic processes, which were shown to potentiate the cytotoxicity of the Pt(IV) prodrugs hitherto examined, was marginal.</div><div class="NLM_p last">It is also especially noteworthy that MDA-MB-231 cancer cells harbor inactivating KRAS mutation that can be an important factor responsible for the resistance of these cancer cells to drugs usually used to treat breast cancer cells.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The RAS gene that KRAS belongs to is the most common oncogene in human cancer; mutations of KRAS are permanently activated by aberrant Ras proteins so that Ras inhibitors, in general, are being studied as a treatment of diseases involving Ras overexpression.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Interestingly, several studies also support a role for MTs in Ras function so that the MT network disrupting agents are efficient inhibitors of processes involving RAS overexpression, such as mitotic progression, cell proliferation, and migration.<a onclick="showRef(event, 'ref71 ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref73 ref74">(71â74)</a> On the basis of the results presented in this report and by analogy with the conclusions of the studies mentioned above in this paragraph, we suggest that the ability of <b>5</b>-based compounds to change the organization of cytoskeleton networks in MDA-MB-231 cells is associated with their capacity to inhibit effects caused by Ras overexpression.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In conclusion, the results of this study demonstrate the exceptionally high potency of <b>5</b> and its Pt(IV) derivatives, in particular, in an aggressive form of breast cancer with limited treatment options, the triple-negative MDA-MB-231 cells, which are known to be highly resistant to clinically used cisplatin (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We suggest, based on the present findings, that significant components of the multimodal MoA of the substitution-inert antitumor platinum compounds based on <b>5</b> in MDA-MB-231 cells are associated with their capability to modify nuclear DNA, reduce the mitochondrial membrane potential, induce the epigenetic processes, and also change the architecture of cytoskeleton networks; the latter mechanism has not been described for other antitumor platinum compounds including those used in the clinic. In other words, changes in the organization of cytoskeleton networks is a new mechanism, which asserts itself in the antitumor effects of platinum anticancer drugs and might play an important role in conveying the preferential and high susceptibility of some cancer cells to the platinum drugs based on <b>5</b>.</div><div class="NLM_p">Notably, the results of this study (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) also show that <b>5</b> and its investigated Pt(IV) derivatives do not encourage microtubule formation but block depolymerization due to the aggregation of already formed microtubules. Thus, <b>5</b> and its Pt(IV) derivatives act by the different mechanism than most of so far described antimicrotubule agents. These agents either inhibit polymerization (e.g., the vinca alkaloids) or prevent depolymerization (disassembly; most commonly used agents in this subclass are paclitaxel, docetaxel, or derivatives of taxol). They act in both cases by binding to their specific binding sites in microtubules and do not induce their aggregation as the platinum compounds based on <b>5</b> discovered in our study do. An advantage of the Pt(IV) derivatives of <b>5</b> as tubulin interference agents is that they can include targeting agents, can be modified for encapsulation into delivery vehicles, and can be administered orally and combined with other drugs. Taken together, although previous studies have identified differences in the cellular response between cisplatin, <b>1</b>, and their DNA binding antitumor derivatives, our report is the first to identify the causal links between drugs based on <b>5</b>, changes in the architecture of cytoskeleton networks, and cell death. Thus, we conclude, based on the present results, that changes in the architecture of cytoskeleton networks are functionally important for substitution-inert platinum antitumor drugs based on <b>5</b>, in contrast to clinically used conventional platinum cytostatics, to kill cancer cells. Additionally, this finding represents a promise of the development of new metal-based anticancer drugs that would be active in a spectrum of human tumors different from that attainable by the platinum drugs investigated in the clinical and preclinical research.</div><div class="NLM_p last">It is generally accepted that microtubules (composed of tubulin) are extremely important in the process of mitosis, during which the duplicated chromosomes of a cell are separated into two identical sets before cleavage of the cell into two daughter cells. Their importance in mitosis and cell division makes microtubules (and hence tubulin) an important target for anticancer drugs so that the systematic development of a chemotype for tubulin interference is urgently needed.<a onclick="showRef(event, 'ref75 ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77 ref78">(75â78)</a> Hence, the findings presented in this study may have important implications for the assessment of metal-based low-molecular-mass compounds in the clinic.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Starting Materials and Reagents</h3><div class="NLM_p last">Commercial reagents and solvents were used as received without further purification. Reaction mixtures and purified products were analyzed by HPLC on a Thermo Scientific UltimaMate 3000 station, equipped with a reversed-phase C18 column (Phenomenex Kinetex 250 Ã 4.6 mm, 5 Î¼m, 100 Ã). UV detection was set at 220 and 260 nm. The samples of <b>5</b> and its Pt(IV) derivatives were eluted with a 0â90% linear gradient of acetonitrile in water with 0.1% trifluoroacetic acid (TFA) over 20 or 30 min, as indicated in the text. Reaction mixtures were separated on a Thermo Scientific UltimaMate 3000 station, equipped with a reversed-phase C18 column (Phenomenex Luna 250 Ã 21.2 mm, 10 Î¼m, 100 Ã). UV detection was set at 220 nm. <b>5</b> and its Pt(IV) derivatives were eluted with a 0â90% linear gradient of acetonitrile in water or with 0.1% trifluoroacetic acid (TFA) over 30 min. The derivatives of <b>1</b> were chromatographed without the 0.1% TFA. All NMR data were collected on a Bruker AVANCE IIITM HD 500 MHz spectrometer using a 500 MHz SmartProbe. <sup>195</sup>Pt NMR data were collected at 107.47 MHz using sw = 217391.3 Hz, aq = 0.002 s, and rd = 0.001 s. The data were processed using MestreNova with a 300 Hz line broadening and backward linear prediction. <sup>1</sup>H spectra were recorded with standard parameters and referenced to internal standard TSP when recorded in D<sub>2</sub>O or residual solvent peak when recorded in DMSO-<i>d</i><sub>6</sub>. <sup>13</sup>C spectra were not recorded since all the complexes are composed of commercial ligands that are merely coordinated to the Pt center by donation of two electrons to an empty orbital of the metal. No carbonâcarbon bonds were broken or formed, and the <sup>13</sup>C spectra of the complexes are practically identical to those of the commercially available ligands; therefore, no new information is provided by these spectra. The best characterization of these complexes is the combination of <sup>195</sup>Pt NMR that verifies bis-carboxylation of the Pt(IV) combined with the <sup>1</sup>H NMR that confirms the ratios between the ligands. This in combination with the HPLC retention times and ESI-MS (when possible) are the best way to characterize the Pt complexes. All the compounds that were used for biological studies were purified by preparative HPLC and then analyzed by analytical HPLC and elemental analysis; their purity was >95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> [Pt(DACH)(OH)<sub>2</sub>(ox)] (<b>1a</b>)</h4><div class="NLM_p last">This complex was prepared as previously described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Briefly, 1 g (2.51 mmol) of <b>1</b> was suspended in 30% H<sub>2</sub>O<sub>2</sub> (10 mL) for 12 h, after which the suspension turned into a clear yellow solution. The solvent was evaporated in vacuo, producing a pale yellow product. Yield: 1.02 g (94%). <sup>195</sup>Pt NMR(H<sub>2</sub>O): +1350 ppm.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> [Pt(DACH)(PhB)(OH)(ox)] (<b>2a</b>)</h4><div class="NLM_p last">A mixture of 393 mg (0.91 mmol) of compound <b>1a</b> and 312.4 mg (1 mmol) of PhB anhydride was dissolved in 20 mL of DMSO. After 12 h, the cloudy solution turned into a clear dark yellow solution. The mother liquor was treated with diethylether (DEE), affording a two-phase system. The DEE phase was removed after centrifugation. This procedure was repeated several times until a sticky yellow solid was obtained. Then, it was dissolved in methanol and precipitated from DEE as an off-white powder. Yield: 249 mg (47%). <sup>195</sup>Pt NMR (DMSO): +1407 ppm.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> [Pt(DACH)(PhB)(OAc)(ox)] (<b>2</b>)</h4><div class="NLM_p last">One hundred milligrams (0.17 mmol) of <b>2a</b> was dissolved in 5 mL of DMF. One milliliter of acetic anhydride was then added (9.8 mmol, in excess). The reaction was stirred overnight. DMF was removed in vacuo. The oily product was dissolved in methanol and precipitated from cold ether. The crude product was purified by preparative HPLC (0â90% linear acetonitrile gradient over 30 min, retention time = 19.30 min). The collected fraction (in H<sub>2</sub>O/ACN) was evaporated, resuspended in water, and lyophilized to give a white product. Yield: 63 mg (60%). <sup>195</sup>Pt NMR (DMSO): +1585 ppm. <sup>1</sup>H NMR Î´ 7.27 (m, 2H<sub>PhB</sub>), 7.17 (m, 3H<sub>PhB</sub>), 3.6 (w, 2H<sub>DACH</sub>), 2.51 (t, 2H<sub>PhB</sub>), 2.26 (t, 2H<sub>PhB</sub>), 2.15 (d, 2H<sub>DACH</sub>), 1.96 (s, 3H<sub>ac</sub>), 1.76 (p, 2H<sub>PhB</sub>), 1.51 (d, 2H<sub>DACH</sub>), 1.42 (w, 2H<sub>DACH</sub>), 1.15 (t, 2H<sub>DACH</sub>). Anal. calcd for C<sub>20</sub>H<sub>28</sub>N<sub>2</sub>O<sub>8</sub>Pt: C, 38.77; H, 4.56; N, 4.42; found: C, 38.55; H, 4.69; N, 4.41.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> [Pt(DACH)(oct)(OAc)(ox)] (<b>3</b>)</h4><div class="NLM_p last">Two hundred forty milligrams (0.507 mmol) of oxaliplatin(OAc)(OH) (<b>1b</b>) (prepared as described in ref <a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a>) was dissolved in 20 mL of DMF. Five hundred fifty milligrams (4 equiv in excess) of octanoic anhydride was then added. The reaction was stirred overnight at room temperature. The reaction mixture was monitored by <sup>195</sup>Pt NMR. When the reaction was complete, DMF was evaporated in vacuo, yielding an oily product. The product was suspended in ether and stirred overnight then centrifuged and dried under air. The product was dissolved in methanol and purified by semipreparative HPLC (0â90% linear acetonitrile gradient over 30 min, retention time = 21.4 min). The collected fraction was evaporated using a vacuum then resuspended in water and lyophilized, affording a white powder. Yield: 220 mg (72.4%). <sup>195</sup>Pt NMR (DMF): single peak at +1597 ppm. <sup>1</sup>H NMR (500 MHz, MeOD) Î´ 2.76 (m, 2H<sub>DACH</sub>), 2.34 (m, 2H<sub>Oct</sub>), 2.27 (br, 2H<sub>DACH</sub>), 2.05 (s, 3H<sub>OAc</sub>), 1.68 (d, 2H<sub>DACH</sub>), 1.54 (br, 2H<sub>DACH</sub>, 2H<sub>Oct</sub>), 1.28 (br, 2H<sub>DACH</sub>, 8H<sub>Oct</sub>), 0.89 (t, 3H<sub>Oct</sub>). Anal. calcd for C<sub>18</sub>H<sub>32</sub>N<sub>2</sub>O<sub>8</sub>Pt: C, 36.06; H, 5.38; N, 4.67; found: C, 35.99; H, 5.29; N, 4.42.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> [Pt(DACH)(PhB)(oct)(ox)] (<b>4</b>)</h4><div class="NLM_p last">One hundred milligrams (0.17mmole) of <b>2a</b> was dissolved in 5 mL of DMF. Octanoic anhydride (190 mg, 4 equiv, 0.69 mmol) was then added. The reaction was stirred for 24 h. DMF was removed in vacuo. The oily product was stirred overnight in DEE, centrifuged, and dried under air. The crude product was purified by semipreparative HPLC (0â100% linear acetonitrile gradient over 15 min, followed by 10 min of acetonitrile plateau; retention time = 17.03 min). The collected fraction (in H<sub>2</sub>O/ACN) was evaporated, resuspended in water, and lyophilized to give a white product. Yield: 37 mg (31%). <sup>195</sup>Pt NMR (DMSO): +1587 ppm. <sup>1</sup>H NMR Î´ 7.29 (m, 2H<sub>PhB</sub>), 7.17 (m, 3H<sub>PhB</sub>), 3.6 (w, 2H<sub>DACH</sub>), 2.51 (t, 2H<sub>PhB</sub>), 2.50 (m, 4H<sub>oct</sub>), 2.26 (t, 2H<sub>PhB</sub>), 2.15 (d, 2H<sub>DACH</sub>), 1.86 (m, 6H<sub>oct</sub>),1.79 (p, 2H<sub>PhB</sub>), 1.51 (d, 2H<sub>DACH</sub>), 1.50 (b, 2H<sub>oct</sub>), 1.42 (w,2H<sub>DACH</sub>), 1.21 (t, 2H<sub>DACH</sub>), 0.88 (t,3H<sub>oct</sub>). Anal. calcd for C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>8</sub>Pt: C, 44.38; H, 5.73; N, 3.98; found: C, 44.25; H, 5.69; N, 4.01.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> [Pt(1<i>S</i>,2<i>S</i>-Diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)]<sup>2+</sup> (<b>5</b>)</h4><div class="NLM_p last"><b>5</b> was synthesized according to a method described in the literature.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Acetic anhydride was purchased and used as received. The other anhydrides were synthesized from their respective acids.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> cct-[Pt(1<i>S</i>,2<i>S</i>-DACH)(5,6-dimethyl-1,10-phenanthroline)(OH)<sub>2</sub>] (<b>5a</b>), <b>6</b>, and <b>7</b> were prepared as previously described.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> cct-[Pt(1<i>S</i>,2<i>S</i>-DACH)(5,6-Dimethyl-1,10-phenanthroline)(PhB)(oct)] (<b>8</b>)</h4><div class="NLM_p last"><b>5a</b> was stirred in DMSO to obtain a final concentration of ca. 15 mg of Pt complex per milliliter of DMSO. Octanoic anhydride (1.2 equiv) was added, and the mixture was stirred at room temperature (RT) in the dark. After one night, the initial yellow suspension turned to a yellow solution. Phenylbutyric anhydride (4 equiv) was added, and the reaction mixture was stirred in the dark at RT for another night. When the second carboxylation was complete, the mixture turned to a brown solution that was filtered. The filtrate was diluted with a volume of ethyl acetate, and diethyl ether was added until a two-phase system was obtained. The two phases were separated by centrifugation, and the upper ether phase was removed. Fresh ether was added to the dark bottom phase, stirred, and then allowed to yield a two-phase system; the mixture was centrifuged, and the upper phase was removed. This procedure was repeated until a dark sticky solid was obtained. It was dissolved in methanol, purified on preparative HPLC (5â65% linear acetonitrile gradient over 20 min, retention time = 17.053 min), and lyophilized, obtaining its trifluoroacetate salt. <sup>1</sup>H NMR (D<sub>2</sub>O) Î´: 9.44 (d, 2H, H2<sub>PHEN</sub>), 9.24 (dd, 2H, H4<sub>PHEN</sub>), 8.33 (m, 2H, H3<sub>PHEN</sub>), 7.15 (t, 2H, Hmeta<sub>PhBu</sub>), 7.14 (t, 2H, Hpara<sub>PhBu</sub>), 6.50 (d, 2H, Hortho<sub>PhBu</sub>), 3.23 (m, 2H, HÎ±DACH), 2.75 (s, 6H, CH<sub>3PHEN</sub>), 2.47 (m, 2H, HÎ²<sub>DACH</sub>), 2.15 (t, 2H, HÎ±<sub>PhBu</sub>), 2.08 (t, 2H, CÎ±H<sub>3Oct</sub>), 1.77 (m, 2H, HÎ²<sub>DACH</sub>), 1.73 (m, 2H, HÎ³<sub>DACH</sub>), 1.46 (t, 2H, HÎ³<sub>PhBu</sub>), 1.34 (m, 2H, HÎ³<sub>DACH</sub>), 1.26 (t, 2H, HÎ²<sub>PhBu</sub>), 0.97 (q, 2H, CÎ²H<sub>3Oct</sub>), 0.88 (q, 2H, CÎ¶H<sub>2Oct</sub>), 0.72 (t, 3H, CÎ·H<sub>3Oct</sub>), 0.61â0.45 (m, 4H, CÎ´H<sub>2Oct</sub> and CÎµH<sub>2Oct</sub>), 0.12 (b, 2H, CÎ³H<sub>3Oct</sub>). <sup>195</sup>Pt NMR (D<sub>2</sub>O) Î´: 694 ppm. ESI-MS: calculated for [MâH]<sup>+</sup> (M<sup>++</sup> = C<sub>38</sub>H<sub>51</sub>N<sub>4</sub>O<sub>4</sub>Pt): <i>m</i>/<i>z</i> = 822.36; experimental: <i>m</i>/<i>z</i> = 822.05. Anal. calcd for: C, 47.11; H, 4.55; N, 5.49: found: C, 46.82; H, 4.73; N, 5.28.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Cell Lines</h3><div class="NLM_p last">The human cervical carcinoma HeLa cells, human colorectal carcinoma cells HCT-116, human ovarian carcinoma A2780 cells, and human breast cancer MCF-7 cells were kindly supplied by Professor B. Keppler, University of Vienna (Austria). Highly invasive breast carcinoma MDA-MB-231 cells and human MRC-5 pd30 cells derived from normal lung tissue were purchased from the European Collection of Authenticated Cell Cultures (ECACC) (Salisbury, UK). Chinese hamster ovary CHO-K1 cell line (wild type) and its derivative MMC-2 carrying the ERCC3/XPB mutation (NER-deficient) cell line were kindly supplied by Dr. M. Pirsel, Cancer Research Institute, Slovak Academy of Sciences, Bratislava (Slovakia). The A2780 cells were grown in RPMI 1640 medium (Biosera, Boussens, France) supplemented with gentamycin (50 Î¼g mL<sup>â1</sup>, Serva, Heidelberg, Germany) and 10% heat-inactivated fetal bovine serum (PAA, Pasching, Austria). The HeLa, MCF-7, HCT-116, CHO-K1, and MMC-2 cells were grown in DMEM medium (high glucose, 4.5 g L<sup>â1</sup>, PAA) supplemented with gentamycin (50 Î¼g mL<sup>â1</sup>, Serva) and 10% heat-inactivated fetal bovine serum (PAA). The MDA-MB-231 and MRC-5 pd30 cells were grown in DMEM medium (high glucose, 4.5 g L<sup>â1</sup>, PAA) supplemented with gentamycin (50 Î¼g mL<sup>â1</sup>, Serva), 10% heat-inactivated fetal bovine serum (PAA), and 1% nonessential amino acids (Sigma-Aldrich, Prague, Czech Republic). The cells were cultured in a humidified incubator at 37 Â°C in a 5% CO<sub>2</sub> atmosphere and subcultured two to three times a week with an appropriate plating density.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Antiproliferative Activity</h3><div class="NLM_p last">Antiproliferative activities of the investigated complexes were evaluated by using a system based on the tetrazolium compound MTT from Calbiochem (Darmstadt, Germany). Stock solutions of <b>1</b> and <b>5</b> were prepared by dissolving the investigated platinum compounds in ultrapure water (Milli-Q, Merck Millipore) to a final concentration of 5 mM. Stock solutions of the other complexes were prepared by dissolving the compounds in DMF to a final concentration of 10 mM. To avoid DMF toxicity, the final DMF concentration in cell culture medium did not exceed 0.5% (v/v). The cells were seeded in 96-well tissue culture plates at a density of 1 Ã 10<sup>4</sup> A2780, MRC-5 cells/well, 8 Ã 10<sup>3</sup> MCF-7 cells/well, 5 Ã 10<sup>3</sup> HeLa, MDA-MB-231, HCT-116, CHO-K1, and MMC-2 cells/well in 100 Î¼L of medium. After overnight incubation (16 h) at 37 Â°C in a 5% CO<sub>2</sub> humidified atmosphere, the cells were treated with the tested compounds in the concentration range of 0 to 50 Î¼M in a final volume of 200 Î¼L/well. After additional 72 h, 20 Î¼L of a freshly diluted MTT solution (1.25 mg mL<sup>â1</sup> in PBS) was added to each well, and the plates were incubated at 37 Â°C in a humidified 5% CO<sub>2</sub> atmosphere for 4 h. At the end of the incubation period, the medium was removed, and the formazan product was dissolved in 100 Î¼L of DMSO. The cell viability was evaluated by measurement of the absorbance at 570 nm (reference, 620 nm) using an absorbance reader (SUNRISE TECAN, SCHOELLER). All experiments were made in triplicate. The reading values were converted to the percentage of control (% cell survival). Cytotoxic effects were expressed as IC<sub>50</sub> values calculated from the curves constructed by plotting cell survival (%) versus drug concentration (Î¼M) (IC<sub>50</sub> = concentration of the agent inhibiting cell growth by 50%). Concentrations of Pt complexes present in the medium during treatment were verified by flameless atomic absorption spectrometry (FAAS).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Cellular Accumulation</h3><div class="NLM_p last">Cellular accumulation of the investigated complexes was determined in highly invasive human breast carcinoma cells MDA-MB-231. In these experiments, 2 Ã 10<sup>6</sup> MDA-MB-231 cells were seeded on 100 mm Petri dishes. After overnight preincubation in a drug-free medium at 37 Â°C in a 5% CO<sub>2</sub> humidified atmosphere, the cells were treated with the platinum compounds at the indicated concentrations for the given periods (37 Â°C, 5% CO<sub>2</sub>). After the treatment, the cells were extensively washed with PBS (37 Â°C), detached using 0.25% trypsin, and washed twice with ice-cold PBS. The cell pellets were stored at â70 Â°C and digested using a microwave acid (HCl) digestion system (CEM Mars). The quantity of platinum taken up by the cells was determined by ICP-MS. All experiments were carried out in triplicate.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Measurement of the Partition Coefficients</h3><div class="NLM_p last">To determine the partition coefficients (P) of the investigated compounds, the âshake flaskâ method was used. Octanol-saturated water (OSW) and water-saturated octanol (WSO) were prepared using analytical grade octanol and ultrapure water. Platinum complexes were dissolved in OSW containing 200 mM NaCl and mixed with WSO in volumetric ratios of 2:1, 1:1, and 1:2. Mixing was done by vortexing for 30 min at room temperature to establish the partition equilibrium. To separate the phases, the samples were centrifuged at 3000<i>g</i> for 5 min. The layers were separated carefully using a fine-tip pipet and then analyzed for metal content by FAAS. The partition coefficients were calculated as a ratio of the concentration of the compound in the octanol layer to that in the aqueous layer [log <i>P</i> = log ([Pt]WSO/[Pt]OSW)].</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Platinum Distribution in Subcellular Compartments</h3><div class="NLM_p last">MDA-MB-231 cells were seeded on Petri dishes at a density of 2 Ã 10<sup>6</sup> cells/dish and incubated overnight. After the following treatment with the platinum compounds, the cells were washed twice with PBS and pelleted. The isolation of individual fractions was carried out according to the manufacturerâs protocol (FractionPREP Cell Fractionation kit; BioVision). The platinum content in the separated fractions (cytosolic, membrane/particulate, nuclear, and cytoskeletal) was determined by ICP-MS. The experiment was carried out in triplicate.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Quantification of Platinum Bound to DNA</h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Quantification in a Cell-Free Medium</h4><div class="NLM_p last">Calf thymus DNA (64 Î¼g mL<sup>â1</sup>) was incubated with 2 Ã 10<sup>â5</sup> M <b>5</b>, <b>1</b>, or their Pt(IV) derivatives in 10 mM NaClO<sub>4</sub> at 37 Â°C in the presence or absence of 2 Ã 10<sup>â5</sup> M sodium ascorbate. Then, the free (unbound) platinum in these samples was removed by gel filtration using Sephadex G-25, and the samples were redissolved in double distilled water. DNA concentration and platinum contents in these samples were determined with the aid of UV and flameless atomic absorption spectrophotometry, respectively.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Quantification in DNA Isolated from the Cells</h4><div class="NLM_p last">MDA-MB-231 cells were treated with the tested compounds at a concentration of 2 Î¼M for 6 h. The cell pellets were stored at â70 Â°C and then lysed in DNAzol (DNAzol, MRC) supplemented with RNase A (100 Î¼g mL<sup>â1</sup>). Genomic DNA was precipitated from the lysate by 100% ethanol, washed twice with 75% ethanol, and resuspended in 8 mM NaOH. The DNA content in each sample was determined by UV spectrophotometry. To avoid the affection of high DNA concentration on detection of platinum in the samples, the DNA samples were digested in the presence of 30% hydrochloric acid (Suprapur, Merck Millipore). The amount of metal bound to nucleic acids was quantified by ICP-MS. All measurements were done in triplicate.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Real-Time Cell Growth Monitoring</h3><div class="NLM_p last">Real-time cell analyzer (RTCA) (xCELLigence RTCA SP Instrument, ROCHE) was employed for growth monitoring of MDA-MB-231 cells in the absence and presence of the investigated compounds. After the background of E-plate reading (100 Î¼L medium), the cells were added (5 Ã 10<sup>3</sup> cells/well; 50 Î¼L) and grown for 22â28 h. The investigated compounds at various concentrations were then added in 50 Î¼L of media. The impedance was monitored for additional 4 days. An arbitrary unit CI (cell index) is a quantitative measure reflecting the status of the cells (number of attached cells and cell status such as morphology) in an electrode-containing well. Normalized CI at a certain time point is given by dividing CI at the time point by CI at a reference time point.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Flow Cytometric Analysis of the Cell Cycle</h3><div class="NLM_p last">MDA-MB-231 cells were seeded at a density of 5 Ã 10<sup>5</sup> cells/well in six-well culture plates. After overnight preincubation in a drug-free medium, the cells were treated for 12, 24, and 48 h with the investigated compounds at final concentrations corresponding to IC<sub>30</sub> values determined for 72 h of treatment. Treated and untreated cells were harvested by trypsinization, washed twice with PBS, resuspended in 70% ethanol, and kept at 4 Â°C overnight. Fixed cells were rinsed twice in PBS and stained with propidium iodide diluted to 50 Î¼g mL<sup>â1</sup> in Vindelâs solution (10 mM Tris-Cl, pH 8.0, 10 mM NaCl, 0.1% Triton X-100, and 100 Î¼g mL<sup>â1</sup> RNase A) for 30 min at 37 Â°C. Cell-cycle profiles were measured with a FACS Verse flow cytometer (Becton Dickinson, Germany) and data analyzed using ModFit LT 4.1 software (Verity Software House). Results were confirmed in three independent experiments.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Cytoskeleton Organization</h3><div class="NLM_p last">MDA-MB-231 cells were seeded on glass-bottom culture dishes (MatTek Corporation, Ashland, MA, USA) at a density of 1 Ã 10<sup>5</sup> cells/dish. After overnight preincubation in a drug-free medium, the cells were treated with the tested compounds for the indicated periods. Following the treatment, the cells were washed twice in PBS and fixed in 100% methanol (ice-cold; 2 min). Methanol was then removed, and the cells were permeabilized with PBST buffer (0.1% Tween-20 in PBS) for 20 min. Following the permeabilization, blocking solution was applied (10% normal donkey serum in PBST) for 1 h. The primary antibody (anti-Î±-tubulin; mouse; Sigma-Aldrich, Prague, Czech Republic; 150:1 dilution) was incubated at room temperature for 2 h. After four washes with PBST, the secondary antibody was added (Alexa Fluor 488 goat anti-mouse; Invitrogen, Thermo Fisher Scientific, Prague, Czech Republic; 2 drops/mL dilution) and incubated for 1 h. Cells were washed five times with PBST, and ProLong<sup>TM</sup> Gold antifade reagent with DAPI (4â²,6-diamidino-2-phenylindole dihydrochloride, Invitrogen, Thermo Fisher Scientific, Prague, Czech Republic) was applied. The images were taken with the laser-scanning microscope Leica TCS SP8 SMD (Leica Microsystems GmbH, Wetzlar, Germany).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Tubulin Polymerization Assay</h3><div class="NLM_p last">Tubulin polymerization was studied in the absence or presence of <b>5</b> and its Pt(IV) derivatives using the HTS-Tubulin Polymerization Assay Biochem Kit (Cytoskeleton, Inc.) following the manufacturerâs instructions. Briefly, 4 mg mL<sup>â1</sup> porcine brain tubulin in general tubulin buffer with or without platinum compounds at the indicated concentrations was filled in spectrophotometry cuvettes and warmed to 37 Â°C. The reaction was started by the addition of GTP to a final concentration of 1 mM. The signal was read at 340 nm for at least 60 min on the UVâVIS Spectrophotometer Varian Cary 4000.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Tubulin Depolymerization Assay</h3><div class="NLM_p last">Tubulin was polymerized following the above procedure with or without platinum compounds. After 80 min at 37 Â°C, the temperature was decreased down to 17 Â°C (0.5 Â°C/min). The signal was read at 340 nm.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Whole Cell Analysis of Microtubule by Flow Cytometry</h3><div class="NLM_p last">MDA-MB-231 cells were grown in six-well plates overnight and then incubated with the investigated compounds for 3 h at the concentrations of 20, 40, or 80 Î¼M. After incubation, the cells were harvested by trypsinization, pelleted, and fixed in 1 mL of 0.5% glutaraldehyde in microtubule stabilizing buffer (MTSB: 80 mM Pipes, pH 6.8, 1 mM MgCl<sub>2</sub>, 5 mM EDTA, and 0.5% Triton X-100). After 10 min at room temperature, 0.7 mL of NaBH<sub>4</sub> in phosphate-buffered saline (PBS) was added to quench glutaraldehyde. The cells were pelleted again and resuspended in 20 Î¼L of 50 Î¼g mL<sup>â1</sup> RNase A in antibody diluting solution (PBS, pH 7.4, 0.2% Triton X-100, 2% BSA, and 0.1% NaN<sub>3</sub>) and incubated overnight (4 Â°C). The next day, the cells were incubated with the anti-Î±-tubulin-FITC antibody (mouse monoclonal; Sigma-Aldrich, Prague; 1:250 dilution) in antibody diluting solution in the dark for 3 h. The cells were vortexed and analyzed by flow cytometry. Tubulin levels based on the geometric mean of FITC fluorescence were normalized to 100% for the control.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> AFM Imaging of Microtubules</h3><div class="NLM_p last">Porcine brain tubulin (Cytoskeleton, Inc.) was polymerized following the same procedure as in the tubulin polymerization assay for 80â90 min. An aliquot was withdrawn, and the microtubules were fixed with 0.1% glutaraldehyde (final concentration). The solution was diluted 40Ã in general tubulin buffer, and a droplet (4 Î¼L) was spotted directly onto freshly cleaved mica (SPI, West Chester, PA) and incubated for 2 min at room temperature. The mica was gently rinsed with Milli-Q water (0.5 mL) and immediately blown dry with compressed air. Imaging was carried out in air using a Bruker MultiMode 8 atomic force microscope operated in ScanAsyst-HR mode and SCANASYST-AIR-HR probes (Bruker, Santa Barbara, CA).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Mitochondrial Membrane Depolarization</h3><div class="NLM_p last">MDA-MB-231 cells were seeded on 96-well plates at a density of 1 Ã 10<sup>4</sup> cells/well and incubated overnight. The medium was removed, and the cells were treated with the platinum compounds in RPMI 1640 (without phenol red) at the given concentrations for the given periods. The medium was removed, and the cells were washed with PBS. Following the TMRE staining (1 nM, 20 min, 0.2% BSA in PBS), the plate was read to measure TMRE fluorescence (excitation/emission = 560 nm/595 nm) on Varian Cary Eclipse. The samples were read in quadruplicate, and the experiment was repeated thrice.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> HDAC Activity Analysis</h3><div class="NLM_p last">The activity of HDAC enzymes was analyzed in MDA-MB-231 cells treated with the investigated compounds. The activity of HDAC was analyzed with the HDAC fluorimetric cellular activity assay kit (Enzo Life Sciences; Farmingdale, NY) in the whole cells following the manufacturerâs protocol. Briefly, the cells were grown in culture media without phenol red. After reaching 80% confluence, the cells were incubated with the tested compounds and the HDAC substrate for 4 h. Samples were treated in octuplicate, and the experiment was performed in triplicate. The HDAC reaction was terminated by addition of 2 Î¼M trichostatin A and further incubation for 15 min at 37 Â°C with the developer. The generated fluorescence signal was read on a fluorescence reader Infinite 200 (TECAN) (360 nm excitation/ 460 nm emission).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> DNA Methylation Analysis</h3><div class="NLM_p last">MDA-MB-231 cells were seeded at the density of 2 Ã 10<sup>6</sup> cells/dish. Cells were harvested following 24 h of incubation with the investigated compounds. Cell pellets were lysed with DNAzol (DNAzol genomic DNA isolation reagent, MRC) supplemented with RNase A (100 Î¼g mL<sup>â1</sup>). The genomic DNA was precipitated with ethanol, washed, and redissolved in water. The DNA content in each sample was determined spectrophotometrically. DNA (0.2 mg) from each sample was used in the Imprint methylated DNA quantification kit (Sigma-Aldrich, USA). The level of DNA methylation was proportional to the 450 nm absorbance. The signals of individual samples were normalized to the control and expressed in percentage.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00489" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00489" class="ext-link">10.1021/acs.jmedchem.9b00489</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">DNA platination in MDA-MB-231 cells treated with the investigated compounds, DNA binding of Pt(IV) complexes derived from <b>5</b> and <b>1</b> in the presence or absence of sodium ascorbate, cell-cycle profiles of MDA-MB-231 cells treated with the investigated platinum complex <b>5</b> and its Pt(IV) derivatives, effects of <b>5</b> and its Pt(IV) derivatives on the organization of the structural network (cytoskeleton) within the cellâs cytoplasm, and mitochondrial membrane hypopolarization of MDA-MB-231 cells treated with the investigated platinum complexes (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Cytotoxicity data of the complexes (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf">jm9b00489_si_001.pdf (850.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_002.csv">jm9b00489_si_002.csv (1.29 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00489" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viktor Brabec</span> - <span class="hlFld-Affiliation affiliation">Czech
Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8233-1393" title="Orcid link">http://orcid.org/0000-0002-8233-1393</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d5b7a7b4b7b0b695bcb7a5fbb6af"><span class="__cf_email__" data-cfemail="b7d5c5d6d5d2d4f7ded5c799d4cd">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hana Kostrhunova</span> - <span class="hlFld-Affiliation affiliation">Czech
Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juraj Zajac</span> - <span class="hlFld-Affiliation affiliation">Czech
Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vojtech Novohradsky</span> - <span class="hlFld-Affiliation affiliation">Czech
Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Kasparkova</span> - <span class="hlFld-Affiliation affiliation">Czech
Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5279-5381" title="Orcid link">http://orcid.org/0000-0002-5279-5381</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaroslav Malina</span> - <span class="hlFld-Affiliation affiliation">Czech
Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janice R. Aldrich-Wright</span> - <span class="hlFld-Affiliation affiliation">School
of Science and Health, Western Sydney University, Penrith South DC 1797, NSW, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuele Petruzzella</span> - <span class="hlFld-Affiliation affiliation">Institute
for Drug Research, School of Pharmacy, The
Hebrew University, Jerusalem 91120, Israel</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roman Sirota</span> - <span class="hlFld-Affiliation affiliation">Institute
for Drug Research, School of Pharmacy, The
Hebrew University, Jerusalem 91120, Israel</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Gibson</span> - <span class="hlFld-Affiliation affiliation">Institute
for Drug Research, School of Pharmacy, The
Hebrew University, Jerusalem 91120, Israel</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by the Czech Science Foundation (Grant No. 18-09502S). The work of D.G. was also supported by the Israel Science Foundation (Grant No. 1611/14) and the Alex Grass Center for Drug Design and Synthesis.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are also indebted to Dr. Karel Soucek (Institute of Biophysics, Czech Academy of Sciences in Brno) for enabling them to use the RTCA equipment (xCELLigence RTCA SP, Roche). The authors acknowledge that their participation in the COST Action CM1406 (Epigenetic Chemical Biology EPICHEMBIO) enabled them to regularly exchange the most recent ideas in the field of epigenetic anticancer metallodrugs with several European colleagues.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">MoA</td><td class="NLM_def"><p class="first last">mechanism of action</p></td></tr><tr><td class="NLM_term">DCA</td><td class="NLM_def"><p class="first last">dichloroacetate</p></td></tr><tr><td class="NLM_term">PhB</td><td class="NLM_def"><p class="first last">phenylbutyrate</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">5,6-Me<sub>2</sub>phen</td><td class="NLM_def"><p class="first last">5,6-dimethyl-1,10-phenanthroline ligand</p></td></tr><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">octanoic acid</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration of compound that causes death in 50% of cells</p></td></tr><tr><td class="NLM_term">DACH</td><td class="NLM_def"><p class="first last">1,2-diaminocyclohexane</p></td></tr><tr><td class="NLM_term">ICP-MS</td><td class="NLM_def"><p class="first last">inductively coupled plasma mass spectrometry</p></td></tr><tr><td class="NLM_term">RTCA</td><td class="NLM_def"><p class="first last">real-time cell analyzer</p></td></tr><tr><td class="NLM_term">TCRP</td><td class="NLM_def"><p class="first last">time-dependent cell response profile</p></td></tr><tr><td class="NLM_term">MT</td><td class="NLM_def"><p class="first last">microtubule</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4â²,6-diamidino-2-phenylindole dihydrochloride</p></td></tr><tr><td class="NLM_term">TMRE</td><td class="NLM_def"><p class="first last">tetramethylrhodamine, ethyl ester</p></td></tr><tr><td class="NLM_term">AFM</td><td class="NLM_def"><p class="first last">atomic force microscopy</p></td></tr><tr><td class="NLM_term">OSW</td><td class="NLM_def"><p class="first last">octanol-saturated water</p></td></tr><tr><td class="NLM_term">WSO</td><td class="NLM_def"><p class="first last">water-saturated octanol</p></td></tr><tr><td class="NLM_term">FAAS</td><td class="NLM_def"><p class="first last">flameless atomic absorption spectrometry</p></td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">cell index</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 79 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Modifications of DNA by platinum complexes: Relation to resistance of tumors to platinum antitumor drugs</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">146</span>, <span class="refDoi">Â DOI: 10.1016/j.drup.2005.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.drup.2005.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=15894512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVSlsr7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=131-146&author=V.+Brabecauthor=J.+Kasparkova&title=Modifications+of+DNA+by+platinum+complexes%3A+Relation+to+resistance+of+tumors+to+platinum+antitumor+drugs&doi=10.1016%2Fj.drup.2005.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Modifications of DNA by platinum complexes</span></div><div class="casAuthors">Brabec, Viktor; Kasparkova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-146</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of platinum drugs in cancer chemotherapy is underscored by the clin. success of cisplatin [cis-diamminedichloroplatinum(II)] and its analogs and by clin. trials of other, less toxic platinum complexes that are active against resistant tumors.  The antitumor effect of platinum complexes is believed to result from their ability to form various types of adducts with DNA.  Nevertheless, drug resistance can occur by several ways: increased drug efflux, drug inactivation, alterations in drug target, processing of drug-induced damage, and evasion of apoptosis.  This review focuses on mechanisms of resistance and sensitivity of tumors to conventional cisplatin assocd. with DNA modifications.  We also discuss mol. mechanisms underlying resistance and sensitivity of tumors to the new platinum compds. synthesized with the goal to overcome resistance of tumors to established platinum drugs.  Importantly, a no. of new platinum compds. were designed to test the hypothesis that there is a correlation between the extent of resistance of tumors to these agents and their ability to induce a certain kind of damage or conformational change in DNA.  Hence, information on DNA-binding modes, as well as recognition and repair of DNA damage is discussed, since this information may be exploited for improved structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoliOk5cSz47LVg90H21EOLACvtfcHk0lgCwaM36ieQvg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVSlsr7K&md5=0b2aedfc594780c9727404fce1b1669d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2005.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2005.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DModifications%2520of%2520DNA%2520by%2520platinum%2520complexes%253A%2520Relation%2520to%2520resistance%2520of%2520tumors%2520to%2520platinum%2520antitumor%2520drugs%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2005%26volume%3D8%26spage%3D131%26epage%3D146%26doi%3D10.1016%2Fj.drup.2005.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">The next generation of platinum drugs: Targeted Pt(II) agents, nanoparticle delivery, and Pt (IV) prodrugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">3436</span>â <span class="NLM_lpage">3486</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrev.5b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=3436-3486&author=T.+C.+Johnstoneauthor=K.+Suntharalingamauthor=S.+J.+Lippard&title=The+next+generation+of+platinum+drugs%3A+Targeted+Pt%28II%29+agents%2C+nanoparticle+delivery%2C+and+Pt+%28IV%29+prodrugs&doi=10.1021%2Facs.chemrev.5b00597"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00597%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520next%2520generation%2520of%2520platinum%2520drugs%253A%2520Targeted%2520Pt%2528II%2529%2520agents%252C%2520nanoparticle%2520delivery%252C%2520and%2520Pt%2520%2528IV%2529%2520prodrugs%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D3436%26epage%3D3486%26doi%3D10.1021%2Facs.chemrev.5b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Einhorn, L. H.</span></span> <span> </span><span class="NLM_article-title">Curing metastatic testicular cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">4592</span>â <span class="NLM_lpage">4595</span>, <span class="refDoi">Â DOI: 10.1073/pnas.072067999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.072067999" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=4592-4595&author=L.+H.+Einhorn&title=Curing+metastatic+testicular+cancer&doi=10.1073%2Fpnas.072067999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.072067999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.072067999%26sid%3Dliteratum%253Aachs%26aulast%3DEinhorn%26aufirst%3DL.%2BH.%26atitle%3DCuring%2520metastatic%2520testicular%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D4592%26epage%3D4595%26doi%3D10.1073%2Fpnas.072067999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseigne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ychou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BouchÃ©, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimbaud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ©couarn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adenis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoul, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgou-Bourgade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la FouchardiÃ©re, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennouna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachet, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemissa-Akouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pere-Verge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assenat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoto-Grillot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducreux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grp Tumeurs
Digestives, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intergrp, P.</span></span> <span> </span><span class="NLM_article-title">FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer</span>. <i>New England J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1817</span>â <span class="NLM_lpage">1825</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Bouch%C3%A9author=R.+Guimbaudauthor=Y.+B%C3%A9couarnauthor=A.+Adenisauthor=J.+L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardi%C3%A9reauthor=J.+Bennounaauthor=J.+B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+Pere-Vergeauthor=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreuxauthor=U.+Grp+Tumeurs%0ADigestivesauthor=P.+Intergrp&title=FOLFIRINOX+versus+Gemcitabine+for+Metastatic+Pancreatic+Cancer&doi=10.1056%2FNEJMoa1011923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouch%25C3%25A9%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DB%25C3%25A9couarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.%2BL.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardi%25C3%25A9re%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DPere-Verge%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26aulast%3DGrp%2BTumeurs%2BDigestives%26aufirst%3DU.%26aulast%3DIntergrp%26aufirst%3DP.%26atitle%3DFOLFIRINOX%2520versus%2520Gemcitabine%2520for%2520Metastatic%2520Pancreatic%2520Cancer%26jtitle%3DNew%2520England%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2FNEJMoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haber, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span> <span> </span><span class="NLM_article-title">The evolving war on cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">19</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.cell.2011.03.026" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=19-24&author=D.+A.+Haberauthor=N.+S.+Grayauthor=J.+Baselga&title=The+evolving+war+on+cancer&doi=10.1016%2Fj.cell.2011.03.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DThe%2520evolving%2520war%2520on%2520cancer%26jtitle%3DCell%26date%3D2011%26volume%3D145%26spage%3D19%26epage%3D24%26doi%3D10.1016%2Fj.cell.2011.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Epigenetic polypharmacology: from combination therapy to multitargeted drugs</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">105</span>, <span class="refDoi">Â DOI: 10.1186/s13148-016-0271-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1186%2Fs13148-016-0271-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27752293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslOgsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=105&author=A.+R.+de%0ALeraauthor=A.+Ganesan&title=Epigenetic+polypharmacology%3A+from+combination+therapy+to+multitargeted+drugs&doi=10.1186%2Fs13148-016-0271-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic polypharmacology: from combination therapy to multitargeted drugs</span></div><div class="casAuthors">de Lera, Angel R.; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105/1-105/21</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The modern drug discovery process has largely focused its attention in the so-called magic bullets, single chem. entities that exhibit high selectivity and potency for a particular target.  This approach was based on the assumption that the deregulation of a protein was causally linked to a disease state, and the pharmacol. intervention through inhibition of the deregulated target was able to restore normal cell function.  However, the use of cocktails or multicomponent drugs to address several targets simultaneously is also popular to treat multifactorial diseases such as cancer and neurol. disorders.  We review the state of the art with such combinations that have an epigenetic target as one of their mechanisms of action.  Epigenetic drug discovery is a rapidly advancing field, and drugs targeting epigenetic enzymes are in the clinic for the treatment of hematol. cancers.  Approved and exptl. epigenetic drugs are undergoing clin. trials in combination with other therapeutic agents via fused or linked pharmacophores in order to benefit from synergistic effects of polypharmacol.  In addn., ligands are being discovered which, as single chem. entities, are able to modulate multiple epigenetic targets simultaneously (multitarget epigenetic drugs).  These multiple ligands should in principle have a lower risk of drug-drug interactions and drug resistance compared to cocktails or multicomponent drugs.  This new generation may rival the so-called magic bullets in the treatment of diseases that arise as a consequence of the deregulation of multiple signaling pathways provided the challenge of optimization of the activities shown by the pharmacophores with the different targets is addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphm-KIEGyYKrVg90H21EOLACvtfcHk0liK4Fwk8YYWaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslOgsbY%253D&md5=7cd89a93a22121cc9db2c7118e2e23f1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs13148-016-0271-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-016-0271-9%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%26aufirst%3DA.%2BR.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DEpigenetic%2520polypharmacology%253A%2520from%2520combination%2520therapy%2520to%2520multitargeted%2520drugs%26jtitle%3DClin.%2520Epigenet.%26date%3D2016%26volume%3D8%26spage%3D105%26doi%3D10.1186%2Fs13148-016-0271-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Multitarget drugs: an epigenetic epiphany</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1227</span>â <span class="NLM_lpage">1241</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201500394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fcmdc.201500394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=26891251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislehu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1227-1241&author=A.+Ganesan&title=Multitarget+drugs%3A+an+epigenetic+epiphany&doi=10.1002%2Fcmdc.201500394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Drugs: an Epigenetic Epiphany</span></div><div class="casAuthors">Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1227-1241</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Epigenetics refers to changes in a biol. phenotype that are not due to an underlying change in genotype.  In eukaryotes, epigenetics involves a set of chem. modifications of the DNA and the histone proteins in nucleosomes.  These dynamic changes are carried out by enzymes and modulate protein-protein and protein-nucleic acid interactions to det. whether specific genes are expressed or silenced.  Both the epigenetic enzymes and recognition domains are currently important drug discovery targets, particularly for the treatment of cancer.  This review summarizes the progress of epigenetic targets that have reached a clin. stage: DNA methyltransferases, histone deacetylases, lysine methyltransferases, lysine demethylases, and bromodomains; this is followed by a comprehensive survey of multitarget drugs that have included an epigenetic target as one of their mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwdZM3u9Wbc7Vg90H21EOLACvtfcHk0ljfkYGinkdCwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislehu7w%253D&md5=736284dc3f05db0032c9a304884f980d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500394%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DMultitarget%2520drugs%253A%2520an%2520epigenetic%2520epiphany%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1227%26epage%3D1241%26doi%3D10.1002%2Fcmdc.201500394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anighoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastelli, G.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology: Challenges and opportunities in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7874</span>â <span class="NLM_lpage">7887</span>, <span class="refDoi">Â DOI: 10.1021/jm5006463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+Challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0ljfkYGinkdCwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520Challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J.-U.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology â Foe or friend?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8955</span>â <span class="NLM_lpage">8971</span>, <span class="refDoi">Â DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology+%E2%80%93+Foe+or+friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0ljfkYGinkdCwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology%2520%25E2%2580%2593%2520Foe%2520or%2520friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) anticancer prodrugs - hypotheses and facts</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12983</span>â <span class="NLM_lpage">12991</span>, <span class="refDoi">Â DOI: 10.1039/C6DT01414C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC6DT01414C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27214873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28XotlCruro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=12983-12991&author=D.+Gibson&title=Platinum%28IV%29+anticancer+prodrugs+-+hypotheses+and+facts&doi=10.1039%2FC6DT01414C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) anticancer prodrugs - hypotheses and facts</span></div><div class="casAuthors">Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12983-12991</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this manuscript we focus on Pt(IV) anticancer prodrugs.  We explore the main working hypotheses for the design of effective Pt(IV) prodrugs and note the exceptions to the common assumptions that are prevalent in the field.  Special attention was devoted to the emerging class of "dual action" Pt(IV) prodrugs, where bioactive ligands are conjugated to the axial positions of platinum in order to obtain orthogonal or complementary effects that will increase the efficacy of killing the cancer cells.  We discuss the rationale behind the design of the "dual action" prodrugs and the results of the pharmacol. studies obtained.  Simultaneous release of two bioactive moieties inside the cancer cells often triggers several processes that together det. the fate of the cell.  Pt(IV) complexes provide many opportunities for applying new concepts in targeting, synergistic cell killing and exploiting novel nanodelivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN31ie6PsEtLVg90H21EOLACvtfcHk0ljfkYGinkdCwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotlCruro%253D&md5=99fca9a3216d25087a0b565f8997c3ae</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC6DT01414C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT01414C%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DPlatinum%2528IV%2529%2520anticancer%2520prodrugs%2520-%2520hypotheses%2520and%2520facts%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26spage%3D12983%26epage%3D12991%26doi%3D10.1039%2FC6DT01414C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osella, D.</span></span> <span> </span><span class="NLM_article-title">Pros and cons of bifunctional platinum(IV) antitumor prodrugs: two are (not always) better than one</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">9813</span>â <span class="NLM_lpage">9820</span>, <span class="refDoi">Â DOI: 10.1039/c4dt00911h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2Fc4dt00911h" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=9813-9820&author=E.+Gabanoauthor=M.+Raveraauthor=D.+Osella&title=Pros+and+cons+of+bifunctional+platinum%28IV%29+antitumor+prodrugs%3A+two+are+%28not+always%29+better+than+one&doi=10.1039%2Fc4dt00911h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2Fc4dt00911h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4dt00911h%26sid%3Dliteratum%253Aachs%26aulast%3DGabano%26aufirst%3DE.%26aulast%3DRavera%26aufirst%3DM.%26aulast%3DOsella%26aufirst%3DD.%26atitle%3DPros%2520and%2520cons%2520of%2520bifunctional%2520platinum%2528IV%2529%2520antitumor%2520prodrugs%253A%2520two%2520are%2520%2528not%2520always%2529%2520better%2520than%2520one%26jtitle%3DDalton%2520Trans.%26date%3D2014%26volume%3D43%26spage%3D9813%26epage%3D9820%26doi%3D10.1039%2Fc4dt00911h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wexselblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">What do we know about the reduction of Pt(IV) pro-drugs?</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">220</span>â <span class="NLM_lpage">229</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2012.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2012.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=22877926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Klsr7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2012&pages=220-229&author=E.+Wexselblattauthor=D.+Gibson&title=What+do+we+know+about+the+reduction+of+Pt%28IV%29+pro-drugs%3F&doi=10.1016%2Fj.jinorgbio.2012.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">What do we know about the reduction of Pt(IV) pro-drugs?</span></div><div class="casAuthors">Wexselblatt, Ezequiel; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">220-229</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Platinum(IV) pro-drugs are an important class of mols. that might improve the pharmacol. properties of the platinum(II) anticancer agents that are currently used in the clinic.  Their axial ligands that are detached during cellular activation by reductive elimination can be used to confer favorable pharmacol. properties to the complexes allowing for potentially lower toxicity and improved efficacy.  This manuscript describes the various approaches taken to design and prep. Pt(IV) complexes that will be effective anticancer agents.  We review the working hypotheses guiding the researchers in the field while pointing out some more recent results that contradict some of the accepted paradigms in the hope of triggering some rethinking of the existing working hypotheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPyz4uDONRLrVg90H21EOLACvtfcHk0liDaz5Wu_YKvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Klsr7L&md5=bc7eedfee3214769162e5e1131a569d5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2012.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2012.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DWhat%2520do%2520we%2520know%2520about%2520the%2520reduction%2520of%2520Pt%2528IV%2529%2520pro-drugs%253F%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D117%26spage%3D220%26epage%3D229%26doi%3D10.1016%2Fj.jinorgbio.2012.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hambley, T. W.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) antitumour compounds: their bioinorganic chemistry</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">49</span>â <span class="NLM_lpage">67</span>, <span class="refDoi">Â DOI: 10.1016/S0010-8545(02)00026-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2FS0010-8545%2802%2900026-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD38XntF2ktbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2002&pages=49-67&author=M.+D.+Hallauthor=T.+W.+Hambley&title=Platinum%28IV%29+antitumour+compounds%3A+their+bioinorganic+chemistry&doi=10.1016%2FS0010-8545%2802%2900026-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) antitumour compounds: their bioinorganic chemistry</span></div><div class="casAuthors">Hall, Matthew D.; Hambley, Trevor W.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">49-67</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  This article reviews the studies undertaken into Pt(IV) antitumor compds. since Barnett Rosenberg 1st noted the activity of Pt(IV) complexes.  The chem. and pharmacol. properties of the drugs are discussed and both the reactions with individual biomols., which have received attention and the characterization of biotransformation products from animal and clin. trials are reviewed.  The bioinorg. chem. of Pt(IV) complexes has not previously been reviewed, and the purpose here is to provide insight into the requirements for the antitumor activity of Pt(IV) complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkHxf962L07rVg90H21EOLACvtfcHk0liDaz5Wu_YKvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntF2ktbs%253D&md5=200992ab1e4313bea2f5c9b3f60ac26f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2802%2900026-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252802%252900026-7%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DHambley%26aufirst%3DT.%2BW.%26atitle%3DPlatinum%2528IV%2529%2520antitumour%2520compounds%253A%2520their%2520bioinorganic%2520chemistry%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2002%26volume%3D232%26spage%3D49%26epage%3D67%26doi%3D10.1016%2FS0010-8545%2802%2900026-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doshi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonpavde, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, C. N.</span></span> <span> </span><span class="NLM_article-title">Clinical and pharmacokinetic evaluation of satraplatin</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1517/17425255.2012.636352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1517%2F17425255.2012.636352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=22098065" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=103-111&author=G.+Doshiauthor=G.+Sonpavdeauthor=C.+N.+Sternberg&title=Clinical+and+pharmacokinetic+evaluation+of+satraplatin&doi=10.1517%2F17425255.2012.636352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.636352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.636352%26sid%3Dliteratum%253Aachs%26aulast%3DDoshi%26aufirst%3DG.%26aulast%3DSonpavde%26aufirst%3DG.%26aulast%3DSternberg%26aufirst%3DC.%2BN.%26atitle%3DClinical%2520and%2520pharmacokinetic%2520evaluation%2520of%2520satraplatin%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2011%26volume%3D8%26spage%3D103%26epage%3D111%26doi%3D10.1517%2F17425255.2012.636352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">22199</span>â <span class="NLM_lpage">22204</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (ÎÏm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0ljz7RoW41SVDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Conjugation of vitamin E analog Î±-TOS to Pt(IV) complexes for dual-targeting anticancer therapy</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2465</span>â <span class="NLM_lpage">2468</span>, <span class="refDoi">Â DOI: 10.1039/c3cc48740g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2Fc3cc48740g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=24452361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVygsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=2465-2468&author=K.+Suntharalingamauthor=Y.+Songauthor=S.+J.+Lippard&title=Conjugation+of+vitamin+E+analog+%CE%B1-TOS+to+Pt%28IV%29+complexes+for+dual-targeting+anticancer+therapy&doi=10.1039%2Fc3cc48740g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of vitamin E analog Î±-TOS to Pt(IV) complexes for dual-targeting anticancer therapy</span></div><div class="casAuthors">Suntharalingam, Kogularamanan; Song, Ying; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2465-2468</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report two platinum(IV) complexes conjugated with a vitamin E analog, Î±-tocopherol succinate (Î±-TOS).  One of the conjugates displays the activity of both cisplatin and Î±-TOS in cancer cells, causing damage to DNA and mitochondria simultaneously.  Accordingly, it serves as a promising dual-targeting anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruxZumJGIJpbVg90H21EOLACvtfcHk0ljz7RoW41SVDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVygsLY%253D&md5=dc381d990f2afa1e349752f4e81976ba</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2Fc3cc48740g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc48740g%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DConjugation%2520of%2520vitamin%2520E%2520analog%2520%25CE%25B1-TOS%2520to%2520Pt%2528IV%2529%2520complexes%2520for%2520dual-targeting%2520anticancer%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D2465%26epage%3D2468%26doi%3D10.1039%2Fc3cc48740g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">133</span>â <span class="NLM_lpage">144</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2015.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.bcp.2015.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=25888926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvVyku7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=133-144&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=New+insights+into+the+molecular+and+epigenetic+effects+of+antitumor+Pt%28IV%29-valproic+acid+conjugates+in+human+ovarian+cancer+cells&doi=10.1016%2Fj.bcp.2015.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-144</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Substitutionally inert Pt(IV) prodrugs, combining bioactive axial ligands with Pt(IV) derivs. of antitumor Pt(II) compds., represent a new generation of anticancer drugs.  The rationale behind these prodrugs is to release, by reductive elimination inside the cancer cell, an active Pt(II) drug which binds nuclear DNA as well as bioactive ligands that may potentiate toxic effects of the Pt(II) drugs by an independent pathway.  Platinum prodrugs, such as Pt(IV) derivs. of cisplatin contg. axial valproic acid (VPA) ligands, destroy cancer cells with greater efficacy than conventional cisplatin.  These axial ligands were chosen because VPA inhibits histone deacetylase (HDAC) activity, thereby decondensing chromatin and subsequently increasing the accessibility of DNA within chromatin to DNA-binding agents.  We examd. the mechanism of cytotoxic activity of Pt(IV) derivs. of cisplatin with VPA axial ligands.  Particular attention was paid to the role of the VPA ligand in these Pt(IV) prodrugs in the mechanism underlying their toxic effects in human ovarian tumor cells.  We demonstrate that (i) treatment of the cells with these prodrugs resulted in enhanced histone H3 acetylation and decondensation of heterochromatin markedly more effectively than free VPA; (ii) of the total Pt inside the cells, a considerably higher fraction of Pt from the Pt(IV)-VPA conjugates is bound to DNA than from the conjugates with biol. inactive ligands.  The results indicate that the enhanced cytotoxicity of the Pt(IV)-VPA conjugates is a consequence of several processes involving enhanced cellular accumulation, downregulation of HDACs and yet other biochem. processes (not involving HDACs) which may potentiate antitumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3LmsPWxK7QLVg90H21EOLACvtfcHk0ljz7RoW41SVDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvVyku7w%253D&md5=27a82b24b212af7c7cfd423ca43e3bf9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DNew%2520insights%2520into%2520the%2520molecular%2520and%2520epigenetic%2520effects%2520of%2520antitumor%2520Pt%2528IV%2529-valproic%2520acid%2520conjugates%2520in%2520human%2520ovarian%2520cancer%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D95%26spage%3D133%26epage%3D144%26doi%3D10.1016%2Fj.bcp.2015.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braude, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexselblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuchlikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2381</span>â <span class="NLM_lpage">2391</span>, <span class="refDoi">Â DOI: 10.1039/C5SC04205D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC5SC04205D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=29997781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVOlsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=2381-2391&author=R.+Raveendranauthor=J.+P.+Braudeauthor=E.+Wexselblattauthor=V.+Novohradskyauthor=O.+Stuchlikovaauthor=V.+Brabecauthor=V.+Gandinauthor=D.+Gibson&title=Pt%28IV%29+derivatives+of+cisplatin+and+oxaliplatin+with+phenylbutyrate+axial+ligands+are+potent+cytotoxic+agents+that+act+by+several+mechanisms+of+action&doi=10.1039%2FC5SC04205D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action</span></div><div class="casAuthors">Raveendran, Raji; Braude, Jeremy Phillip; Wexselblatt, Ezequiel; Novohradsky, Vojtech; Stuchlikova, Olga; Brabec, Viktor; Gandin, Valentina; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2381-2391</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Our study demonstrates that Pt(IV) deriv. of cisplatin, with two axial PhB ligands, ctc-[Pt(NH3)2(PhB)2Cl2], is a very potent cytotoxic agent against many different human cancer cell lines and is up to 100 fold more potent than cisplatin, and significantly more potent than the Pt(IV) derivs. of cisplatin with either two hydroxido, two acetato or two valproato ligands.  The high potency of this compd. (and some others) is due to several factors including enhanced internalization, probably driven by "synergistic accumulation" of both the Pt moiety and the phenylbutyrate, that correlates with enhanced DNA binding and cytotoxicity.  Ctc-[Pt(NH3)2(PhB)2Cl2] inhibits 60-70% HDAC activity in cancer cells, at levels below the IC50 values of PhB, suggesting synergism between Pt and PhB.  Mechanistically, ctc-[Pt(NH3)2(PhB)2Cl2] induces activation of caspases (3 and 9) triggering apoptotic signaling via the mitochondrial pathway.  Data also suggest that the antiproliferative effect of ctc-[Pt(NH3)2(PhB)2Cl2] may not depend of p53.  Pt(IV) derivs. of cisplatin with either two axial PhB or valproate ligands are more potent than their oxaliplatin analogs.  Ctc-[Pt(NH3)2(PhB)2Cl2] is significantly more potent than its valproate analog ctc-[Pt(NH3)2(VPA)2Cl2].  These compds. combine multiple effects such as efficient uptake of both Pt and PhB with DNA binding, HDAC inhibition and activation of caspases to effectively kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUvxQyimpaX7Vg90H21EOLACvtfcHk0lgBD9YNZFqpuw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVOlsg%253D%253D&md5=0599753b615d64adcf6a4014defc1327</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2FC5SC04205D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC04205D%26sid%3Dliteratum%253Aachs%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DBraude%26aufirst%3DJ.%2BP.%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DStuchlikova%26aufirst%3DO.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DPt%2528IV%2529%2520derivatives%2520of%2520cisplatin%2520and%2520oxaliplatin%2520with%2520phenylbutyrate%2520axial%2520ligands%2520are%2520potent%2520cytotoxic%2520agents%2520that%2520act%2520by%2520several%2520mechanisms%2520of%2520action%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D2381%26epage%3D2391%26doi%3D10.1039%2FC5SC04205D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span> <span> </span><span class="NLM_article-title">A platinum(IV) anticancer prodrug targeting nucleotide excision repair to overcome cisplatin resistance</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">15564</span>â <span class="NLM_lpage">15568</span>, <span class="refDoi">Â DOI: 10.1002/anie.201608936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fanie.201608936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yju7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=15564-15568&author=Z.+Wangauthor=Z.+Xuauthor=G.+Zhu&title=A+platinum%28IV%29+anticancer+prodrug+targeting+nucleotide+excision+repair+to+overcome+cisplatin+resistance&doi=10.1002%2Fanie.201608936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance</span></div><div class="casAuthors">Wang, Zhigang; Xu, Zoufeng; Zhu, Guangyu</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">15564-15568</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA damage response plays a key role not only in maintaining genome integrity but also in mediating the antitumor efficacy of DNA-damaging antineoplastic drugs.  Herein, we report the rational design and evaluation of a PtIV anticancer prodrug inhibiting nucleotide excision repair (NER), one of the most pivotal processes after the formation of cisplatin-induced DNA damage that deactivates the drug and leads to drug resistance in the clinic.  This dual-action prodrug enters cells efficiently and causes DNA damage while simultaneously inhibiting NER to promote apoptotic response.  The prodrug is strongly active against the proliferation of cisplatin-resistant human cancer cells with an up to 88-fold increase in growth inhibition compared with cisplatin, and the prodrug is much more active than a mixt. of cisplatin and an NER inhibitor.  Our study highlights the importance of targeting downstream pathways after the formation of Pt-induced DNA damage as a novel strategy to conquer cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5lc5oE4qMXrVg90H21EOLACvtfcHk0lgBD9YNZFqpuw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yju7fK&md5=551b6004833ce071b79c923cdf9483ca</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.201608936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201608936%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DG.%26atitle%3DA%2520platinum%2528IV%2529%2520anticancer%2520prodrug%2520targeting%2520nucleotide%2520excision%2520repair%2520to%2520overcome%2520cisplatin%2520resistance%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D15564%26epage%3D15568%26doi%3D10.1002%2Fanie.201608936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4686</span>â <span class="NLM_lpage">4700</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2017.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.bmc.2017.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28728896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFynsrbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4686-4700&author=X.+Huangauthor=R.+Huangauthor=S.+Gouauthor=Z.+Wangauthor=Z.+Liaoauthor=H.+Wang&title=Platinum%28IV%29+complexes+conjugated+with+phenstatin+analogue+as+inhibitors+of+microtubule+polymerization+and+reverser+of+multidrug+resistance&doi=10.1016%2Fj.bmc.2017.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance</span></div><div class="casAuthors">Huang, Xiaochao; Huang, Rizhen; Gou, Shaohua; Wang, Zhimei; Liao, Zhixin; Wang, Hengshan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4686-4700</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pt(IV) complexes comprising a phenstatin analog, as dual-targeting Pt(IV) prodrug, were designed and synthesized.  They were found not only to carry the DNA binding platinum warhead into the tumor cells, but also to have a small mol. unit to inhibit tubulin polymn.  In vitro evaluation results revealed that Pt(IV) complexes showed better and more potent activity against the test human cancer cells including cisplatin resistant cell lines than their corresponding Pt(II) counterparts.  In addn., the Pt(IV) deriv. of cisplatin, complex 10, exhibited highly selective inhibition in human cancer cells and displayed no obvious toxicity to two human normal cell lines, resp.  Mechanism study suggested that complex I induced cell-cycle arrest at the G2/M phase and caused apoptotic cell death of human lung cancer NCI-H460 cells through the mitochondrial mediated pathway.  Moreover, complex I effectively inhibited the tumor growth in the NCI-H460 xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzt6XOfYO-rVg90H21EOLACvtfcHk0lgBD9YNZFqpuw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFynsrbN&md5=953e8445ffd3733e53ff013356f002dd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DGou%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DPlatinum%2528IV%2529%2520complexes%2520conjugated%2520with%2520phenstatin%2520analogue%2520as%2520inhibitors%2520of%2520microtubule%2520polymerization%2520and%2520reverser%2520of%2520multidrug%2520resistance%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4686%26epage%3D4700%26doi%3D10.1016%2Fj.bmc.2017.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanellato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pracharova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3751</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-03864-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fs41598-017-03864-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28623355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BC1cnptFGisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=3751&author=V.+Novohradskyauthor=I.+Zanellatoauthor=C.+Marzanoauthor=J.+Pracharovaauthor=J.+Kasparkovaauthor=D.+Gibsonauthor=V.+Gandinauthor=D.+Osellaauthor=V.+Brabec&title=Epigenetic+and+antitumor+effects+of+platinum%28IV%29-octanoato+conjugates&doi=10.1038%2Fs41598-017-03864-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates</span></div><div class="casAuthors">Novohradsky Vojtech; Kasparkova Jana; Brabec Viktor; Zanellato Ilaria; Osella Domenico; Marzano Cristina; Gandin Valentina; Pracharova Jitka; Gibson Dan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3751</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We present the anticancer properties of cis, cis, trans-[Pt(IV)(NH3)2Cl2(OA)2] [Pt(IV)diOA] (OA = octanoato), Pt(IV) derivative of cisplatin containing two OA units appended to the axial positions of a six-coordinate Pt(IV) center.  Our results demonstrate that Pt(IV)diOA is a potent cytotoxic agent against many cancer cell lines (the IC50 values are approximately two orders of magnitude lower than those of clinically used cisplatin or Pt(IV) derivatives with biologically inactive axial ligands).  Importantly, Pt(IV)diOA overcomes resistance to cisplatin, is significantly more potent than its branched Pt(IV) valproato isomer and exhibits promising in vivo antitumor activity.  The potency of Pt(IV)diOA is a consequence of several factors including enhanced cellular accumulation correlating with enhanced DNA platination and cytotoxicity.  Pt(IV)diOA induces DNA hypermethylation and reduces mitochondrial membrane potential in cancer cells at levels markedly lower than the IC50 value of free OA suggesting the synergistic action of platinum and OA moieties.  Collectively, the remarkable antitumor effects of Pt(IV)diOA are a consequence of the enhanced cellular uptake which makes it possible to simultaneously accumulate high levels of both cisplatin and OA in cells.  The simultaneous dual action of cisplatin and OA by different mechanisms in tumor cells may result in a markedly enhanced and unique antitumor effects of Pt(IV) prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJFccvOyb6-YvKgEt20y1XfW6udTcc2eaaiYpk13XjXLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnptFGisQ%253D%253D&md5=de8c0401375343881d826185537f25ef</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-03864-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-03864-w%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZanellato%26aufirst%3DI.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DPracharova%26aufirst%3DJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DOsella%26aufirst%3DD.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DEpigenetic%2520and%2520antitumor%2520effects%2520of%2520platinum%2528IV%2529-octanoato%2520conjugates%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D3751%26doi%3D10.1038%2Fs41598-017-03864-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanellato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottone, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osella, D.</span></span> <span> </span><span class="NLM_article-title">An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">14174</span>â <span class="NLM_lpage">14185</span>, <span class="refDoi">Â DOI: 10.1039/C7DT02928D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7DT02928D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28984330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtL%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=14174-14185&author=E.+Gabanoauthor=M.+Raveraauthor=I.+Zanellatoauthor=S.+Tinelloauthor=A.+Gallinaauthor=B.+Rangoneauthor=V.+Gandinauthor=C.+Marzanoauthor=M.+G.+Bottoneauthor=D.+Osella&title=An+unsymmetric+cisplatin-based+Pt%28IV%29+derivative+containing+2-%282-propynyl%29octanoate%3A+a+very+efficient+multi-action+antitumor+prodrug+candidate&doi=10.1039%2FC7DT02928D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate</span></div><div class="casAuthors">Gabano, Elisabetta; Ravera, Mauro; Zanellato, Ilaria; Tinello, Stefano; Gallina, Andrea; Rangone, Beatrice; Gandin, Valentina; Marzano, Cristina; Bottone, Maria Grazia; Osella, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">14174-14185</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The design, synthesis, characterization and biol. properties of a Pt(IV) complex contg. the very active inhibitor of histone deacetylase (2-propynyl)octanoic acid, POA, as an axial ligand are reported here.  The title complex, namely (OC-6-44)-acetatodiamminedichlorido(2-(2-propynyl)octanoato)platinum(IV) (I), contg. POA in racemic or in enantiomeric forms, was one/two orders of magnitude more active than cisplatin, depending on the chemo-sensitivity of the cancer cell lines.  Moreover, I exhibited similar or even better antiproliferative activity than (OC-6-33)-diamminedichloridobis(2-propylpentanoato)platinum(IV), contg. two mols. of the well-known histone deacetylase inhibitor 2-propylpentanoic (valproic) acid.  The high potency of I is likely due to its high cellular accumulation and to the synergism between the DNA-damaging cisplatin and the histone deacetylase inhibitor POA, both released upon the intracellular redn. of I.  Prodrug I, after oral administration, caused an impressive redn. of the tumor mass (94%) in a model of solid tumor (murine Lewis lung carcinoma), compared to that of the control, whereas (i.p.) cisplatin induced a tumor regression of 75% only.  A good accumulation of I was obsd. in the tumor mass.  The time course of the body wt. attested that cisplatin induced elevated anorexia, whereas treatment with I did not induce significant body wt. loss throughout the therapeutic expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroh-E9hmmzn7Vg90H21EOLACvtfcHk0ljrjizSR4sN0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtL%252FL&md5=75b8c007a4ba673f3a6055127d83da86</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC7DT02928D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT02928D%26sid%3Dliteratum%253Aachs%26aulast%3DGabano%26aufirst%3DE.%26aulast%3DRavera%26aufirst%3DM.%26aulast%3DZanellato%26aufirst%3DI.%26aulast%3DTinello%26aufirst%3DS.%26aulast%3DGallina%26aufirst%3DA.%26aulast%3DRangone%26aufirst%3DB.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DBottone%26aufirst%3DM.%2BG.%26aulast%3DOsella%26aufirst%3DD.%26atitle%3DAn%2520unsymmetric%2520cisplatin-based%2520Pt%2528IV%2529%2520derivative%2520containing%25202-%25282-propynyl%2529octanoate%253A%2520a%2520very%2520efficient%2520multi-action%2520antitumor%2520prodrug%2520candidate%26jtitle%3DDalton%2520Trans.%26date%3D2017%26volume%3D46%26spage%3D14174%26epage%3D14185%26doi%3D10.1039%2FC7DT02928D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro-Ranninger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiroga, A. G.</span></span> <span> </span><span class="NLM_article-title">Enhanced cytotoxicity and reactivity of a novel platinum(IV) family with DNA-targeting naphthalimide ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6175</span>â <span class="NLM_lpage">6183</span>, <span class="refDoi">Â DOI: 10.1021/acs.inorgchem.7b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1Gku7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=6175-6183&author=F.+Navasauthor=F.+Mendesauthor=I.+Santosauthor=C.+Navarro-Ranningerauthor=S.+Cabreraauthor=A.+G.+Quiroga&title=Enhanced+cytotoxicity+and+reactivity+of+a+novel+platinum%28IV%29+family+with+DNA-targeting+naphthalimide+ligands&doi=10.1021%2Facs.inorgchem.7b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands</span></div><div class="casAuthors">Navas, Francisco; Mendes, Filipa; Santos, Isabel; Navarro-Ranninger, Carmen; Cabrera, Silvia; Quiroga, Adoracion G.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6175-6183</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pt(IV) complexes are known as prodrugs that can potentially overcome cisplatin limitations by slowing down its reactivity and, once reduced, act as the corresponding Pt(II) drugs.  We report a new approach toward trans Pt(IV) complexes, conceived to afford nonconventional active trans Pt(II) complexes with dual-targeting properties.  The redn. of the complexes has been studied in the presence of ascorbic acid and glutathione, showing that different species are formed in the process.  The interaction with DNA after redn. has been also studied and correlated to the formation of Pt(II) species.  The cytotoxicity profile of the Pt(IV) complexes corroborated the rationale behind this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcPCxn9jf7ULVg90H21EOLACvtfcHk0ljrjizSR4sN0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1Gku7k%253D&md5=d0fa3ece9345eff99f7a0e67ddc5f880</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b00136%26sid%3Dliteratum%253Aachs%26aulast%3DNavas%26aufirst%3DF.%26aulast%3DMendes%26aufirst%3DF.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DNavarro-Ranninger%26aufirst%3DC.%26aulast%3DCabrera%26aufirst%3DS.%26aulast%3DQuiroga%26aufirst%3DA.%2BG.%26atitle%3DEnhanced%2520cytotoxicity%2520and%2520reactivity%2520of%2520a%2520novel%2520platinum%2528IV%2529%2520family%2520with%2520DNA-targeting%2520naphthalimide%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D6175%26epage%3D6183%26doi%3D10.1021%2Facs.inorgchem.7b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKeon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devocelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. M.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11318</span>â <span class="NLM_lpage">11321</span>, <span class="refDoi">Â DOI: 10.1039/C7CC04764A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7CC04764A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28967013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGgu7bK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=11318-11321&author=A.+M.+McKeonauthor=J.+Noonanauthor=M.+Devocelleauthor=B.+M.+Murphyauthor=D.+M.+Griffith&title=Platinum%28IV%29+oxaliplatin-peptide+conjugates+targeting+memHsp70%2B+phenotype+in+colorectal+cancer+cells&doi=10.1039%2FC7CC04764A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells</span></div><div class="casAuthors">McKeon, A. M.; Noonan, J.; Devocelle, M.; Murphy, B. M.; Griffith, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">82</span>),
    <span class="NLM_cas:pages">11318-11321</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Novel Pt(IV) tumor penetrating peptide (TPP) conjugates are reported.  They are the first example of metallodrugs to target a membrane bound heat shock protein 70 pos. (memHSP70+) phenotype in cancer cells.  The conjugates exhibit superior cytotoxicity as compared to oxaliplatin alone in Pt resistant colorectal cancer cells with relatively high memHSP70+ expression.  Substitution of TPP in Pt(IV) peptide conjugates with scrambled peptide (ScP) essentially abolishes the obsd. cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUaQamhAZ9WbVg90H21EOLACvtfcHk0ligTIHzs_xfBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGgu7bK&md5=fa61de39ad4f01159ec86c6f5e9aca55</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7CC04764A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC04764A%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeon%26aufirst%3DA.%2BM.%26aulast%3DNoonan%26aufirst%3DJ.%26aulast%3DDevocelle%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DB.%2BM.%26aulast%3DGriffith%26aufirst%3DD.%2BM.%26atitle%3DPlatinum%2528IV%2529%2520oxaliplatin-peptide%2520conjugates%2520targeting%2520memHsp70%252B%2520phenotype%2520in%2520colorectal%2520cancer%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D11318%26epage%3D11321%26doi%3D10.1039%2FC7CC04764A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almotairy, A. R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erxleben, A.</span></span> <span> </span><span class="NLM_article-title">Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2017.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2017.09.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2017&pages=1-7&author=A.+R.+Z.+Almotairyauthor=V.+Gandinauthor=L.+Morrisonauthor=C.+Marzanoauthor=D.+Montagnerauthor=A.+Erxleben&title=Antitumor+platinum%28IV%29+derivatives+of+carboplatin+and+the+histone+deacetylase+inhibitor+4-phenylbutyric+acid&doi=10.1016%2Fj.jinorgbio.2017.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DAlmotairy%26aufirst%3DA.%2BR.%2BZ.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DMorrison%26aufirst%3DL.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DMontagner%26aufirst%3DD.%26aulast%3DErxleben%26aufirst%3DA.%26atitle%3DAntitumor%2520platinum%2528IV%2529%2520derivatives%2520of%2520carboplatin%2520and%2520the%2520histone%2520deacetylase%2520inhibitor%25204-phenylbutyric%2520acid%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D177%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.jinorgbio.2017.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braude, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">A quadruple-action platinum(IV) prodrug with anticancer activity against KRAS mutated cancer cell lines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11539</span>â <span class="NLM_lpage">11544</span>, <span class="refDoi">Â DOI: 10.1002/anie.201706739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fanie.201706739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11539-11544&author=E.+Petruzzellaauthor=J.+P.+Braudeauthor=J.+R.+Aldrich-Wrightauthor=V.+Gandinauthor=D.+Gibson&title=A+quadruple-action+platinum%28IV%29+prodrug+with+anticancer+activity+against+KRAS+mutated+cancer+cell+lines&doi=10.1002%2Fanie.201706739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines</span></div><div class="casAuthors">Petruzzella, Emanuele; Braude, Jeremy Phillip; Aldrich-Wright, Janice R.; Gandin, Valentina; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11539-11544</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We developed a novel PtIV prodrug that simultaneously releases four different bioactive moieties inside the cancer cell.  Its cytotoxicity against monolayer cultures (2D) and spheroid (3D) cancer cells is significantly better than cisplatin.  It is 200-450-fold more potent than cisplatin against KRAS mutated pancreatic and colon cancers and is 40-fold more selective towards KRAS mutated cells compared to non-cancerous.  This is important since RAS proteins play a role in regulating cell differentiation, proliferation, and survival and KRAS is mutated in 90 % of pancreatic adenocarcinomas, 45 % of colorectal cancers, and 35 % of lung adenocarcinomas.  The selectivity index, detd. by dividing the IC50 value in non-cancerous cells by that of a cancerous cell line, is two-fold better than cisplatin, attesting to preferential cytotoxicity towards neoplastic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQHgQHWGMgbVg90H21EOLACvtfcHk0ligTIHzs_xfBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ&md5=4a9c4fcc8d6006775b09c9e4c246d175</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706739%26sid%3Dliteratum%253Aachs%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DBraude%26aufirst%3DJ.%2BP.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DA%2520quadruple-action%2520platinum%2528IV%2529%2520prodrug%2520with%2520anticancer%2520activity%2520against%2520KRAS%2520mutated%2520cancer%2520cell%2520lines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11539%26epage%3D11544%26doi%3D10.1002%2Fanie.201706739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarski, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GrÃ¼nert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span> <span> </span><span class="NLM_article-title">Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">488</span>â <span class="NLM_lpage">495</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.200600211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fcmdc.200600211" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=488-495&author=D.+M.+Fisherauthor=P.+J.+Bednarskiauthor=R.+Gr%C3%BCnertauthor=P.+Turnerauthor=R.+R.+Fentonauthor=J.+R.+Aldrich-Wright&title=Chiral+platinum%28II%29+metallointercalators+with+potent+in+vitro+cytotoxic+activity&doi=10.1002%2Fcmdc.200600211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600211%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BM.%26aulast%3DBednarski%26aufirst%3DP.%2BJ.%26aulast%3DGr%25C3%25BCnert%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DP.%26aulast%3DFenton%26aufirst%3DR.%2BR.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26atitle%3DChiral%2520platinum%2528II%2529%2520metallointercalators%2520with%2520potent%2520in%2520vitro%2520cytotoxic%2520activity%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D488%26epage%3D495%26doi%3D10.1002%2Fcmdc.200600211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Multi-action Pt(IV) anticancer agents; do we understand how they work?</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">77</span>â <span class="NLM_lpage">84</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2018.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2018.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=30471522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ymu7bL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2019&pages=77-84&author=D.+Gibson&title=Multi-action+Pt%28IV%29+anticancer+agents%3B+do+we+understand+how+they+work%3F&doi=10.1016%2Fj.jinorgbio.2018.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-action Pt(IV) anticancer agents; do we understand how they work?</span></div><div class="casAuthors">Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Pt(IV) complexes act as prodrugs that are activated inside cancer cells releasing cytotoxic Pt(II) drugs such as cisplatin as well as two axial ligands.  These ligands can be used to confer favorable pharmacol. properties to the prodrug.  They can be innocent spectators, targeting agents or bioactive moieties.  When the ligands are bioactive moieties such as enzyme inhibitors or antiproliferative agents, the prodrug attacks several cellular targets at the same time acting as a multi-action prodrug.  These compds. are very potent and often overcome resistance to cisplatin.  Despite solid rationalization and careful design, often there is no correlation between the ability of the bioactive ligand to inhibit the target enzyme and the cytotoxicity.  This might be because most bioactive ligands affect several cellular functions and not only the ones they were designed to inhibit.  Thus, even "dual action" prodrugs might in reality be multi-action prodrugs.  This class of multi-action Pt(IV) prodrugs seems to have great potential in the attempts to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKUt_0wXsE5bVg90H21EOLACvtfcHk0lhs6-3BlUsoFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ymu7bL&md5=a199a637a9b7064be424d40a295d9a34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2018.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2018.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DMulti-action%2520Pt%2528IV%2529%2520anticancer%2520agents%253B%2520do%2520we%2520understand%2520how%2520they%2520work%253F%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2019%26volume%3D191%26spage%3D77%26epage%3D84%26doi%3D10.1016%2Fj.jinorgbio.2018.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kidani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukagoshi, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anti-tumor activities of platinum(II) complexes of 1,2-diaminocyclohexane isomers and their related derivatives</span>. <i>J. Clin. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">197</span>â <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaE2sXktVShu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1977&pages=197-209&author=Y.+Kidaniauthor=K.+Inagakiauthor=R.+Saitoauthor=S.+Tsukagoshi&title=Synthesis+and+anti-tumor+activities+of+platinum%28II%29+complexes+of+1%2C2-diaminocyclohexane+isomers+and+their+related+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anti-tumor activities of platinum(II) complexes of 1,2-diaminocyclohexane isomers and their related derivatives</span></div><div class="casAuthors">Kidani, Y.; Inagaki, K.; Saito, R.; Tsukagoshi, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hematology and Oncology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-209</span>CODEN:
                <span class="NLM_cas:coden">JCHODP</span>;
        ISSN:<span class="NLM_cas:issn">0162-9360</span>.
    </div><div class="casAbstract">Pt(II) complexes with cis- [1436-59-5], d-trans [21436-03-3], and l-trans-1,2-diaminocyclohexane [20439-47-8] were prepd. and tested for antitumor activity.  The Pt(II) complexes included the Cl, oxalate, malonate, and methylmalonate salts and the uracil complexes.  The l-trans-1,2-diaminocyclohexane complexes showed the greatest neoplasm inhibiting activity.  In contrast, complexes of Cu and Ni with 1,2-diaminocyclohexane were inactive.  The conformational difference obsd. in this study may give very important information in the study of the mechanism of Pt complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpylOJGUQa6c7Vg90H21EOLACvtfcHk0lhs6-3BlUsoFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVShu7Y%253D&md5=dded18668af28b91b6de3fdc05c1d1c5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKidani%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DTsukagoshi%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520anti-tumor%2520activities%2520of%2520platinum%2528II%2529%2520complexes%2520of%25201%252C2-diaminocyclohexane%2520isomers%2520and%2520their%2520related%2520derivatives%26jtitle%3DJ.%2520Clin.%2520Hematol.%2520Oncol.%26date%3D1977%26volume%3D7%26spage%3D197%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kidani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukagoshi, S.</span></span> <span> </span><span class="NLM_article-title">Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers and their related complexes</span>. <i>Gann</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">921</span>â <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1976&pages=921-922&author=Y.+Kidaniauthor=K.+Inagakiauthor=S.+Tsukagoshi&title=Examination+of+antitumor+activities+of+platinum+complexes+of+1%2C2-diaminocyclohexane+isomers+and+their+related+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKidani%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DK.%26aulast%3DTsukagoshi%26aufirst%3DS.%26atitle%3DExamination%2520of%2520antitumor%2520activities%2520of%2520platinum%2520complexes%2520of%25201%252C2-diaminocyclohexane%2520isomers%2520and%2520their%2520related%2520complexes%26jtitle%3DGann%26date%3D1976%26volume%3D67%26spage%3D921%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnesano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannunzio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coluccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natile, G.</span></span> <span> </span><span class="NLM_article-title">Effect of chirality in platinum drugs</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">286</span>â <span class="NLM_lpage">297</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2014.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ccr.2014.07.016" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2015&pages=286-297&author=F.+Arnesanoauthor=A.+Pannunzioauthor=M.+Colucciaauthor=G.+Natile&title=Effect+of+chirality+in+platinum+drugs&doi=10.1016%2Fj.ccr.2014.07.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DArnesano%26aufirst%3DF.%26aulast%3DPannunzio%26aufirst%3DA.%26aulast%3DColuccia%26aufirst%3DM.%26aulast%3DNatile%26aufirst%3DG.%26atitle%3DEffect%2520of%2520chirality%2520in%2520platinum%2520drugs%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D284%26spage%3D286%26epage%3D297%26doi%3D10.1016%2Fj.ccr.2014.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pages, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeschele, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span> <span> </span><span class="NLM_article-title">Combining the platinum(II) drug candidate kiteplatin with 1,10-phenanthroline analogues</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2156</span>â <span class="NLM_lpage">2163</span>, <span class="refDoi">Â DOI: 10.1039/C7DT04108J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7DT04108J" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=2156-2163&author=B.+J.+Pagesauthor=J.+Sakoffauthor=J.+Gilbertauthor=Y.+Zhangauthor=S.+M.+Kellyauthor=J.+D.+Hoescheleauthor=J.+R.+Aldrich-Wright&title=Combining+the+platinum%28II%29+drug+candidate+kiteplatin+with+1%2C10-phenanthroline+analogues&doi=10.1039%2FC7DT04108J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC7DT04108J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT04108J%26sid%3Dliteratum%253Aachs%26aulast%3DPages%26aufirst%3DB.%2BJ.%26aulast%3DSakoff%26aufirst%3DJ.%26aulast%3DGilbert%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DS.%2BM.%26aulast%3DHoeschele%26aufirst%3DJ.%2BD.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26atitle%3DCombining%2520the%2520platinum%2528II%2529%2520drug%2520candidate%2520kiteplatin%2520with%25201%252C10-phenanthroline%2520analogues%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26spage%3D2156%26epage%3D2163%26doi%3D10.1039%2FC7DT04108J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovejoy, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagpacan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacomini, K. M.</span></span> <span> </span><span class="NLM_article-title">Organic cation transporters are determinants of oxaliplatin cytotoxicity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">8847</span>â <span class="NLM_lpage">8857</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-06-0769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1158%2F0008-5472.CAN-06-0769" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8847-8857&author=S.+Zhangauthor=K.+S.+Lovejoyauthor=J.+E.+Shimaauthor=L.+L.+Lagpacanauthor=Y.+Shuauthor=A.+Lapukauthor=Y.+Chenauthor=T.+Komoriauthor=J.+W.+Grayauthor=X.+Chenauthor=S.+J.+Lippardauthor=K.+M.+Giacomini&title=Organic+cation+transporters+are+determinants+of+oxaliplatin+cytotoxicity&doi=10.1158%2F0008-5472.CAN-06-0769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-0769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-0769%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLovejoy%26aufirst%3DK.%2BS.%26aulast%3DShima%26aufirst%3DJ.%2BE.%26aulast%3DLagpacan%26aufirst%3DL.%2BL.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DLapuk%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKomori%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DOrganic%2520cation%2520transporters%2520are%2520determinants%2520of%2520oxaliplatin%2520cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8847%26epage%3D8857%26doi%3D10.1158%2F0008-5472.CAN-06-0769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶schl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varbanov, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">264</span>â <span class="NLM_lpage">274</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2016.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27055943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BC28fotFartw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=264-274&author=S.+G%C3%B6schlauthor=H.+P.+Varbanovauthor=S.+Theinerauthor=M.+A.+Jakupecauthor=M.+Galanskiauthor=B.+K.+Keppler&title=The+role+of+the+equatorial+ligands+for+the+redox+behavior%2C+mode+of+cellular+accumulation+and+cytotoxicity+of+platinum%28IV%29+prodrugs&doi=10.1016%2Fj.jinorgbio.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs</span></div><div class="casAuthors">Goschl Simone; Galanski Markus; Varbanov Hristo P; Theiner Sarah; Keppler Bernhard K; Jakupec Michael A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of inorganic biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">264-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current study aims to elucidate the possible reasons for the significantly different pharmacological behavior of platinum(IV) complexes with cisplatin-, carboplatin- or nedaplatin-like cores and how this difference can be related to their main physicochemical properties.  Chlorido-containing complexes are reduced fast (within hours) by ascorbate and are able to unwind plasmid DNA in the presence of ascorbate, while their tri- and tetracarboxylato analogs are generally inert under the same conditions.  Comparison of the lipophilicity, cellular accumulation and cytotoxicity of the investigated platinum compounds revealed the necessity to define new structure-property/activity relationships (SPRs and SARs).  The higher activity and improved accumulation of platinum(IV) complexes bearing Cl(-) in equatorial position cannot only be attributed to passive diffusion facilitated by their lipophilicity.  Therefore, further platinum accumulation experiments under conditions where active/facilitated transport mechanisms are suppressed were performed.  Under hypothermic conditions (4Â°C), accumulation of dichloridoplatinum(IV) complexes is reduced down to 10% of the amount determined at 37Â°C.  These findings suggest the involvement of active and/or facilitated transport in cellular uptake of platinum(IV) complexes with a cisplatin-like core.  Studies with ATP depletion mediated by oligomycin and low glucose partially confirmed these observations, but their feasibility was severely limited in the adherent cell culture setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLmoZWYt2uxdHxxy173TfNfW6udTcc2eY0HhE64OZqG7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fotFartw%253D%253D&md5=bde61949f69036e84c95aa4b53c26b79</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6schl%26aufirst%3DS.%26aulast%3DVarbanov%26aufirst%3DH.%2BP.%26aulast%3DTheiner%26aufirst%3DS.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DGalanski%26aufirst%3DM.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DThe%2520role%2520of%2520the%2520equatorial%2520ligands%2520for%2520the%2520redox%2520behavior%252C%2520mode%2520of%2520cellular%2520accumulation%2520and%2520cytotoxicity%2520of%2520platinum%2528IV%2529%2520prodrugs%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D160%26spage%3D264%26epage%3D274%26doi%3D10.1016%2Fj.jinorgbio.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5777</span>â <span class="NLM_lpage">5783</span>, <span class="refDoi">Â DOI: 10.1021/ic200607j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic200607j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=5777-5783&author=Z.+Liuauthor=L.+Salassaauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Contrasting+reactivity+and+cancer+cell+cytotoxicity+of+isoelectronic+organometallic+iridium%28III%29+complexes&doi=10.1021%2Fic200607j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span></div><div class="casAuthors">Liu, Zhe; Salassa, Luca; Habtemariam, Abraha; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5777-5783</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iridium(III) half-sandwich neutral cyclometalated 2-phenylpyridine (Hphpy) complex [Cp*Ir(phpy)Cl] (2, Cp* = Î·5-C5Me5) undergo substitution of the chloro ligand for nucleobases, exhibiting a promising cytotoxicity against human ovarian cancer cells.  Replacing the N,N-chelating ligand 2,2'-bipyridine (bpy) in the IrIII Î·5-pentamethylcyclopentadienyl complex [Cp*Ir(bpy)Cl]+ (1) with the C,N-chelating ligand Hphpy to give 2 switches on cytotoxicity toward A2780 human ovarian cancer cells (IC50 values of >100 Î¼M for 1 and 10.8 Î¼M for 2).  Ir-Cl hydrolysis is rapid for both complexes (hydrolysis equil. reached in <5 min at 278 K).  Complex 2 forms adducts with both 9-ethylguanine (9-EtG) and 9-methyladenine (9-MeA), but preferentially with 9-EtG when in competition (ca. 85% of total Ir after 24 h).  The x-ray crystal structure of [(Î·5-C5Me5)Ir(phpy)(9-EtG-N7)]NO3Â·1.5CH2Cl2 (3) confirms N7 binding to guanine.  Two-dimensional NMR spectra show that complex 2 binds to adenine mainly through N1, consistent with d. functional theory (DFT) calcns.  DFT calcns. indicate an interaction between the nitrogen of the NH2 group (9-MeA) and carbons from phpy in the adenine adduct of complex 2.  Calcns. show that the most stable geometry of the adduct [Cp*Ir(phpy)(9-EtG-ÎºN7)]+ (3b) has the C6 of 9-EtG orientated toward the pyridine ring of phpy, and for [Cp*Ir(phpy)(9-MeA-ÎºN1)]+ (4(N1)a), the NH2 group of 9-EtA is adjacent to the Ph ring side of phpy.  Complex 2 is more hydrophobic than complex 1, with log P values of 1.57 and -0.95, resp.  The strong nucleobase binding and high hydrophobicity of complex 2 probably contribute to its promising anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqMjGMrbypdbVg90H21EOLACvtfcHk0lhj6A3Dcy1KHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D&md5=b60e6409afb934203732b78ce3169b6e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fic200607j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic200607j%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DContrasting%2520reactivity%2520and%2520cancer%2520cell%2520cytotoxicity%2520of%2520isoelectronic%2520organometallic%2520iridium%2528III%2529%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D2011%26volume%3D50%26spage%3D5777%26epage%3D5783%26doi%3D10.1021%2Fic200607j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">72</span>â <span class="NLM_lpage">79</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=25063910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Khu7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2014&pages=72-79&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=Antitumor+platinum%28IV%29+derivatives+of+oxaliplatin+with+axial+valproato+ligands&doi=10.1016%2Fj.jinorgbio.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-79</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We report new anticancer prodrugs, platinum(IV) derivs. of oxaliplatin conjugated with valproic acid (VPA), a well-known drug having histone deacetylase inhibitory activity.  Like most platinum(IV) derivs., the cytotoxicity of the conjugates was lower in cell culture than that of oxaliplatin, but greater than those of its Pt(IV) deriv. contg. biol. inactive axial ligands in several cancer cell lines.  Notably, these conjugates display activity in both cisplatin sensitive- and resistant tumor cells capable of both markedly enhanced accumulation in tumor cells and acting in a dual threat manner, concurrently targeting histone deacetylase and genomic DNA.  These results demonstrate the dual targeting strategy to be a valuable route to pursue in the design of platinum agents which may be more effective in cancer types that are typically resistant to therapy by conventional cisplatin.  Moreover, platinum(IV) derivs. contg. VPA axial ligands seem to be promising dual-targeting candidates for addnl. preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUyC3cksfQ2rVg90H21EOLACvtfcHk0lhj6A3Dcy1KHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Khu7rL&md5=9bb753b45976997c1ab2b0416d1fd89a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DAntitumor%2520platinum%2528IV%2529%2520derivatives%2520of%2520oxaliplatin%2520with%2520axial%2520valproato%2520ligands%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D140%26spage%3D72%26epage%3D79%26doi%3D10.1016%2Fj.jinorgbio.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abassi, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirstein, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaylord, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Kinetic cell-based morphological screening: Prediction of mechanism of compound action and off-target effects</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">712</span>â <span class="NLM_lpage">723</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2009.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.chembiol.2009.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=19635408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=712-723&author=Y.+A.+Abassiauthor=B.+Xiauthor=W.+F.+Zhangauthor=P.+F.+Yeauthor=S.+L.+Kirsteinauthor=M.+R.+Gaylordauthor=S.+C.+Feinsteinauthor=X.+B.+Wangauthor=X.+Xu&title=Kinetic+cell-based+morphological+screening%3A+Prediction+of+mechanism+of+compound+action+and+off-target+effects&doi=10.1016%2Fj.chembiol.2009.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects</span></div><div class="casAuthors">Abassi, Yama A.; Xi, Biao; Zhang, Wenfu; Ye, Peifang; Kirstein, Shelli L.; Gaylord, Michelle R.; Feinstein, Stuart C.; Wang, Xiaobo; Xu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">712-723</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: We describe a cell-based kinetic profiling approach using impedance readout for monitoring the effect of small mol. compds.  This noninvasive readout allows continuous sampling of cellular responses to biol. active compds. and the ensuing kinetic profile provides information regarding the temporal interaction of compds. with cells.  The utility of this approach was tested by screening a library contg. FDA approved drugs, exptl. compds., and nature compds.  Compds. with similar activity produced similar impedance-based time-dependent cell response profiles (TCRPs).  The compds. were clustered based on TCRP similarity.  We identified novel mechanisms for existing drugs, confirmed previously reported calcium modulating activity for COX-2 inhibitor celecoxib, and identified an addnl. mechanism for the exptl. compd. monastrol.  We also identified and characterized a new antimitotic agent.  Our findings indicate that the TCRP approach provides predictive mechanistic information for small mol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA6tm5nSc0P7Vg90H21EOLACvtfcHk0lgMpQoEGC7uMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLs%253D&md5=aee918ffcbd38ac87a6239062dae3771</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DAbassi%26aufirst%3DY.%2BA.%26aulast%3DXi%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DW.%2BF.%26aulast%3DYe%26aufirst%3DP.%2BF.%26aulast%3DKirstein%26aufirst%3DS.%2BL.%26aulast%3DGaylord%26aufirst%3DM.%2BR.%26aulast%3DFeinstein%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BB.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DKinetic%2520cell-based%2520morphological%2520screening%253A%2520Prediction%2520of%2520mechanism%2520of%2520compound%2520action%2520and%2520off-target%2520effects%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D712%26epage%3D723%26doi%3D10.1016%2Fj.chembiol.2009.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1491</span>â <span class="NLM_lpage">1501</span>, <span class="refDoi">Â DOI: 10.1039/C4MT00112E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC4MT00112E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=24828756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1491-1501&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=A.+Kisovaauthor=H.+Kostrhunovaauthor=Z.+Liuauthor=P.+J.+Sadlerauthor=J.+Kasparkovaauthor=V.+Brabec&title=A+dual-targeting%2C+apoptosis-inducing+organometallic+half-sandwich+iridium+anticancer+complex&doi=10.1039%2FC4MT00112E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Kisova, Anna; Kostrhunova, Hana; Liu, Zhe; Sadler, Peter J.; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1491-1501</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cellular mechanism of action of an iridium(III) half-sandwich complex [(Î·5-C5Me4C6H4C6H5)Ir(phen)Cl]PF6 (phen = phenanthroline) (1) is reported.  Complex 1 was used to treat several cell lines, including cisplatin-sensitive, cisplatin-resistant (with intrinsic and acquired resistance) carcinoma cells with wild type p53 status as well as the cells with no intact p53 gene, and nontumorigenic cells.  Complex 1 preferentially kills cancer cells over nontumorigenic cells and exhibits no cross-resistance with cisplatin.  It appears to retain significant activity in human tumor cell lines that are refractory or poorly responsive to cisplatin, and in contrast to cisplatin it displays a high activity in human tumor cell lines that are characterized by both wild type and mutant p53 gene.  The mechanism of cell killing was established through detailed cell-based assays.  Complex 1 exhibits dual effects in killing cancer cells causing nuclear DNA damage and mitochondrial dysfunction involving ROS prodn. simultaneously.  Flow cytometric studies and impedance-based monitoring of cellular responses to 1 demonstrated that 1 acts more quickly than cisplatin to induce cell death and that 1 is a more effective apoptosis inducer than cisplatin in particular in early stages of treatment, when the apoptotic effects predominate over necrosis.  Overall, our findings confirm that 1 and its iridium derivs. represent promising candidates for further pre-clin. studies and new addns. to the growing family of nonplatinum metal-based anticancer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rhP03baUXLVg90H21EOLACvtfcHk0lgMpQoEGC7uMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK&md5=5180cef5e67873d2336bb4cf2b24f95a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FC4MT00112E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00112E%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DKisova%26aufirst%3DA.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DA%2520dual-targeting%252C%2520apoptosis-inducing%2520organometallic%2520half-sandwich%2520iridium%2520anticancer%2520complex%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26spage%3D1491%26epage%3D1501%26doi%3D10.1039%2FC4MT00112E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irelan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abassi, Y. A.</span></span> <span> </span><span class="NLM_article-title">Screening and identification of small molecule compounds perturbing mitosis using time-dependent cellular response profiles</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">6495</span>â <span class="NLM_lpage">6503</span>, <span class="refDoi">Â DOI: 10.1021/ac1007877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac1007877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2010&pages=6495-6503&author=N.+Keauthor=B.+Xiauthor=P.+Yeauthor=W.+Xuauthor=M.+Zhengauthor=L.+Maoauthor=M.+J.+Wuauthor=J.+Zhuauthor=J.+Wuauthor=W.+Zhangauthor=J.+Zhangauthor=J.+Irelanauthor=X.+Wangauthor=X.+Xuauthor=Y.+A.+Abassi&title=Screening+and+identification+of+small+molecule+compounds+perturbing+mitosis+using+time-dependent+cellular+response+profiles&doi=10.1021%2Fac1007877"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fac1007877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac1007877%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIrelan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DAbassi%26aufirst%3DY.%2BA.%26atitle%3DScreening%2520and%2520identification%2520of%2520small%2520molecule%2520compounds%2520perturbing%2520mitosis%2520using%2520time-dependent%2520cellular%2520response%2520profiles%26jtitle%3DAnal.%2520Chem.%26date%3D2010%26volume%3D82%26spage%3D6495%26epage%3D6503%26doi%3D10.1021%2Fac1007877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic platinum coordination compounds. DNA binding agents</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">2</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2017.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ccr.2017.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVyksb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2017&pages=2-31&author=V.+Brabecauthor=O.+Hrabinaauthor=J.+Kasparkova&title=Cytotoxic+platinum+coordination+compounds.+DNA+binding+agents&doi=10.1016%2Fj.ccr.2017.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic platinum coordination compounds. DNA binding agents</span></div><div class="casAuthors">Brabec, Viktor; Hrabina, Ondrej; Kasparkova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2-31</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Despite the widespread use of antineoplastic platinum drugs, a no. of accompanying disadvantages exist.  In connection with attempts to circumvent these problems, new platinum compds. have been prepd. and mechanisms underlying their biol. activity have been extensively investigated.  These mechanistic investigations involve research focused on understanding interactions of platinum agents with DNA since DNA binding and recognition of DNA modified by these metallodrugs are the important processes responsible for their anticancer properties.  In this review, we discuss how various classes of platinum(II) complexes, which can interact with DNA by coordination, intercalation and other noncovalent modes of binding or by a combination of these DNA binding modes, can alter the cellular response induced by conventional platinum drugs.  We describe that these alterations can be achieved by changing: (i) the nature and structure of the DNA lesion induced; (ii) conformational alterations induced in DNA by these lesions; and (iii) various cellular signaling pathways initiated by platinum-DNA damage.  We anticipate that summarization of the results on DNA binding of cytotoxic platinum compds. may help to shed light on their potency and will make it possible to create new strategies to design rationally new anticancer platinum compds. and/or combine platinum drugs with other cytotoxic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon1KJpzvhkYrVg90H21EOLACvtfcHk0liuPwRBQ1of0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVyksb8%253D&md5=f2b5a9076242507a8742327d05651a33</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2017.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2017.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DHrabina%26aufirst%3DO.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DCytotoxic%2520platinum%2520coordination%2520compounds.%2520DNA%2520binding%2520agents%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2017%26volume%3D351%26spage%3D2%26epage%3D31%26doi%3D10.1016%2Fj.ccr.2017.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harper, B. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman-Ezra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirota, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Probing the interactions of cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and its PtIVDerivatives with human serum</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">510</span>â <span class="NLM_lpage">519</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201700092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fcmdc.201700092" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=510-519&author=B.+W.+J.+Harperauthor=A.+Friedman-Ezraauthor=R.+Sirotaauthor=E.+Petruzzellaauthor=J.+R.+Aldrich-Wrightauthor=D.+Gibson&title=Probing+the+interactions+of+cytotoxic+%5BPt%281S%2C2S-DACH%29%285%2C6-dimethyl-1%2C10-phenanthroline%29%5D+and+its+PtIVDerivatives+with+human+serum&doi=10.1002%2Fcmdc.201700092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700092%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DB.%2BW.%2BJ.%26aulast%3DFriedman-Ezra%26aufirst%3DA.%26aulast%3DSirota%26aufirst%3DR.%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DProbing%2520the%2520interactions%2520of%2520cytotoxic%2520%255BPt%25281S%252C2S-DACH%2529%25285%252C6-dimethyl-1%252C10-phenanthroline%2529%255D%2520and%2520its%2520PtIVDerivatives%2520with%2520human%2520serum%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D510%26epage%3D519%26doi%3D10.1002%2Fcmdc.201700092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2793</span>â <span class="NLM_lpage">2800</span>, <span class="refDoi">Â DOI: 10.1021/mp200597r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200597r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=2793-2800&author=J.+Yangauthor=X.+Sunauthor=W.+Maoauthor=M.+Suiauthor=J.+Tangauthor=Y.+Shen&title=Conjugate+of+Pt%28IV%29-histone+deacetylase+inhibitor+as+a+prodrug+for+cancer+chemotherapy&doi=10.1021%2Fmp200597r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugate of Pt(IV)-Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy</span></div><div class="casAuthors">Yang, Jun; Sun, Xuanrong; Mao, Weiwei; Sui, Meihua; Tang, Jianbin; Shen, Youqing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2793-2800</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Platinum(IV) prodrug diaminedichlorodihydroxyplatinum (ACHP) conjugated with a histone deacetylase (HDAC) inhibitor valproic acid (VA), VAAP, exhibited strong synergistic cytotoxicity, about 50-100 times more cytotoxic than ACHP or its simple mixt. with VA, against various human carcinoma cell lines.  VAAP could be quickly absorbed in the cell membrane and diffused into the cytosol.  VAAP loaded in polyethylene glycol-polycaprolactone micelles (PEG-PCL) was taken up via endocytosis.  The cytosolic VAAP was intracellular reduced to Pt(II) and released VA eliciting a HDAC inhibitory effect and subsequently induced cell cycle arrest at the S phase in 24 h and cell apoptosis in a time-dependent manner.  The in vivo antitumor expt. on A549-xenograft tumor model showed that VAAP dispersed in Tween 80 or loaded in PEG-PCL nanoparticles had long blood circulation times and thereby high accumulation in tumors and exerted a significant in vivo inhibitory effect on tumor growth with low systemic toxicity.  Therefore, this novel conjugate is very promising for cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeW1MFD6bedbVg90H21EOLACvtfcHk0liuPwRBQ1of0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK&md5=838e90dcb852b4dddeb424832f46ab15</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fmp200597r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200597r%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DConjugate%2520of%2520Pt%2528IV%2529-histone%2520deacetylase%2520inhibitor%2520as%2520a%2520prodrug%2520for%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D2793%26epage%3D2800%26doi%3D10.1021%2Fmp200597r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blajeski, A.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottke, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S. H.</span></span> <span> </span><span class="NLM_article-title">G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1172/JCI13275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1172%2FJCI13275" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=91-99&author=A.%0AL.+Blajeskiauthor=V.+A.+Phanauthor=T.+J.+Kottkeauthor=S.+H.+Kaufmann&title=G%281%29+and+G%282%29+cell-cycle+arrest+following+microtubule+depolymerization+in+human+breast+cancer+cells&doi=10.1172%2FJCI13275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1172%2FJCI13275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13275%26sid%3Dliteratum%253Aachs%26aulast%3DBlajeski%26aufirst%3DA.%2BL.%26aulast%3DPhan%26aufirst%3DV.%2BA.%26aulast%3DKottke%26aufirst%3DT.%2BJ.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DG%25281%2529%2520and%2520G%25282%2529%2520cell-cycle%2520arrest%2520following%2520microtubule%2520depolymerization%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D110%26spage%3D91%26epage%3D99%26doi%3D10.1172%2FJCI13275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. H.</span></span> <span> </span><span class="NLM_article-title">Mycotoxin citrinin induced cell cycle G2/M arrest and numerical chromosomal aberration associated with disruption of microtubule formation in human cells</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">84</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.1093/toxsci/kfq309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1093%2Ftoxsci%2Fkfq309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=20929984" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=84-92&author=C.+H.+Changauthor=F.+Y.+Yuauthor=T.+S.+Wuauthor=L.+T.+Wangauthor=B.+H.+Liu&title=Mycotoxin+citrinin+induced+cell+cycle+G2%2FM+arrest+and+numerical+chromosomal+aberration+associated+with+disruption+of+microtubule+formation+in+human+cells&doi=10.1093%2Ftoxsci%2Fkfq309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq309%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DYu%26aufirst%3DF.%2BY.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DWang%26aufirst%3DL.%2BT.%26aulast%3DLiu%26aufirst%3DB.%2BH.%26atitle%3DMycotoxin%2520citrinin%2520induced%2520cell%2520cycle%2520G2%252FM%2520arrest%2520and%2520numerical%2520chromosomal%2520aberration%2520associated%2520with%2520disruption%2520of%2520microtubule%2520formation%2520in%2520human%2520cells%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D119%26spage%3D84%26epage%3D92%26doi%3D10.1093%2Ftoxsci%2Fkfq309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Oliveira Niero, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado-Santelli, G. M.</span></span> <span> </span><span class="NLM_article-title">Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi">Â DOI: 10.1186/1756-9966-32-31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1186%2F1756-9966-32-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=23701745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2qurvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=31&author=E.+L.+de%0AOliveira+Nieroauthor=G.+M.+Machado-Santelli&title=Cinnamic+acid+induces+apoptotic+cell+death+and+cytoskeleton+disruption+in+human+melanoma+cells&doi=10.1186%2F1756-9966-32-31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells</span></div><div class="casAuthors">de Oliveira Niero, Evandro Luis; Machado-Santelli, Glaucia Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Anticancer activities of cinnamic acid derivs. include induction of apoptosis by irreversible DNA damage leading to cell death.  The present work aimed to compare the cytotoxic and genotoxic potential of cinnamic acid in human melanoma cell line (HT-144) and human melanocyte cell line derived from blue nevus (NGM).  Viability assay showed that the IC50 for HT-144 cells was 2.4 mM, while NGM cells were more resistant to the treatment.  The growth inhibition was probably assocd. with DNA damage leading to DNA synthesis inhibition, as shown by BrdU incorporation assay, induction of nuclear aberrations and then apoptosis.  The frequency of cell death caused by cinnamic acid was higher in HT-144 cells.  Activated-caspase 3 staining showed apoptosis after 24 h of treatment with cinnamic acid 3.2 mM in HT-144 cells, but not in NGM.  We obsd. microtubules disorganization after cinnamic acid exposure, but this event and cell death seem to be independent according to M30 and tubulin labeling.  The frequency of micronucleated HT-144 cells was higher after treatment with cinnamic acid (0.4 and 3.2 mM) when compared to the controls.  Cinnamic acid 3.2 mM also increased the frequency of micronucleated NGM cells indicating genotoxic activity of the compd., but the effects were milder.  Binucleation and multinucleation counting showed similar results.  We conclude that cinnamic acid has effective antiproliferative activity against melanoma cells.  However, the increased frequency of micronucleation in NGM cells warrants the possibility of genotoxicity and needs further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTLjZZfx2E77Vg90H21EOLACvtfcHk0ljHfCC10qrkWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2qurvK&md5=a37503718007e3602fd2987f656f18eb</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-32-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-32-31%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BOliveira%2BNiero%26aufirst%3DE.%2BL.%26aulast%3DMachado-Santelli%26aufirst%3DG.%2BM.%26atitle%3DCinnamic%2520acid%2520induces%2520apoptotic%2520cell%2520death%2520and%2520cytoskeleton%2520disruption%2520in%2520human%2520melanoma%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D32%26spage%3D31%26doi%3D10.1186%2F1756-9966-32-31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, M.</span></span> <span> </span><span class="NLM_article-title">Cucurbitacins: elucidation of their interactions with the cytoskeleton</span>. <i>PeerJ</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e3357</span> <span class="refDoi">Â DOI: 10.7717/peerj.3357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.7717%2Fpeerj.3357" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&author=X.+Wangauthor=M.+Tanakaauthor=H.+S.+Peixotoauthor=M.+Wink&title=Cucurbitacins%3A+elucidation+of+their+interactions+with+the+cytoskeleton&doi=10.7717%2Fpeerj.3357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.7717%2Fpeerj.3357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7717%252Fpeerj.3357%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DPeixoto%26aufirst%3DH.%2BS.%26aulast%3DWink%26aufirst%3DM.%26atitle%3DCucurbitacins%253A%2520elucidation%2520of%2520their%2520interactions%2520with%2520the%2520cytoskeleton%26jtitle%3DPeerJ%26date%3D2017%26volume%3D5%26doi%3D10.7717%2Fpeerj.3357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wawruszak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luszczki, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabarska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumbarewicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmoszynska-Graniczka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepulak, A.</span></span> <span> </span><span class="NLM_article-title">Assessment of interactions between cisplatin and two histone deacetylase inhibitors in MCF7, T47D and MDA-MB-231 human breast cancer cell lines â An isobolographic analysis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0143013</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0143013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1371%2Fjournal.pone.0143013" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=A.+Wawruszakauthor=J.+J.+Luszczkiauthor=A.+Grabarskaauthor=E.+Gumbarewiczauthor=M.+Dmoszynska-Graniczkaauthor=K.+Polbergauthor=A.+Stepulak&title=Assessment+of+interactions+between+cisplatin+and+two+histone+deacetylase+inhibitors+in+MCF7%2C+T47D+and+MDA-MB-231+human+breast+cancer+cell+lines+%E2%80%93+An+isobolographic+analysis&doi=10.1371%2Fjournal.pone.0143013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0143013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0143013%26sid%3Dliteratum%253Aachs%26aulast%3DWawruszak%26aufirst%3DA.%26aulast%3DLuszczki%26aufirst%3DJ.%2BJ.%26aulast%3DGrabarska%26aufirst%3DA.%26aulast%3DGumbarewicz%26aufirst%3DE.%26aulast%3DDmoszynska-Graniczka%26aufirst%3DM.%26aulast%3DPolberg%26aufirst%3DK.%26aulast%3DStepulak%26aufirst%3DA.%26atitle%3DAssessment%2520of%2520interactions%2520between%2520cisplatin%2520and%2520two%2520histone%2520deacetylase%2520inhibitors%2520in%2520MCF7%252C%2520T47D%2520and%2520MDA-MB-231%2520human%2520breast%2520cancer%2520cell%2520lines%2520%25E2%2580%2593%2520An%2520isobolographic%2520analysis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0143013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauzi, A. Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omar, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, A. L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alitheen, N. B.</span></span> <span> </span><span class="NLM_article-title">Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro</span>. <i>Chin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">46</span>, <span class="refDoi">Â DOI: 10.1186/s13020-016-0118-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1186%2Fs13020-016-0118-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27891174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVaqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=46&author=A.+Z.+M.+Pauziauthor=S.+K.+Yeapauthor=N.+Abuauthor=K.+L.+Limauthor=A.+R.+Omarauthor=S.+A.+Azizauthor=A.+L.+T.+Chowauthor=T.+Subramaniauthor=S.+G.+Tanauthor=N.+B.+Alitheen&title=Combination+of+cisplatin+and+bromelain+exerts+synergistic+cytotoxic+effects+against+breast+cancer+cell+line+MDA-MB-231+in+vitro&doi=10.1186%2Fs13020-016-0118-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro</span></div><div class="casAuthors">Pauzi, Ahmad Zaim Mat; Yeap, Swee Keong; Abu, Nadiah; Lim, Kian Lam; Omar, Abdul Rahman; Abdul Aziz, Suraini; Chow, Adam Leow Thean; Subramani, Tamilselvan; Tan, Soon Guan; Alitheen, Noorjahan Banu</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">46/1-46/11</span>CODEN:
                <span class="NLM_cas:coden">CMHEBK</span>;
        ISSN:<span class="NLM_cas:issn">1749-8546</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Bromelain, which is a cysteine endopeptidase commonly found in pineapple stems, has been investigated as a potential anti-cancer agent for the treatment of breast cancer.  However, information pertaining to the effects of combining bromelain with existing chemotherapeutic drugs remains scarce.  This study aimed to investigate the possible synergistic cytotoxic effects of using bromelain in combination with cisplatin on MDA-MB-231 human breast cancer cells.  Method: MDA-MB-231 cells were treated with different concns. (0.24-9.5 Î¼M) of bromelain or cisplatin alone, as well as four different combinations of these two agents to assess their individual and combination effects after 24 and 48 h.  Cell viability was analyzed using an MTT assay.  The induction of apoptosis was assessed using cell cycle anal. and an Annexin V-FITC assay.  The role of the mitochondrial membrane potential in the apoptotic process was assessed using a JC-1 staining assay.  Apoptotic protein levels were assessed by western blot anal. and proteome profiling using an antibody array kit.  Results: Single-agent treatment with cisplatin or bromelain led to dose- and time-dependent decreases in the viability of the MDA-MB-231 cells at 24 and 48 h.  Furthermore, most of the combinations evaluated in this study displayed synergistic effects against MDA-MB-231 cells at 48 h, with combination 1 (bromelain 2 Î¼M + cisplatin 1.5 Î¼M) exhibiting the greatest synergistic effect (P = 0.000).  The results of subsequent assays indicated that combination 1 treatment induced apoptosis via mitochondria-mediated pathway.  Combination 1 also resulted in significant decreases in the levels of several apoptotic proteins such as Bcl-x and HSP70, compared with bromelain (P = 0.002 and 0.000, resp.) or cisplatin (P = 0.000 and 0.001, resp.) single treatment.  Notably, MDA-MB-231 cells treated with combination 1 showed increased levels of the pro-apoptotic proteins Bax compared with those treated with bromelain (P = 0.000) or cisplatin single treatment (P = 0.043).  Conclusion: Bromelain in combination with cisplatin synergistically enhanced the induction of apoptosis in MDA-MB-231 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyeb8iXrNGTrVg90H21EOLACvtfcHk0ljHfCC10qrkWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVaqsw%253D%253D&md5=bcfb97c62e39f4799ca1e3682f3edc12</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2Fs13020-016-0118-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13020-016-0118-5%26sid%3Dliteratum%253Aachs%26aulast%3DPauzi%26aufirst%3DA.%2BZ.%2BM.%26aulast%3DYeap%26aufirst%3DS.%2BK.%26aulast%3DAbu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DK.%2BL.%26aulast%3DOmar%26aufirst%3DA.%2BR.%26aulast%3DAziz%26aufirst%3DS.%2BA.%26aulast%3DChow%26aufirst%3DA.%2BL.%2BT.%26aulast%3DSubramani%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DS.%2BG.%26aulast%3DAlitheen%26aufirst%3DN.%2BB.%26atitle%3DCombination%2520of%2520cisplatin%2520and%2520bromelain%2520exerts%2520synergistic%2520cytotoxic%2520effects%2520against%2520breast%2520cancer%2520cell%2520line%2520MDA-MB-231%2520in%2520vitro%26jtitle%3DChin.%2520Med.%26date%3D2016%26volume%3D11%26spage%3D46%26doi%3D10.1186%2Fs13020-016-0118-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, C. T.</span></span> <span> </span><span class="NLM_article-title">Multi-target therapeutics: when the whole is greater than the sum of the parts</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">34</span>â <span class="NLM_lpage">42</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+therapeutics%3A+when+the+whole+is+greater+than+the+sum+of+the+parts&doi=10.1016%2Fj.drudis.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2eb4p0tTrpNucbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520therapeutics%253A%2520when%2520the%2520whole%2520is%2520greater%2520than%2520the%2520sum%2520of%2520the%2520parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42%26doi%3D10.1016%2Fj.drudis.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DoldÃ¡n-Martelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ­guez, D. G.</span></span> <span> </span><span class="NLM_article-title">Synergistic interaction between selective drugs in cell populations models</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0117558</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0117558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1371%2Fjournal.pone.0117558" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=V.+Dold%C3%A1n-Martelliauthor=D.+G.+M%C3%ADguez&title=Synergistic+interaction+between+selective+drugs+in+cell+populations+models&doi=10.1371%2Fjournal.pone.0117558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0117558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0117558%26sid%3Dliteratum%253Aachs%26aulast%3DDold%25C3%25A1n-Martelli%26aufirst%3DV.%26aulast%3DM%25C3%25ADguez%26aufirst%3DD.%2BG.%26atitle%3DSynergistic%2520interaction%2520between%2520selective%2520drugs%2520in%2520cell%2520populations%2520models%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0117558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Analysis of combined drug effects: a new look at a very old problem</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">450</span>â <span class="NLM_lpage">454</span>, <span class="refDoi">Â DOI: 10.1016/0165-6147(83)90490-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2F0165-6147%2883%2990490-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=450-454&author=T.-C.+Chouauthor=P.+Talalay&title=Analysis+of+combined+drug+effects%3A+a+new+look+at+a+very+old+problem&doi=10.1016%2F0165-6147%2883%2990490-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of combined drug effects:  a new look at a very old problem</span></div><div class="casAuthors">Chou, Ting Chao; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">450-4</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A simple, general and novel method for the quant. anal. of combined drug effects is presented.  The procedure dets. if the drug combinations are additive, synergistic or antagonistic, regardless of whether the dose-effect curves are hyperbolic (first order) or sigmoidal (higher order), or whether the effects of the drugs are totally independent or not.  The proposed method (median-effect plot) suffers from fewer restrictions and is more widely applicable than the isobologram or the fractional product method.  It provides insight into the nature of the dose-effect relationship with relatively few measurements.  The procedure is illustrated by analyzing the combined lethal effects of 2 insecticides on house-flies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObQzLgU9z07Vg90H21EOLACvtfcHk0lhiSpMOgm1D4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D&md5=af5698ed81a74924a1a296dacc8ce691</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2883%2990490-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252883%252990490-X%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.-C.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DAnalysis%2520of%2520combined%2520drug%2520effects%253A%2520a%2520new%2520look%2520at%2520a%2520very%2520old%2520problem%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1983%26volume%3D4%26spage%3D450%26epage%3D454%26doi%3D10.1016%2F0165-6147%2883%2990490-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Quantitative-analysis of dose-effect relationships - the combined effects of multiple-drugs or enzyme-inhibitors</span>. <i>Adv. Enzyme Regul.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">55</span>, <span class="refDoi">Â DOI: 10.1016/0065-2571(84)90007-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2F0065-2571%2884%2990007-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=6382953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaL2cXktlaksLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1984&pages=27-55&author=T.+C.+Chouauthor=P.+Talalay&title=Quantitative-analysis+of+dose-effect+relationships+-+the+combined+effects+of+multiple-drugs+or+enzyme-inhibitors&doi=10.1016%2F0065-2571%2884%2990007-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of dose-effect relationships:  the combined effects of multiple drugs or enzyme inhibitors</span></div><div class="casAuthors">Chou, Ting Chao; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzyme Regulation</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-55</span>CODEN:
                <span class="NLM_cas:coden">AEZRA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-2571</span>.
    </div><div class="casAbstract">A simplified exptl. design method for the anal. of multiple drug effects and for detg. summation, synergism, and antagonism is described.  The method is not limited by: whether the dose-effect relations are hyperbolic or sigmoidal, whether the effects are mutually exclusive or nonexclusive, whether the ligand interactions are competitive, noncompetitive, or uncompetitive, or whether the drugs are agonists or antagonists.  The method is independent of the no. of drugs involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX4wNupCqgpbVg90H21EOLACvtfcHk0lhiSpMOgm1D4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktlaksLk%253D&md5=055a2711b52dde49389c3f526352333d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2F0065-2571%2884%2990007-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0065-2571%252884%252990007-4%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DQuantitative-analysis%2520of%2520dose-effect%2520relationships%2520-%2520the%2520combined%2520effects%2520of%2520multiple-drugs%2520or%2520enzyme-inhibitors%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D1984%26volume%3D22%26spage%3D27%26epage%3D55%26doi%3D10.1016%2F0065-2571%2884%2990007-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risinger, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooberry, S. L.</span></span> <span> </span><span class="NLM_article-title">Microtubule dynamics as a target in oncology</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">255</span>â <span class="NLM_lpage">261</span>, <span class="refDoi">Â DOI: 10.1016/j.ctrv.2008.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ctrv.2008.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=19117686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVantrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=255-261&author=A.+L.+Risingerauthor=F.+J.+Gilesauthor=S.+L.+Mooberry&title=Microtubule+dynamics+as+a+target+in+oncology&doi=10.1016%2Fj.ctrv.2008.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule dynamics as a target in oncology</span></div><div class="casAuthors">Risinger, April L.; Giles, Francis J.; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Drugs that affect microtubule dynamics, including the taxanes and vinca alkaloids, have been a mainstay in the treatment of leukemias and solid tumors for decades.  New, more effective microtubule-targeting agents continue to enter into clin. trials and some, including the epothilone ixapebilone, have been approved for use.  In contrast, several other drugs of this class with promising preclin. data were later shown to be ineffective or intolerable in animal models or clin. trials.  In this review, we discuss the mol. mechanisms as well as preclin. and clin. results for a variety of microtubule-targeting agents in various stages of development.  We also offer a frank discussion of which microtubule-targeting agents are amenable to further development based on their availability, efficacy and toxic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2wR_5ls3DLVg90H21EOLACvtfcHk0ljA2_FPf7zMKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVantrg%253D&md5=2d18cb599b5c35f1e0bc0292c183826f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2008.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2008.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DMicrotubule%2520dynamics%2520as%2520a%2520target%2520in%2520oncology%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2009%26volume%3D35%26spage%3D255%26epage%3D261%26doi%3D10.1016%2Fj.ctrv.2008.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gernert, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettles, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span> <span> </span><span class="NLM_article-title">Drugs that target dynamic microtubules: A new molecular perspective</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">443</span>â <span class="NLM_lpage">481</span>, <span class="refDoi">Â DOI: 10.1002/med.20242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fmed.20242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=21381049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=443-481&author=R.+A.+Stantonauthor=K.+M.+Gernertauthor=J.+H.+Nettlesauthor=R.+Aneja&title=Drugs+that+target+dynamic+microtubules%3A+A+new+molecular+perspective&doi=10.1002%2Fmed.20242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs that target dynamic microtubules: A new molecular perspective</span></div><div class="casAuthors">Stanton, Richard A.; Gernert, Kim M.; Nettles, James H.; Aneja, Ritu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-481</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle app.  As such, there is a wide variety of compds. currently in clin. use and in development that act as antimitotic agents by altering microtubule dynamics.  Although these diverse mols. are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research.  In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biol. function relative to the mol. vectors of microtubule assembly or disassembly.  These "biol. vectors" can thus be used as a spatiotemporal context to describe mol. mechanisms by which microtubule-targeting drugs work. Â© 2011 Wiley Periodicals, Inc.  Med Res Rev, 31, No. 3, 443-481, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6_lcUQbXYrVg90H21EOLACvtfcHk0ljA2_FPf7zMKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D&md5=acce5b9cc89581a7dab0236072b68c72</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fmed.20242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20242%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DGernert%26aufirst%3DK.%2BM.%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DAneja%26aufirst%3DR.%26atitle%3DDrugs%2520that%2520target%2520dynamic%2520microtubules%253A%2520A%2520new%2520molecular%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2011%26volume%3D31%26spage%3D443%26epage%3D481%26doi%3D10.1002%2Fmed.20242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minton, A. P.</span></span> <span> </span><span class="NLM_article-title">Turbidity as a probe of tubulin polymerization kinetics: A theoretical and experimental re-examination</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">198</span>â <span class="NLM_lpage">213</span>, <span class="refDoi">Â DOI: 10.1016/j.ab.2005.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ab.2005.07.011" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2005&pages=198-213&author=D.+Hallauthor=A.+P.+Minton&title=Turbidity+as+a+probe+of+tubulin+polymerization+kinetics%3A+A+theoretical+and+experimental+re-examination&doi=10.1016%2Fj.ab.2005.07.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2005.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2005.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DD.%26aulast%3DMinton%26aufirst%3DA.%2BP.%26atitle%3DTurbidity%2520as%2520a%2520probe%2520of%2520tubulin%2520polymerization%2520kinetics%253A%2520A%2520theoretical%2520and%2520experimental%2520re-examination%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D345%26spage%3D198%26epage%3D213%26doi%3D10.1016%2Fj.ab.2005.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span> <span> </span><span class="NLM_article-title">Taxol-induced polymerization of purified tubulin - Mechanism of action</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">10435</span>â <span class="NLM_lpage">10441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1981&pages=10435-10441&author=N.+Kumar&title=Taxol-induced+polymerization+of+purified+tubulin+-+Mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26atitle%3DTaxol-induced%2520polymerization%2520of%2520purified%2520tubulin%2520-%2520Mechanism%2520of%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1981%26volume%3D256%26spage%3D10435%26epage%3D10441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farshori, P. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goode, D.</span></span> <span> </span><span class="NLM_article-title">Effects of the microtubule depolymerizing and stabilizing agents Nocodazole and taxol on glucose-induced insulin secretion from hamster islet tumor (HIT) cells</span>. <i>J. Submicrosc. Cytol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">137</span>â <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=7912644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1Whs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1994&pages=137-146&author=P.+Q.+Farshoriauthor=D.+Goode&title=Effects+of+the+microtubule+depolymerizing+and+stabilizing+agents+Nocodazole+and+taxol+on+glucose-induced+insulin+secretion+from+hamster+islet+tumor+%28HIT%29+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the microtubule-depolymerizing and -stabilizing agents nocodazole and taxol on glucose-induced insulin secretion from hamster islet tumor (HIT) cells</span></div><div class="casAuthors">Farshori, P.Q.; Goode, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Submicroscopic Cytology and Pathology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-46</span>CODEN:
                <span class="NLM_cas:coden">JSCPEE</span>;
        ISSN:<span class="NLM_cas:issn">1122-9497</span>.
    </div><div class="casAbstract">HIT cells retain much of the capacity of normal Î²-cells to act as glucose sensors.  When stimulated with glucose or glucose plus forskolin, HIT cells released much more insulin than unstimulated cells.  Ultrastructural anal. revealed that the secretory product of these cells was stored in membrane-bound granules that assocd. with microtubules under certain circumstances.  Immunofluorescence studies using insulin antibody confirmed the presence of insulin in granular structures in these cells.  The microtubule inhibitor nocodazole reduced the no. of polymd. microtubules and inhibited the sustained phase of insulin secretion by HIT cells.  Thus, the structural integrity of microtubules is important for the sustained phase of the insulin secretion to occur.  The microtubule-stabilizing drug taxol did not decrease insulin secretion.  Since taxol blocks microtubule depolymn., microtubule polymn.-depolymn. alone does not appear to be responsible for insulin granule transport.  The increased use of these drugs in cancer research and therapy makes it important to understand their effects on insulin secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHKTYgtaKlorVg90H21EOLACvtfcHk0ljA2_FPf7zMKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1Whs7k%253D&md5=43b38fc01de7aeadf6b9fcd1ef003805</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarshori%26aufirst%3DP.%2BQ.%26aulast%3DGoode%26aufirst%3DD.%26atitle%3DEffects%2520of%2520the%2520microtubule%2520depolymerizing%2520and%2520stabilizing%2520agents%2520Nocodazole%2520and%2520taxol%2520on%2520glucose-induced%2520insulin%2520secretion%2520from%2520hamster%2520islet%2520tumor%2520%2528HIT%2529%2520cells%26jtitle%3DJ.%2520Submicrosc.%2520Cytol.%2520Pathol.%26date%3D1994%26volume%3D26%26spage%3D137%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaskin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, C. R.</span></span> <span> </span><span class="NLM_article-title">Microtubule assembly in the absence of added nucleotides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">765</span>â <span class="NLM_lpage">768</span>, <span class="refDoi">Â DOI: 10.1073/pnas.70.3.765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.70.3.765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=4514990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=765-768&author=M.+L.+Shelanskiauthor=F.+Gaskinauthor=C.+R.+Cantor&title=Microtubule+assembly+in+the+absence+of+added+nucleotides&doi=10.1073%2Fpnas.70.3.765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule assembly in the absence of added nucleotides</span></div><div class="casAuthors">Shelanski, Michael L.; Gaskin, Felicia; Cantor, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">765-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Microtubule assembly was enhanced by the addn. of M sucrose or 4 M glycerol to the reassembly mixt.  Tubulin was purified from guinea pig brain readily and in good yield by tycles of assembly in glycerol-contg. solns  The tubules assembled in glycerol and sucrose were more stable than tubules formed in the absence of these compds.  Assembly occurred in glycerol or sucrose in he absence of ATP or GT but was greatly accelerated by their presence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVpPUVyzxhcbVg90H21EOLACvtfcHk0lgYI2o_EbpWlg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D&md5=c0eb0f728884f0a0eba421d633c9031b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.70.3.765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.70.3.765%26sid%3Dliteratum%253Aachs%26aulast%3DShelanski%26aufirst%3DM.%2BL.%26aulast%3DGaskin%26aufirst%3DF.%26aulast%3DCantor%26aufirst%3DC.%2BR.%26atitle%3DMicrotubule%2520assembly%2520in%2520the%2520absence%2520of%2520added%2520nucleotides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1973%26volume%3D70%26spage%3D765%26epage%3D768%26doi%3D10.1073%2Fpnas.70.3.765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timasheff, S. N.</span></span> <span> </span><span class="NLM_article-title">In vitro reconstitution of calf brain microtubules: effects of solution variables</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1754</span>â <span class="NLM_lpage">1764</span>, <span class="refDoi">Â DOI: 10.1021/bi00627a037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00627a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaE2sXhvVCkuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1977&pages=1754-1764&author=J.+C.+Leeauthor=S.+N.+Timasheff&title=In+vitro+reconstitution+of+calf+brain+microtubules%3A+effects+of+solution+variables&doi=10.1021%2Fbi00627a037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro reconstitution of calf brain microtubules:  effects of solution variables</span></div><div class="casAuthors">Lee, James C.; Timasheff, Serge N.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1754-64</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The effects of soln. variables on the in vitro reconstitution of calf brain tubulin were investigated at pH 7.0.  Reconstitution of microtubules was successful in a variety of buffer systems.  Microtubule formation was promoted by Mg2+ and GTP, but inhibited by Ca2+.  The dependence of the apparent assocn. const. for microtubule formation on ligand concn. was analyzed.  The formation of a tubulin-tubulin contact involves the binding of 1 addnl. Mg2+/tubulin dimer.  Microtubule formation is also accompanied by the apparent binding of 1 addnl. proton and the release of H2O mols., as suggested by thermodyn. parameters.  The reaction is entropy driven with an apparent heat capacity change, ÎCp, of -1500 cal/degree-mol.  The enhancement of tubulin reassembly by glycerol is most likely due to nonspecific protein-solvent general thermodyn. interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMRSO63LMZTrVg90H21EOLACvtfcHk0lgYI2o_EbpWlg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhvVCkuro%253D&md5=0764be20538284d0834b08ca054e751e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fbi00627a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00627a037%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTimasheff%26aufirst%3DS.%2BN.%26atitle%3DIn%2520vitro%2520reconstitution%2520of%2520calf%2520brain%2520microtubules%253A%2520effects%2520of%2520solution%2520variables%26jtitle%3DBiochemistry%26date%3D1977%26volume%3D16%26spage%3D1754%26epage%3D1764%26doi%3D10.1021%2Fbi00627a037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savarin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curmi, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PastrÃ©, D.</span></span> <span> </span><span class="NLM_article-title">Rapid assembly and collective behavior of microtubule bundles in the presence of polyamines</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">205</span>â <span class="NLM_lpage">216</span>, <span class="refDoi">Â DOI: 10.1016/j.bpj.2011.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.bpj.2011.05.022" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2011&pages=205-216&author=L.+Hamonauthor=P.+Savarinauthor=P.+A.+Curmiauthor=D.+Pastr%C3%A9&title=Rapid+assembly+and+collective+behavior+of+microtubule+bundles+in+the+presence+of+polyamines&doi=10.1016%2Fj.bpj.2011.05.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2011.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2011.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DL.%26aulast%3DSavarin%26aufirst%3DP.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DPastr%25C3%25A9%26aufirst%3DD.%26atitle%3DRapid%2520assembly%2520and%2520collective%2520behavior%2520of%2520microtubule%2520bundles%2520in%2520the%2520presence%2520of%2520polyamines%26jtitle%3DBiophys.%2520J.%26date%3D2011%26volume%3D101%26spage%3D205%26epage%3D216%26doi%3D10.1016%2Fj.bpj.2011.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieder, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodjakov, A.</span></span> <span> </span><span class="NLM_article-title">Mitosis through the microscope: Advances in seeing inside live dividing cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1126/science.1082177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1126%2Fscience.1082177" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=91-96&author=C.+L.+Riederauthor=A.+Khodjakov&title=Mitosis+through+the+microscope%3A+Advances+in+seeing+inside+live+dividing+cells&doi=10.1126%2Fscience.1082177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1082177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1082177%26sid%3Dliteratum%253Aachs%26aulast%3DRieder%26aufirst%3DC.%2BL.%26aulast%3DKhodjakov%26aufirst%3DA.%26atitle%3DMitosis%2520through%2520the%2520microscope%253A%2520Advances%2520in%2520seeing%2520inside%2520live%2520dividing%2520cells%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D91%26epage%3D96%26doi%3D10.1126%2Fscience.1082177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Whole cell microtubule analysis by flow cytometry</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>420</i></span>,  <span class="NLM_fpage">26</span>â <span class="NLM_lpage">32</span>, <span class="refDoi">Â DOI: 10.1016/j.ab.2011.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ab.2011.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=21893022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKitbnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2012&pages=26-32&author=K.+C.+Morrisonauthor=P.+J.+Hergenrother&title=Whole+cell+microtubule+analysis+by+flow+cytometry&doi=10.1016%2Fj.ab.2011.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Whole cell microtubule analysis by flow cytometry</span></div><div class="casAuthors">Morrison, Karen C.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-32</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Perturbation of the tubulin/microtubule dynamic in cells is perhaps the single most important mode of action of anticancer drugs.  Std. methods for identifying and evaluating compds. for their ability to alter tubulin polymn. are low throughput, labor intensive, expensive, or make their assessment in vitro.  Here the authors report a method to rapidly quantify the extent of tubulin polymn. in whole cells using flow cytometry, and the authors use this technique to evaluate compds. that stabilize and destabilize microtubule formation.  This facile method is useful for conveniently, quant., and cost-effectively comparing small mols. that perturb tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZgQAWuTSkLVg90H21EOLACvtfcHk0lgYI2o_EbpWlg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKitbnM&md5=e4c4be8f87985c5eb9ce4a87d82e3fb6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2011.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2011.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DK.%2BC.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DWhole%2520cell%2520microtubule%2520analysis%2520by%2520flow%2520cytometry%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D420%26spage%3D26%26epage%3D32%26doi%3D10.1016%2Fj.ab.2011.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDIQQ)]Cl</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">437</span>â <span class="NLM_lpage">443</span>, <span class="refDoi">Â DOI: 10.1039/C3MT00364G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC3MT00364G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=24514456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsFGgu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=437-443&author=K.+Suntharalingamauthor=J.+J.+Wilsonauthor=W.+Linauthor=S.+J.+Lippard&title=A+dual-targeting%2C+p53-independent%2C+apoptosis-inducing+platinum%28II%29+anticancer+complex%2C+%5BPt%28BDIQQ%29%5DCl&doi=10.1039%2FC3MT00364G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeting, p53-independent, apoptosis-inducing platinum(ii) anticancer complex, [Pt(BDIQQ)]Cl</span></div><div class="casAuthors">Suntharalingam, Kogularamanan; Wilson, Justin J.; Lin, Wei; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-443</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The therapeutic index and cellular mechanism of action of [Pt(BDIQQ)]Cl, a monocationic, square-planar platinum(ii) complex, are reported. [Pt(BDIQQ)]Cl was used to treat several cell lines, including wild type and cisplatin-resistant ovarian carcinoma cells (A2780 and A2780CP70) and non-proliferating lung carcinoma cells (A549). [Pt(BDIQQ)]Cl selectively kills cancer cells over healthy cells and exhibits no cross-resistance with cisplatin.  The mechanism of cell killing was established through detailed cell-based assays. [Pt(BDIQQ)]Cl exhibits dual-threat capabilities, targeting nuclear DNA and mitochondria simultaneously. [Pt(BDIQQ)]Cl induces DNA damage, leading to p53 enrichment, mitochondrial membrane potential depolarisation, and caspase-mediated apoptosis. [Pt(BDIQQ)]Cl also accumulates in the mitochondria, resulting in direct mitochondrial damage.  Flow cytometric studies demonstrated that [Pt(BDIQQ)]Cl has no significant effect on cell cycle progression.  Remarkably, p53-status is a not a determinant of [Pt(BDIQQ)]Cl activity.  In p53-null cells, [Pt(BDIQQ)]Cl induces cell death through mitochondrial dysfunction.  Cancers with p53-null status could therefore be targeted using [Pt(BDIQQ)]Cl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPCsuBh2qa3rVg90H21EOLACvtfcHk0lgWlBOr0MRCng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsFGgu78%253D&md5=552e3f54dba546369f777d9c06f396a3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1039%2FC3MT00364G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MT00364G%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DJ.%2BJ.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DA%2520dual-targeting%252C%2520p53-independent%252C%2520apoptosis-inducing%2520platinum%2528II%2529%2520anticancer%2520complex%252C%2520%255BPt%2528BDIQQ%2529%255DCl%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26spage%3D437%26epage%3D443%26doi%3D10.1039%2FC3MT00364G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemann, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Necroptosis-inducing rhenium(V) oxo complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2967</span>â <span class="NLM_lpage">2974</span>, <span class="refDoi">Â DOI: 10.1021/ja511978y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja511978y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2msbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=2967-2974&author=K.+Suntharalingamauthor=S.+G.+Awuahauthor=P.+M.+Brunoauthor=T.+C.+Johnstoneauthor=F.+Wangauthor=W.+Linauthor=Y.-R.+Zhengauthor=J.+E.+Pageauthor=M.+T.+Hemannauthor=S.+J.+Lippard&title=Necroptosis-inducing+rhenium%28V%29+oxo+complexes&doi=10.1021%2Fja511978y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis-Inducing Rhenium(V) Oxo Complexes</span></div><div class="casAuthors">Suntharalingam, Kogularamanan; Awuah, Samuel G.; Bruno, Peter M.; Johnstone, Timothy C.; Wang, Fang; Lin, Wei; Zheng, Yao-Rong; Page, Julia E.; Hemann, Michael T.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2967-2974</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rhenium(V) oxo complexes of general formula [ReO(OMe)(NÌN)Cl2], where NÌN = 4,7-diphenyl-1,10-phenanthroline, 1, or 3,4,7,8-tetramethyl-1,10-phenanthroline, 2, effectively kill cancer cells by triggering necroptosis, a non-apoptotic form of cell death.  Both complexes evoke necrosome (RIP1-RIP3)-dependent intracellular reactive oxygen species (ROS) prodn. and propidium iodide uptake.  The complexes also induce mitochondrial membrane potential depletion, a possible downstream effect of ROS prodn.  Apparently, 1 and 2 are the first rhenium complexes to evoke cellular events consistent with programmed necrosis in cancer cells.  Furthermore, 1 and 2 display low acute toxicity in C57BL/6 mice and reasonable stability in fresh human blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrocO9cnc07Vg90H21EOLACvtfcHk0lgWlBOr0MRCng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2msbc%253D&md5=902f2e791f1f6eb4ea93a1f68dcf5fae</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja511978y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja511978y%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26aulast%3DBruno%26aufirst%3DP.%2BM.%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DY.-R.%26aulast%3DPage%26aufirst%3DJ.%2BE.%26aulast%3DHemann%26aufirst%3DM.%2BT.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DNecroptosis-inducing%2520rhenium%2528V%2529%2520oxo%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D2967%26epage%3D2974%26doi%3D10.1021%2Fja511978y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zajac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">97</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2015.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2015.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=26780576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2016&pages=89-97&author=J.+Zajacauthor=H.+Kostrhunovaauthor=V.+Novohradskyauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=Potentiation+of+mitochondrial+dysfunction+in+tumor+cells+by+conjugates+of+metabolic+modulator+dichloroacetate+with+a+Pt%28IV%29+derivative+of+oxaliplatin&doi=10.1016%2Fj.jinorgbio.2015.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span></div><div class="casAuthors">Zajac, Juraj; Kostrhunova, Hana; Novohradsky, Vojtech; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mol. and cellular mechanisms of enhanced toxic effects in tumor cells of the Pt(IV) derivs. of antitumor oxaliplatin contg. axial dichloroacetate (DCA) ligands were investigated.  DCA ligands were chosen because DCA has shown great potential as an apoptosis sensitizer and anticancer agent reverting the Wartburg effect.  In addn., DCA reverses mitochondrial changes in a wide range of cancers, promoting tumor cell apoptosis in a mitochondrial-dependent pathway.  We demonstrate that (i) the transformation of oxaliplatin to its Pt(IV) derivs. contg. axial DCA ligands markedly enhances toxicity in cancer cells and helps overcome inherent and acquired resistance to cisplatin and oxaliplatin; (ii) a significant fraction of the intact mols. of DCA conjugates with Pt(IV) deriv. of oxaliplatin accumulates in cancer cells where it releases free DCA; (iii) mechanism of biol. action of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands is connected with the effects of DCA released in cancer cells from the Pt(IV) prodrugs on mitochondria and metab. of glucose; (iv) treatments with the Pt(IV) derivs. of oxaliplatin contg. DCA ligands activate an autophagic response in human colorectal cancer cells; (v) the toxic effects in cancer cells of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands can be potentiated if cells are treated with these prodrugs in combination with 5-fluorouracil.  These properties of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands provide opportunities for further development of new platinum-based agents with the capability of killing cancer cells resistant to conventional antitumor platinum drugs used in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2vp2jhBrirVg90H21EOLACvtfcHk0lgWlBOr0MRCng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D&md5=3b66039a74fa4741e11698a76d2ef394</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZajac%26aufirst%3DJ.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DPotentiation%2520of%2520mitochondrial%2520dysfunction%2520in%2520tumor%2520cells%2520by%2520conjugates%2520of%2520metabolic%2520modulator%2520dichloroacetate%2520with%2520a%2520Pt%2528IV%2529%2520derivative%2520of%2520oxaliplatin%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D156%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.jinorgbio.2015.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harper, B. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirota, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccioli, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and in vitro and in vivo anticancer activity of Pt(IV) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)]</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7005</span>â <span class="NLM_lpage">7019</span>, <span class="refDoi">Â DOI: 10.1039/C7DT01054K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7DT01054K" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7005-7019&author=B.+W.+J.+Harperauthor=E.+Petruzzellaauthor=R.+Sirotaauthor=F.+F.+Faccioliauthor=J.+R.+Aldrich-Wrightauthor=V.+Gandinauthor=D.+Gibson&title=Synthesis%2C+characterization+and+in+vitro+and+in+vivo+anticancer+activity+of+Pt%28IV%29+derivatives+of+%5BPt%281S%2C2S-DACH%29%285%2C6-dimethyl-1%2C10-phenanthroline%29%5D&doi=10.1039%2FC7DT01054K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2FC7DT01054K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT01054K%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DB.%2BW.%2BJ.%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DSirota%26aufirst%3DR.%26aulast%3DFaccioli%26aufirst%3DF.%2BF.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%2520of%2520Pt%2528IV%2529%2520derivatives%2520of%2520%255BPt%25281S%252C2S-DACH%2529%25285%252C6-dimethyl-1%252C10-phenanthroline%2529%255D%26jtitle%3DDalton%2520Trans.%26date%3D2017%26volume%3D46%26spage%3D7005%26epage%3D7019%26doi%3D10.1039%2FC7DT01054K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yellol, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuchlikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yellol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Organoruthenium complexes with C N ligands are highly potent cytotoxic agents that act by a new mechanism of action</span>. <i>Chem. â Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">15294</span>â <span class="NLM_lpage">15299</span>, <span class="refDoi">Â DOI: 10.1002/chem.201703581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fchem.201703581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28922506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=15294-15299&author=V.+Novohradskyauthor=J.+Yellolauthor=O.+Stuchlikovaauthor=M.+D.+Santanaauthor=H.+Kostrhunovaauthor=G.+Yellolauthor=J.+Kasparkovaauthor=D.+Bautistaauthor=J.+Ruizauthor=V.+Brabec&title=Organoruthenium+complexes+with+C+N+ligands+are+highly+potent+cytotoxic+agents+that+act+by+a+new+mechanism+of+action&doi=10.1002%2Fchem.201703581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Organoruthenium Complexes with C-N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action</span></div><div class="casAuthors">Novohradsky, Vojtech; Yellol, Jyoti; Stuchlikova, Olga; Santana, Maria Dolores; Kostrhunova, Hana; Yellol, Gorakh; Kasparkova, Jana; Bautista, Delia; Ruiz, Jose; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">15294-15299</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The study demonstrates that four novel kinetically inert C,N-cyclometalated RuII complexes of the type [Ru(C-N)(N-N)2][PF6] contg. a handle for functionalization on the C-N ligand are very potent cytotoxic agents against several different human cancer cell lines and are up to 400-fold more potent than clin. used cisplatin.  In addn., the investigated ruthenium complexes are less cytotoxic in noncancerous cells, and exhibit higher selectivity for cancer cells than conventional platinum anticancer drugs.  The high potency of the investigated ruthenium compds. can be attributed to several factors, including enhanced internalization and their capability to change mitochondrial transmembrane potential in cells.  The new ruthenium complexes also interfere with protein synthesis with a markedly higher potency than conventional inhibitors of DNA translation.  Notably, the latter mechanism has not been hitherto described for other cytotoxic Ru compds. and cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo_fKsxB7IHbVg90H21EOLACvtfcHk0liv3_ZV6LVEdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrjL&md5=624b39cf521b7f44e73007c117e65b9e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703581%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DYellol%26aufirst%3DJ.%26aulast%3DStuchlikova%26aufirst%3DO.%26aulast%3DSantana%26aufirst%3DM.%2BD.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DYellol%26aufirst%3DG.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBautista%26aufirst%3DD.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DOrganoruthenium%2520complexes%2520with%2520C%2520N%2520ligands%2520are%2520highly%2520potent%2520cytotoxic%2520agents%2520that%2520act%2520by%2520a%2520new%2520mechanism%2520of%2520action%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D15294%26epage%3D15299%26doi%3D10.1002%2Fchem.201703581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julsing, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Methylation of DNA repair genes and the efficacy of DNA targeted anticancer treatment</span>. <i>Oncol. Discov.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi">Â DOI: 10.7243/2052-6199-2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.7243%2F2052-6199-2-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=3&author=J.+R.+Julsingauthor=G.+J.+Peters&title=Methylation+of+DNA+repair+genes+and+the+efficacy+of+DNA+targeted+anticancer+treatment&doi=10.7243%2F2052-6199-2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.7243%2F2052-6199-2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7243%252F2052-6199-2-3%26sid%3Dliteratum%253Aachs%26aulast%3DJulsing%26aufirst%3DJ.%2BR.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DMethylation%2520of%2520DNA%2520repair%2520genes%2520and%2520the%2520efficacy%2520of%2520DNA%2520targeted%2520anticancer%2520treatment%26jtitle%3DOncol.%2520Discov.%26date%3D2014%26volume%3D2%26spage%3D3%26doi%3D10.7243%2F2052-6199-2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llewellyn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, J.</span></span> <span> </span><span class="NLM_article-title">BRAF, KRAS and PIK3CA mutation and sensitivity to trastuzumab in breast cancer cell line model</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2209</span>â <span class="NLM_lpage">2213</span>, <span class="refDoi">Â DOI: 10.22034/APJCP.2017.18.8.2209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.22034%2FAPJCP.2017.18.8.2209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28843257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BC1cbhvVOmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2209-2213&author=S.+Patraauthor=V.+Youngauthor=L.+Llewellynauthor=J.+N.+Senapatiauthor=J.+Mathew&title=BRAF%2C+KRAS+and+PIK3CA+mutation+and+sensitivity+to+trastuzumab+in+breast+cancer+cell+line+model&doi=10.22034%2FAPJCP.2017.18.8.2209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model</span></div><div class="casAuthors">Patra Satyajit; Young Vanesa; Llewellyn Leslie; Senapati Jitendra N; Mathew Jesil</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2209-2213</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Studies show that approximately 20% of all breast cancer patients have a breast tumor that tests positive for Human Epidermal Growth Factor Receptor 2, otherwise known as the HER2 gene.  As such, treatments for breast cancer usually include drugs that target HER2.  The drug Trastuzumab is a recombinant antibody that has been approved by the FDA for the treatment of these HER2 positive breast cancers.  However, researchers have found that mutations in associated genes, PIK3CA and KRAS, can cause the tumor to become resistant to Trastuzumab.  The purpose of this article is to evaluate the sensitivity of the cancer cell lines to the drug Trastuzumab and investigate how this sensitivity is compromised by the PIK3CA, KRAS and BRAF gene mutations.  Trastuzumab responsiveness was evaluated in breast cancer cell lines by treating the lines with an optimal concentration of the drug followed by a proliferation assay of the cell lines in the presence of monoclonal antibodies.  We determined the optimum concentration of Trastuzumab to be 7 Î¼g/well.  The BRAF and KRAS mutated cell line, MDA-MB-231, showed the least sensitivity after being treated with trastuzumab when compared to the sensitivity of the PIK3CA mutated cell lines, MCF-7 and MDA-MB-361, and the KRAS/ BRAF/ PIK3CA cell line, MDA-MB-453.  Clinical observations show that mutations in BRAF and KRAS genes in breast cancer cells do lower the responsiveness of Trastuzumab drug treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJq-HpTS29KN-cVm4E2RlLfW6udTcc2ebeBTlo6yqVMLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbhvVOmsA%253D%253D&md5=dbc566be6c367b4e44c1987912a87bbf</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.22034%2FAPJCP.2017.18.8.2209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.22034%252FAPJCP.2017.18.8.2209%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DV.%26aulast%3DLlewellyn%26aufirst%3DL.%26aulast%3DSenapati%26aufirst%3DJ.%2BN.%26aulast%3DMathew%26aufirst%3DJ.%26atitle%3DBRAF%252C%2520KRAS%2520and%2520PIK3CA%2520mutation%2520and%2520sensitivity%2520to%2520trastuzumab%2520in%2520breast%2520cancer%2520cell%2520line%2520model%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2017%26volume%3D18%26spage%3D2209%26epage%3D2213%26doi%3D10.22034%2FAPJCP.2017.18.8.2209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Downward, J.</span></span> <span> </span><span class="NLM_article-title">Targeting RAS signalling pathways in cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi">Â DOI: 10.1038/nrc969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fnrc969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=12509763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD38XpvVertbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=11&author=J.+Downward&title=Targeting+RAS+signalling+pathways+in+cancer+therapy&doi=10.1038%2Fnrc969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RAS signalling pathways in cancer therapy</span></div><div class="casAuthors">Downward, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-22</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The RAS proteins control signaling pathways that are key regulators of several aspects of normal cell growth and malignant transformation.  They are aberrant in most human tumors due to activating mutations in the RAS genes themselves or to alterations in upstream or downstream signaling components.  Rational therapies that target the RAS pathways might inhibit tumor growth, survival and spread.  Several of these new therapeutic agents are showing promise in the clinic and many more are being developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwKF9JX2sXtbVg90H21EOLACvtfcHk0liv3_ZV6LVEdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpvVertbo%253D&md5=85ea9312480c3ca01f2a94faae7b84e7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnrc969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc969%26sid%3Dliteratum%253Aachs%26aulast%3DDownward%26aufirst%3DJ.%26atitle%3DTargeting%2520RAS%2520signalling%2520pathways%2520in%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D11%26doi%3D10.1038%2Fnrc969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gloushankova, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyubimova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tint, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feder, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiliev, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfand, I. M.</span></span> <span> </span><span class="NLM_article-title">Role of the microtubular system in morphological organization of normal and oncogene-transfected epithelial cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">8597</span>â <span class="NLM_lpage">8601</span>, <span class="refDoi">Â DOI: 10.1073/pnas.91.18.8597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.91.18.8597" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8597-8601&author=N.+A.+Gloushankovaauthor=A.+V.+Lyubimovaauthor=I.+S.+Tintauthor=H.+H.+Federauthor=J.+M.+Vasilievauthor=I.+M.+Gelfand&title=Role+of+the+microtubular+system+in+morphological+organization+of+normal+and+oncogene-transfected+epithelial+cells&doi=10.1073%2Fpnas.91.18.8597"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8597%26sid%3Dliteratum%253Aachs%26aulast%3DGloushankova%26aufirst%3DN.%2BA.%26aulast%3DLyubimova%26aufirst%3DA.%2BV.%26aulast%3DTint%26aufirst%3DI.%2BS.%26aulast%3DFeder%26aufirst%3DH.%2BH.%26aulast%3DVasiliev%26aufirst%3DJ.%2BM.%26aulast%3DGelfand%26aufirst%3DI.%2BM.%26atitle%3DRole%2520of%2520the%2520microtubular%2520system%2520in%2520morphological%2520organization%2520of%2520normal%2520and%2520oncogene-transfected%2520epithelial%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D8597%26epage%3D8601%26doi%3D10.1073%2Fpnas.91.18.8597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, L.</span></span> <span> </span><span class="NLM_article-title">The Ras-related GTPase Rac1 binds tubulin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">3756</span>â <span class="NLM_lpage">3762</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.7.3756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1074%2Fjbc.271.7.3756" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=3756-3762&author=A.+Bestauthor=S.+Ahmedauthor=R.+Kozmaauthor=L.+Lim&title=The+Ras-related+GTPase+Rac1+binds+tubulin&doi=10.1074%2Fjbc.271.7.3756"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.7.3756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.7.3756%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DKozma%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DL.%26atitle%3DThe%2520Ras-related%2520GTPase%2520Rac1%2520binds%2520tubulin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D3756%26epage%3D3762%26doi%3D10.1074%2Fjbc.271.7.3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yvon, A.-M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span> <span> </span><span class="NLM_article-title">Taxol suppresses dynamics of individual microtubules in living human tumor cells</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">947</span>â <span class="NLM_lpage">959</span>, <span class="refDoi">Â DOI: 10.1091/mbc.10.4.947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1091%2Fmbc.10.4.947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10198049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaK1MXisVGks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=947-959&author=A.-M.+C.+Yvonauthor=P.+Wadsworthauthor=M.+A.+Jordan&title=Taxol+suppresses+dynamics+of+individual+microtubules+in+living+human+tumor+cells&doi=10.1091%2Fmbc.10.4.947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Taxol suppresses dynamics of individual microtubules in living human tumor cells</span></div><div class="casAuthors">Yvon, Anne-Marie C.; Wadsworth, Patricia; Jordan, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">947-959</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Microtubules are intrinsically dynamic polymers, and their dynamics play a crucial role in mitotic spindle assembly, the mitotic checkpoint, and chromosome movement.  The authors hypothesized that, in living cells, suppression of microtubule dynamics is responsible for the ability of taxol to inhibit mitotic progression and cell proliferation.  Using quant. fluorescence video microscopy, the authors examd. the effects of taxol (30-100 nM) on the dynamics of individual microtubules in 2 living human tumor cell lines: Caov-3 ovarian adenocarcinoma cells and A-498 kidney carcinoma cells.  Taxol accumulated more in Caov-3 cells than in A-498 cells.  At equivalent intracellular taxol concns., dynamic instability was inhibited similarly in the 2 cell lines.  Microtubule shortening rates were inhibited in Caov-3 cells and in A-498 cells by 32 and 26%, growing rates were inhibited by 24 and 18%, and dynamicity was inhibited by 31 and 63%, resp.  All mitotic spindles were abnormal, and many interphase cells became multinucleate (Caov-3, 30%; A-498, 58%).  Taxol blocked cell cycle progress at the metaphase/anaphase transition and inhibited cell proliferation.  The results indicate that suppression of microtubule dynamics by taxol deleteriously affects the ability of cancer cells to properly assemble a mitotic spindle, pass the metaphase/anaphase checkpoint, and produce progeny.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJFjcttggzWLVg90H21EOLACvtfcHk0lhgE6r4v1GMwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVGks70%253D&md5=9419edf05d76d4abc3ef10235c79fbc5</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1091%2Fmbc.10.4.947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.10.4.947%26sid%3Dliteratum%253Aachs%26aulast%3DYvon%26aufirst%3DA.-M.%2BC.%26aulast%3DWadsworth%26aufirst%3DP.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DTaxol%2520suppresses%2520dynamics%2520of%2520individual%2520microtubules%2520in%2520living%2520human%2520tumor%2520cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1999%26volume%3D10%26spage%3D947%26epage%3D959%26doi%3D10.1091%2Fmbc.10.4.947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">32242</span>â <span class="NLM_lpage">32250</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M110.160820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1074%2Fjbc.M110.160820" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32242-32250&author=H.+Yangauthor=A.+Gangulyauthor=F.+Cabral&title=Inhibition+of+cell+migration+and+cell+division+correlates+with+distinct+effects+of+microtubule+inhibiting+drugs&doi=10.1074%2Fjbc.M110.160820"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.160820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.160820%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DCabral%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520cell%2520migration%2520and%2520cell%2520division%2520correlates%2520with%2520distinct%2520effects%2520of%2520microtubule%2520inhibiting%2520drugs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32242%26epage%3D32250%26doi%3D10.1074%2Fjbc.M110.160820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span> <span> </span><span class="NLM_article-title">Microtubules as a target for anticancer drugs</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">253</span>â <span class="NLM_lpage">265</span>, <span class="refDoi">Â DOI: 10.1038/nrc1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+target+for+anticancer+drugs&doi=10.1038%2Fnrc1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0lhgE6r4v1GMwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520target%2520for%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265%26doi%3D10.1038%2Fnrc1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sackett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span> <span> </span><span class="NLM_article-title">Tubulin/microtubules: Still a promising target for new chemotherapeutic agents</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">182</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.1093/jnci/92.3.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1093%2Fjnci%2F92.3.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10655426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BD3c7it1GjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=182-183&author=P.+Giannakakouauthor=D.+Sackettauthor=T.+Fojo&title=Tubulin%2Fmicrotubules%3A+Still+a+promising+target+for+new+chemotherapeutic+agents&doi=10.1093%2Fjnci%2F92.3.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin/microtubules: still a promising target for new chemotherapeutic agents</span></div><div class="casAuthors">Giannakakou P; Sackett D; Fojo T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-3</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlgIiZscAk1srRqEXsZufAfW6udTcc2eaK2zi3LVYeyLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7it1GjsQ%253D%253D&md5=dfad57d5c9ba54ecd5f43589ec175af6</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.3.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.3.182%26sid%3Dliteratum%253Aachs%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DSackett%26aufirst%3DD.%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DTubulin%252Fmicrotubules%253A%2520Still%2520a%2520promising%2520target%2520for%2520new%2520chemotherapeutic%2520agents%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D182%26epage%3D183%26doi%3D10.1093%2Fjnci%2F92.3.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prota, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bargsten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liniger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, M. O.</span></span> <span> </span><span class="NLM_article-title">A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">13817</span>â <span class="NLM_lpage">13821</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1408124111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.1408124111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=25114240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCju7vM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=13817-13821&author=A.+E.+Protaauthor=K.+Bargstenauthor=J.+F.+Diazauthor=M.+Marshauthor=C.+Cuevasauthor=M.+Linigerauthor=C.+Neuhausauthor=J.+M.+Andreuauthor=K.+H.+Altmannauthor=M.+O.+Steinmetz&title=A+new+tubulin-binding+site+and+pharmacophore+for+microtubule-destabilizing+anticancer+drugs&doi=10.1073%2Fpnas.1408124111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs</span></div><div class="casAuthors">Prota, Andrea E.; Bargsten, Katja; Diaz, J. Fernando; Marsh, May; Cuevas, Carmen; Liniger, Marc; Neuhaus, Christian; Andreu, Jose M.; Altmann, Karl-Heinz; Steinmetz, Michel O.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13817-13821</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The recent success of antibody-drug conjugates (ADCs) in the treatment of cancer has led to a revived interest in microtubule-destabilizing agents.  Here, we detd. the high-resoln. crystal structure of the complex between tubulin and maytansine, which is part of an ADC that is approved by the US Food and Drug Administration (FDA) for the treatment of advanced breast cancer.  We found that the drug binds to a site on Î²-tubulin that is distinct from the vinca domain and that blocks the formation of longitudinal tubulin interactions in microtubules.  We also solved crystal structures of tubulin in complex with both a variant of rhizoxin and the phase 1 drug PM060184.  Consistent with biochem. and mutagenesis data, we found that the two compds. bound to the same site as maytansine and that the structures revealed a common pharmacophore for the three ligands.  Our results delineate a distinct mol. mechanism of action for the inhibition of microtubule assembly by clin. relevant agents.  They further provide a structural basis for the rational design of potent microtubule-destabilizing agents, thus opening opportunities for the development of next-generation ADCs for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4icqk698gLVg90H21EOLACvtfcHk0ljC9xCAxTEQjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCju7vM&md5=798cae320e427ff76c2099387d9e6ba4</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1408124111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1408124111%26sid%3Dliteratum%253Aachs%26aulast%3DProta%26aufirst%3DA.%2BE.%26aulast%3DBargsten%26aufirst%3DK.%26aulast%3DDiaz%26aufirst%3DJ.%2BF.%26aulast%3DMarsh%26aufirst%3DM.%26aulast%3DCuevas%26aufirst%3DC.%26aulast%3DLiniger%26aufirst%3DM.%26aulast%3DNeuhaus%26aufirst%3DC.%26aulast%3DAndreu%26aufirst%3DJ.%2BM.%26aulast%3DAltmann%26aufirst%3DK.%2BH.%26aulast%3DSteinmetz%26aufirst%3DM.%2BO.%26atitle%3DA%2520new%2520tubulin-binding%2520site%2520and%2520pharmacophore%2520for%2520microtubule-destabilizing%2520anticancer%2520drugs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D13817%26epage%3D13821%26doi%3D10.1073%2Fpnas.1408124111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerikan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruss, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kigoshi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiebel, E.</span></span> <span> </span><span class="NLM_article-title">The Î³-tubulin-specific inhibitor gatastatin reveals temporal requirements of microtubule nucleation during the cell cycle</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8722</span>, <span class="refDoi">Â DOI: 10.1038/ncomms9722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fncomms9722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=26503935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCns7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8722&author=T.+Chinenauthor=P.+Liuauthor=S.+Shiodaauthor=J.+Pagelauthor=B.+Cerikanauthor=T.+C.+Linauthor=O.+Grussauthor=Y.+Hayashiauthor=H.+Takenoauthor=T.+Shimaauthor=Y.+Okadaauthor=I.+Hayakawaauthor=Y.+Hayashiauthor=H.+Kigoshiauthor=T.+Usuiauthor=E.+Schiebel&title=The+%CE%B3-tubulin-specific+inhibitor+gatastatin+reveals+temporal+requirements+of+microtubule+nucleation+during+the+cell+cycle&doi=10.1038%2Fncomms9722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The Î³-tubulin-specific inhibitor gatastatin reveals temporal requirements of microtubule nucleation during the cell cycle</span></div><div class="casAuthors">Chinen, Takumi; Liu, Peng; Shioda, Shuya; Pagel, Judith; Cerikan, Berati; Lin, Tien-chen; Gruss, Oliver; Hayashi, Yoshiki; Takeno, Haruka; Shima, Tomohiro; Okada, Yasushi; Hayakawa, Ichiro; Hayashi, Yoshio; Kigoshi, Hideo; Usui, Takeo; Schiebel, Elmar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8722</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibitors of microtubule (MT) assembly or dynamics that target Î±/Î²-tubulin are widely exploited in cancer therapy and biol. research.  However, specific inhibitors of the MT nucleator Î³-tubulin that would allow testing temporal functions of Î³-tubulin during the cell cycle are yet to be identified.  By evolving Î²-tubulin-binding drugs we now find that the glaziovianin A deriv. gatastatin is a Î³-tubulin-specific inhibitor.  Gatastatin decreased interphase MT dynamics of human cells without affecting MT no.  Gatastatin inhibited assembly of the mitotic spindle in prometaphase.  Addn. of gatastatin to preformed metaphase spindles altered MT dynamics, reduced the no. of growing MTs and shortened spindle length.  Furthermore, gatastatin prolonged anaphase duration by affecting anaphase spindle structure, indicating the continuous requirement of MT nucleation during mitosis.  Thus, gatastatin facilitates the dissection of the role of Î³-tubulin during the cell cycle and reveals the sustained role of Î³-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrffZKKt6KhELVg90H21EOLACvtfcHk0ljC9xCAxTEQjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCns7fK&md5=2b9dd9c0e362bea8ae1b1473debaff9e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms9722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9722%26sid%3Dliteratum%253Aachs%26aulast%3DChinen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DShioda%26aufirst%3DS.%26aulast%3DPagel%26aufirst%3DJ.%26aulast%3DCerikan%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DT.%2BC.%26aulast%3DGruss%26aufirst%3DO.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DTakeno%26aufirst%3DH.%26aulast%3DShima%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DI.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKigoshi%26aufirst%3DH.%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DSchiebel%26aufirst%3DE.%26atitle%3DThe%2520%25CE%25B3-tubulin-specific%2520inhibitor%2520gatastatin%2520reveals%2520temporal%2520requirements%2520of%2520microtubule%2520nucleation%2520during%2520the%2520cell%2520cycle%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8722%26doi%3D10.1038%2Fncomms9722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheate, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikac, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span> <span> </span><span class="NLM_article-title">The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1049</span>â <span class="NLM_lpage">1058</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2007.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2007.04.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1049-1058&author=S.+Kempauthor=N.+J.+Wheateauthor=D.+P.+Buckauthor=M.+Nikacauthor=J.+G.+Collinsauthor=J.+R.+Aldrich-Wright&title=The+effect+of+ancillary+ligand+chirality+and+phenanthroline+functional+group+substitution+on+the+cytotoxicity+of+platinum%28II%29-based+metallointercalators&doi=10.1016%2Fj.jinorgbio.2007.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2007.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2007.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DS.%26aulast%3DWheate%26aufirst%3DN.%2BJ.%26aulast%3DBuck%26aufirst%3DD.%2BP.%26aulast%3DNikac%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DJ.%2BG.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520effect%2520of%2520ancillary%2520ligand%2520chirality%2520and%2520phenanthroline%2520functional%2520group%2520substitution%2520on%2520the%2520cytotoxicity%2520of%2520platinum%2528II%2529-based%2520metallointercalators%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2007%26volume%3D101%26spage%3D1049%26epage%3D1058%26doi%3D10.1016%2Fj.jinorgbio.2007.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Subhendu Karmakar, Hana Kostrhunova, Tereza Ctvrtlikova, Vojtech Novohradsky, Dan Gibson, <span class="NLM_string-name hlFld-ContribAuthor">Viktor Brabec</span>. </span><span class="cited-content_cbyCitation_article-title">Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13861-13877. <a href="https://doi.org/10.1021/acs.jmedchem.0c01400" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01400%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPlatinum%252528IV%252529-Estramustine%252BMultiaction%252BProdrugs%252BAre%252BEffective%252BAntiproliferative%252BAgents%252Bagainst%252BProstate%252BCancer%252BCells%26aulast%3DKarmakar%26aufirst%3DSubhendu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10082020%26date%3D11112020%26volume%3D63%26issue%3D22%26spage%3D13861%26epage%3D13877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hana Crlikova, Jaroslav Malina, Vojtech Novohradsky, Hana Kostrhunova, Roan A. S. Vasdev, James D. Crowley, Jana Kasparkova, <span class="NLM_string-name hlFld-ContribAuthor">Viktor Brabec</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative Activity and Associated DNA Interactions of [Co2L3]6+ Cylinders Derived from Bis(bidentate) 2-Pyridyl-1,2,3-triazole Ligands. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (8)
                                     , 1448-1455. <a href="https://doi.org/10.1021/acs.organomet.0c00146" title="DOI URL">https://doi.org/10.1021/acs.organomet.0c00146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.0c00146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.0c00146%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DAntiproliferative%252BActivity%252Band%252BAssociated%252BDNA%252BInteractions%252Bof%252B%25255BCo2L3%25255D6%25252B%252BCylinders%252BDerived%252Bfrom%252BBis%252528bidentate%252529%252B2-Pyridyl-1%25252C2%25252C3-triazole%252BLigands%26aulast%3DCrlikova%26aufirst%3DHana%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29022020%26date%3D13042020%26volume%3D39%26issue%3D8%26spage%3D1448%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qin  Qin</span>, <span class="hlFld-ContribAuthor ">Zu-Zhuang  Wei</span>, <span class="hlFld-ContribAuthor ">Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Jia-Jing  Zeng</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Strong in vitro and in vivo cytotoxic effects of two platinum(II) complexes with cryptolepine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (7)
                                     , 1419-1426. <a href="https://doi.org/10.1007/s00044-021-02739-0" title="DOI URL">https://doi.org/10.1007/s00044-021-02739-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02739-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02739-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStrong%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bcytotoxic%252Beffects%252Bof%252Btwo%252Bplatinum%252528II%252529%252Bcomplexes%252Bwith%252Bcryptolepine%252Bderivatives%26aulast%3DQin%26aufirst%3DLi-Qin%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D7%26spage%3D1419%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan-Shan  Liao</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Zu-Yu  Mo</span>, <span class="hlFld-ContribAuthor ">Cheng  Hou</span>, <span class="hlFld-ContribAuthor ">Gui-Fa  Su</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Ni(
              ii
              ), Cu(
              ii
              ) and Zn(
              ii
              ) complexes with the 1-trifluoroethoxyl-2,9,10-trimethoxy-7-oxoaporphine ligand simultaneously target microtubules and mitochondria for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (9)
                                     , 2225-2247. <a href="https://doi.org/10.1039/D0QI01463J" title="DOI URL">https://doi.org/10.1039/D0QI01463J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QI01463J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QI01463J%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Frontiers%26atitle%3DNi%252528%252Bii%252B%252529%25252C%252BCu%252528%252Bii%252B%252529%252Band%252BZn%252528%252Bii%252B%252529%252Bcomplexes%252Bwith%252Bthe%252B1-trifluoroethoxyl-2%25252C9%25252C10-trimethoxy-7-oxoaporphine%252Bligand%252Bsimultaneously%252Btarget%252Bmicrotubules%252Band%252Bmitochondria%252Bfor%252Bcancer%252Btherapy%26aulast%3DLiao%26aufirst%3DLan-Shan%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D9%26spage%3D2225%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Min  Wei</span>, <span class="hlFld-ContribAuthor ">Zu-Zhuang  Wei</span>, <span class="hlFld-ContribAuthor ">Jia-Jing  Zeng</span>, <span class="hlFld-ContribAuthor ">Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structures and anticancer potentials of five platinum(II) complexes with benzothiazole-benzopyran targeting mitochondria. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2021,</strong> <em>196 </em>, 115004. <a href="https://doi.org/10.1016/j.poly.2020.115004" title="DOI URL">https://doi.org/10.1016/j.poly.2020.115004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2020.115004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2020.115004%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DSynthesis%25252C%252Bstructures%252Band%252Banticancer%252Bpotentials%252Bof%252Bfive%252Bplatinum%252528II%252529%252Bcomplexes%252Bwith%252Bbenzothiazole-benzopyran%252Btargeting%252Bmitochondria%26aulast%3DWei%26aufirst%3DQing-Min%26date%3D2021%26volume%3D196%26spage%3D115004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shibo  Lin</span>, <span class="hlFld-ContribAuthor ">Yuru  Liang</span>, <span class="hlFld-ContribAuthor ">Jiayi  Cheng</span>, <span class="hlFld-ContribAuthor ">Feng  Pan</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113256. <a href="https://doi.org/10.1016/j.ejmech.2021.113256" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113256%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bdiaryl-2H-azirines%25253A%252BAntitumor%252Bhybrids%252Bfor%252Bdual-targeting%252Btubulin%252Band%252BDNA%26aulast%3DLin%26aufirst%3DShibo%26date%3D2021%26volume%3D214%26spage%3D113256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnab  Bhattacharyya</span>, <span class="hlFld-ContribAuthor ">Aida  Jameei</span>, <span class="hlFld-ContribAuthor ">Rupak  Saha</span>, <span class="hlFld-ContribAuthor ">Aditya  Garai</span>, <span class="hlFld-ContribAuthor ">Anjali A.  Karande</span>, <span class="hlFld-ContribAuthor ">Akhil R.  Chakravarty</span>. </span><span class="cited-content_cbyCitation_article-title">BODIPY-linked
              cis
              -dichlorido zinc(
              ii
              ) conjugates: the strategic design of organelle-specific next-generation theranostic photosensitizers. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2021,</strong> <em>50 </em>
                                    (1)
                                     , 103-115. <a href="https://doi.org/10.1039/D0DT03342A" title="DOI URL">https://doi.org/10.1039/D0DT03342A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT03342A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT03342A%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DBODIPY-linked%252Bcis%252B-dichlorido%252Bzinc%252528%252Bii%252B%252529%252Bconjugates%25253A%252Bthe%252Bstrategic%252Bdesign%252Bof%252Borganelle-specific%252Bnext-generation%252Btheranostic%252Bphotosensitizers%26aulast%3DBhattacharyya%26aufirst%3DArnab%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D1%26spage%3D103%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tai-Ming  Shao</span>, <span class="hlFld-ContribAuthor ">Zu-Zhuang  Wei</span>, <span class="hlFld-ContribAuthor ">Xiao-Ling  Luo</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Jia-Jing  Zeng</span>, <span class="hlFld-ContribAuthor ">Chun-Jie  Liang</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">High cytotoxic and apoptotic effects of platinum(
              ii
              ) complexes bearing the 4-acridinol ligand. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (45)
                                     , 19885-19890. <a href="https://doi.org/10.1039/D0NJ04753H" title="DOI URL">https://doi.org/10.1039/D0NJ04753H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ04753H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ04753H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DHigh%252Bcytotoxic%252Band%252Bapoptotic%252Beffects%252Bof%252Bplatinum%252528%252Bii%252B%252529%252Bcomplexes%252Bbearing%252Bthe%252B4-acridinol%252Bligand%26aulast%3DShao%26aufirst%3DTai-Ming%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D45%26spage%3D19885%26epage%3D19890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine K. J.  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao  Gui</span>, <span class="hlFld-ContribAuthor ">Peter  Kappen</span>, <span class="hlFld-ContribAuthor ">Anna K.  Renfrew</span>, <span class="hlFld-ContribAuthor ">Trevor W.  Hambley</span>. </span><span class="cited-content_cbyCitation_article-title">The effect of charge on the uptake and resistance to reduction of platinum(
              iv
              ) complexes in human serum and whole blood models. </span><span class="cited-content_cbyCitation_journal-name">Metallomics</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 1599-1615. <a href="https://doi.org/10.1039/D0MT00157K" title="DOI URL">https://doi.org/10.1039/D0MT00157K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MT00157K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MT00157K%26sid%3Dliteratum%253Aachs%26jtitle%3DMetallomics%26atitle%3DThe%252Beffect%252Bof%252Bcharge%252Bon%252Bthe%252Buptake%252Band%252Bresistance%252Bto%252Breduction%252Bof%252Bplatinum%252528%252Biv%252B%252529%252Bcomplexes%252Bin%252Bhuman%252Bserum%252Band%252Bwhole%252Bblood%252Bmodels%26aulast%3DChen%26aufirst%3DCatherine%2BK.%2BJ.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D1599%26epage%3D1615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James D.  Hoeschele</span>, <span class="hlFld-ContribAuthor ">Jana  Kasparkova</span>, <span class="hlFld-ContribAuthor ">Hana  Kostrhunova</span>, <span class="hlFld-ContribAuthor ">Olga  Novakova</span>, <span class="hlFld-ContribAuthor ">Jitka  Pracharova</span>, <span class="hlFld-ContribAuthor ">Paul  Pineau</span>, <span class="hlFld-ContribAuthor ">Viktor  Brabec</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl2] analogs. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 913-924. <a href="https://doi.org/10.1007/s00775-020-01809-9" title="DOI URL">https://doi.org/10.1007/s00775-020-01809-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-020-01809-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-020-01809-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bantiproliferative%252Bactivity%252Bin%252Bcancer%252Bcells%252Band%252BDNA%252Binteraction%252Bstudies%252Bof%252B%25255BPt%252528cis-1%25252C3-diaminocycloalkane%252529Cl2%25255D%252Banalogs%26aulast%3DHoeschele%26aufirst%3DJames%2BD.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D913%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Awatif Rashed Z.  Almotairy</span>, <span class="hlFld-ContribAuthor ">Diego  Montagner</span>, <span class="hlFld-ContribAuthor ">Liam  Morrison</span>, <span class="hlFld-ContribAuthor ">Michael  Devereux</span>, <span class="hlFld-ContribAuthor ">Orla  Howe</span>, <span class="hlFld-ContribAuthor ">Andrea  Erxleben</span>. </span><span class="cited-content_cbyCitation_article-title">Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>210 </em>, 111125. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111125" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111125%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DPt%252528IV%252529%252Bpro-drugs%252Bwith%252Ban%252Baxial%252BHDAC%252Binhibitor%252Bdemonstrate%252Bmultimodal%252Bmechanisms%252Binvolving%252BDNA%252Bdamage%252Band%252Bapoptosis%252Bindependent%252Bof%252Bcisplatin%252Bresistance%252Bin%252BA2780%25252FA2780cis%252Bcells%26aulast%3DAlmotairy%26aufirst%3DAwatif%2BRashed%2BZ.%26date%3D2020%26volume%3D210%26spage%3D111125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dale L.  Ang</span>, <span class="hlFld-ContribAuthor ">Celine  Kelso</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Beck</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Ralph</span>, <span class="hlFld-ContribAuthor ">David G.  Harman</span>, <span class="hlFld-ContribAuthor ">Janice R.  Aldrich-Wright</span>. </span><span class="cited-content_cbyCitation_article-title">A study of Pt(II)âphenanthroline complex interactions with double-stranded and G-quadruplex DNA by ESIâMS, circular dichroism, and computational docking. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2020,</strong> <em>25 </em>
                                    (3)
                                     , 429-440. <a href="https://doi.org/10.1007/s00775-020-01773-4" title="DOI URL">https://doi.org/10.1007/s00775-020-01773-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-020-01773-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-020-01773-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DA%252Bstudy%252Bof%252BPt%252528II%252529%2525E2%252580%252593phenanthroline%252Bcomplex%252Binteractions%252Bwith%252Bdouble-stranded%252Band%252BG-quadruplex%252BDNA%252Bby%252BESI%2525E2%252580%252593MS%25252C%252Bcircular%252Bdichroism%25252C%252Band%252Bcomputational%252Bdocking%26aulast%3DAng%26aufirst%3DDale%2BL.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D3%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hana  Crlikova</span>, <span class="hlFld-ContribAuthor ">Hana  Kostrhunova</span>, <span class="hlFld-ContribAuthor ">Jitka  Pracharova</span>, <span class="hlFld-ContribAuthor ">MÃ¡tÃ©  Kozsup</span>, <span class="hlFld-ContribAuthor ">SÃ¡ndor  Nagy</span>, <span class="hlFld-ContribAuthor ">PÃ©ter  BuglyÃ³</span>, <span class="hlFld-ContribAuthor ">Viktor  Brabec</span>, <span class="hlFld-ContribAuthor ">Jana  Kasparkova</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 339-350. <a href="https://doi.org/10.1007/s00775-020-01765-4" title="DOI URL">https://doi.org/10.1007/s00775-020-01765-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-020-01765-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-020-01765-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DAntiproliferative%25252C%252BDNA%252Bbinding%25252C%252Band%252Bcleavage%252Bproperties%252Bof%252Bdinuclear%252BCo%252528III%252529%252Bcomplexes%252Bcontaining%252Bthe%252Bbioactive%252Bquinizarin%252Bligand%26aulast%3DCrlikova%26aufirst%3DHana%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D339%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moumita  Maji</span>, <span class="hlFld-ContribAuthor ">Subhendu  Karmakar</span>, <span class="hlFld-ContribAuthor ">Ruturaj</span>, <span class="hlFld-ContribAuthor ">Arnab  Gupta</span>, <span class="hlFld-ContribAuthor ">Arindam  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Oxamusplatin: a cytotoxic Pt(
              ii
              ) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancer. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (8)
                                     , 2547-2558. <a href="https://doi.org/10.1039/C9DT04269E" title="DOI URL">https://doi.org/10.1039/C9DT04269E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9DT04269E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9DT04269E%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DOxamusplatin%25253A%252Ba%252Bcytotoxic%252BPt%252528%252Bii%252B%252529%252Bcomplex%252Bof%252Ba%252Bnitrogen%252Bmustard%252Bwith%252Bresistance%252Bto%252Bthiol%252Bbased%252Bsequestration%252Bdisplays%252Benhanced%252Bselectivity%252Btowards%252Bcancer%26aulast%3DMaji%26aufirst%3DMoumita%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D8%26spage%3D2547%26epage%3D2558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishant M.  Deo</span>, <span class="hlFld-ContribAuthor ">Jennette  Sakoff</span>, <span class="hlFld-ContribAuthor ">Jayne  Gilbert</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Janice R.  Aldrich Wright</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterisation and potent cytotoxicity of unconventional platinum(
              iv
              ) complexes with modified lipophilicity. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2019,</strong> <em>48 </em>
                                    (46)
                                     , 17217-17227. <a href="https://doi.org/10.1039/C9DT03339D" title="DOI URL">https://doi.org/10.1039/C9DT03339D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9DT03339D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9DT03339D%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DSynthesis%25252C%252Bcharacterisation%252Band%252Bpotent%252Bcytotoxicity%252Bof%252Bunconventional%252Bplatinum%252528%252Biv%252B%252529%252Bcomplexes%252Bwith%252Bmodified%252Blipophilicity%26aulast%3DDeo%26aufirst%3DKrishant%2BM.%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D46%26spage%3D17217%26epage%3D17227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishant M.  Deo</span>, <span class="hlFld-ContribAuthor ">Jennette  Sakoff</span>, <span class="hlFld-ContribAuthor ">Jayne  Gilbert</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Janice R.  Aldrich Wright</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterisation and influence of lipophilicity on cellular accumulation and cytotoxicity of unconventional platinum(
              iv
              ) prodrugs as potent anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2019,</strong> <em>48 </em>
                                    (46)
                                     , 17228-17240. <a href="https://doi.org/10.1039/C9DT04049H" title="DOI URL">https://doi.org/10.1039/C9DT04049H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9DT04049H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9DT04049H%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DSynthesis%25252C%252Bcharacterisation%252Band%252Binfluence%252Bof%252Blipophilicity%252Bon%252Bcellular%252Baccumulation%252Band%252Bcytotoxicity%252Bof%252Bunconventional%252Bplatinum%252528%252Biv%252B%252529%252Bprodrugs%252Bas%252Bpotent%252Banticancer%252Bagents%26aulast%3DDeo%26aufirst%3DKrishant%2BM.%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D46%26spage%3D17228%26epage%3D17240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Yanhui  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhouxiao  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Bu</span>, <span class="hlFld-ContribAuthor ">Tong  Sun</span>, <span class="hlFld-ContribAuthor ">Hanjin  Wang</span>, <span class="hlFld-ContribAuthor ">Handong  Sun</span>, <span class="hlFld-ContribAuthor ">Xiufeng  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Up-regulation of SPC25 promotes breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2019,</strong> <em>11 </em>
                                    (15)
                                     , 5689-5704. <a href="https://doi.org/10.18632/aging.102153" title="DOI URL">https://doi.org/10.18632/aging.102153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.102153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.102153%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DUp-regulation%252Bof%252BSPC25%252Bpromotes%252Bbreast%252Bcancer%26aulast%3DWang%26aufirst%3DQian%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D15%26spage%3D5689%26epage%3D5704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Quadruple-action platinum(IV) prodrug with an anticancer activity described in a recently published article.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Platinum complexes used in this study and their abbreviations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cellular accumulation of <b>1</b>, <b>5</b>, and its Pt(IV) derivatives in MDA-MB-231 cells. The amount of Pt in the cell membrane (green), cytosol (pink), nucleus (orange), and cytoskeleton (blue) is shown. The data represent the percentage of Pt in different fractions over total uptake. Cells were exposed to platinum compounds (2 Î¼M) for 6 h. All results are expressed as the mean Â± SD from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Impedance-based time-dependent cell response profiling. The TCRPs of MDA-MB-231 cells treated with increasing concentrations of the investigated platinum complexes ranging from IC<sub>10</sub> to IC<sub>98</sub> (determined previously with MTT assay for the 72 h treatment). The trend of the concentrations growth was as follows: black (control) < orange < green < blue < purple < pink. Data were normalized to the time of the treatment and expressed as the normalized cell index.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cell-cycle distribution of MDA-MB-231 cells after treatment with the investigated compounds at concentrations corresponding to IC<sub>30</sub> values (found for these compounds in MDA-MB-231 cells treated for 72 h) for 12, 24, and 48 h (first, second, and third column for each compound, respectively). Percentage of cells in (A) G<sub>2</sub>/M and (B) S phases. The data were acquired using ModFit software and represent the percentages as mean Â± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A, B) Tubulin assembly curves. Polymerization was followed in the absence (solid lines) or the presence of (A) 30 or 60 Î¼M concentration of <b>5</b> (dashed and dotted lines, respectively) and (B) 30 or 60 Î¼M concentration of <b>8</b> (dashed and dotted lines, respectively). (C) Microtubule disassembly induced by the decrease in temperature (0.5 Â°C/min) in the presence of 20, 40, and 80 Î¼M concentration of <b>5</b> (dashed, dash-dotted, and dotted lines, respectively). The absorbance at 37 Â°C (<i>t</i> = 0) was assessed as 1. (D) Whole cell analysis of microtubule by flow cytometry. MDA-MB-231 cells were treated with indicated concentrations of <b>5</b> (light gray) and <b>8</b> (dark gray) for 3 h. The cells were stained with anti-Î±-tubulin-FITC antibody. The value of fluorescence of untreated control was taken as 100%. The data represent a mean of three independent experiments. (*) indicates <i>P</i> < 0.05; (***) indicates <i>P</i> < 0.001 based on a two-tailed Studentâs <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/medium/jm-2019-00489j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect on microtubule morphology. Tubulin purified from porcine brain (4 mg mL<sup>â1</sup>) was polymerized (A) without or (B) with 80 Î¼M <b>5</b> or (C) <b>8</b>. After 90 min polymerization, aliquots were withdrawn, fixed with glutaraldehyde solution, and diluted 40-fold. Four microliters of the sample was transferred onto mica, dried, and analyzed with AFM. The scale bars represent 1 Î¼m.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00489/20190516/images/large/jm-2019-00489j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00489&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 79 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Modifications of DNA by platinum complexes: Relation to resistance of tumors to platinum antitumor drugs</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">131</span>â <span class="NLM_lpage">146</span>, <span class="refDoi">Â DOI: 10.1016/j.drup.2005.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.drup.2005.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=15894512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVSlsr7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=131-146&author=V.+Brabecauthor=J.+Kasparkova&title=Modifications+of+DNA+by+platinum+complexes%3A+Relation+to+resistance+of+tumors+to+platinum+antitumor+drugs&doi=10.1016%2Fj.drup.2005.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Modifications of DNA by platinum complexes</span></div><div class="casAuthors">Brabec, Viktor; Kasparkova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-146</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of platinum drugs in cancer chemotherapy is underscored by the clin. success of cisplatin [cis-diamminedichloroplatinum(II)] and its analogs and by clin. trials of other, less toxic platinum complexes that are active against resistant tumors.  The antitumor effect of platinum complexes is believed to result from their ability to form various types of adducts with DNA.  Nevertheless, drug resistance can occur by several ways: increased drug efflux, drug inactivation, alterations in drug target, processing of drug-induced damage, and evasion of apoptosis.  This review focuses on mechanisms of resistance and sensitivity of tumors to conventional cisplatin assocd. with DNA modifications.  We also discuss mol. mechanisms underlying resistance and sensitivity of tumors to the new platinum compds. synthesized with the goal to overcome resistance of tumors to established platinum drugs.  Importantly, a no. of new platinum compds. were designed to test the hypothesis that there is a correlation between the extent of resistance of tumors to these agents and their ability to induce a certain kind of damage or conformational change in DNA.  Hence, information on DNA-binding modes, as well as recognition and repair of DNA damage is discussed, since this information may be exploited for improved structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoliOk5cSz47LVg90H21EOLACvtfcHk0lhzHBx15QLFYQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVSlsr7K&md5=0b2aedfc594780c9727404fce1b1669d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2005.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2005.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DModifications%2520of%2520DNA%2520by%2520platinum%2520complexes%253A%2520Relation%2520to%2520resistance%2520of%2520tumors%2520to%2520platinum%2520antitumor%2520drugs%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2005%26volume%3D8%26spage%3D131%26epage%3D146%26doi%3D10.1016%2Fj.drup.2005.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">The next generation of platinum drugs: Targeted Pt(II) agents, nanoparticle delivery, and Pt (IV) prodrugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">3436</span>â <span class="NLM_lpage">3486</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrev.5b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=3436-3486&author=T.+C.+Johnstoneauthor=K.+Suntharalingamauthor=S.+J.+Lippard&title=The+next+generation+of+platinum+drugs%3A+Targeted+Pt%28II%29+agents%2C+nanoparticle+delivery%2C+and+Pt+%28IV%29+prodrugs&doi=10.1021%2Facs.chemrev.5b00597"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00597%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520next%2520generation%2520of%2520platinum%2520drugs%253A%2520Targeted%2520Pt%2528II%2529%2520agents%252C%2520nanoparticle%2520delivery%252C%2520and%2520Pt%2520%2528IV%2529%2520prodrugs%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D3436%26epage%3D3486%26doi%3D10.1021%2Facs.chemrev.5b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Einhorn, L. H.</span></span> <span> </span><span class="NLM_article-title">Curing metastatic testicular cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">4592</span>â <span class="NLM_lpage">4595</span>, <span class="refDoi">Â DOI: 10.1073/pnas.072067999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.072067999" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=4592-4595&author=L.+H.+Einhorn&title=Curing+metastatic+testicular+cancer&doi=10.1073%2Fpnas.072067999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.072067999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.072067999%26sid%3Dliteratum%253Aachs%26aulast%3DEinhorn%26aufirst%3DL.%2BH.%26atitle%3DCuring%2520metastatic%2520testicular%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D4592%26epage%3D4595%26doi%3D10.1073%2Fpnas.072067999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseigne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ychou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BouchÃ©, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimbaud, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ©couarn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adenis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoul, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourgou-Bourgade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la FouchardiÃ©re, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennouna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachet, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemissa-Akouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pere-Verge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assenat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoto-Grillot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducreux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grp Tumeurs
Digestives, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intergrp, P.</span></span> <span> </span><span class="NLM_article-title">FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer</span>. <i>New England J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>364</i></span>,  <span class="NLM_fpage">1817</span>â <span class="NLM_lpage">1825</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1011923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1056%2FNEJMoa1011923" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1817-1825&author=T.+Conroyauthor=F.+Desseigneauthor=M.+Ychouauthor=O.+Bouch%C3%A9author=R.+Guimbaudauthor=Y.+B%C3%A9couarnauthor=A.+Adenisauthor=J.+L.+Raoulauthor=S.+Gourgou-Bourgadeauthor=C.+de+la+Fouchardi%C3%A9reauthor=J.+Bennounaauthor=J.+B.+Bachetauthor=F.+Khemissa-Akouzauthor=D.+Pere-Vergeauthor=C.+Delbaldoauthor=E.+Assenatauthor=B.+Chauffertauthor=P.+Michelauthor=C.+Montoto-Grillotauthor=M.+Ducreuxauthor=U.+Grp+Tumeurs%0ADigestivesauthor=P.+Intergrp&title=FOLFIRINOX+versus+Gemcitabine+for+Metastatic+Pancreatic+Cancer&doi=10.1056%2FNEJMoa1011923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1011923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1011923%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DT.%26aulast%3DDesseigne%26aufirst%3DF.%26aulast%3DYchou%26aufirst%3DM.%26aulast%3DBouch%25C3%25A9%26aufirst%3DO.%26aulast%3DGuimbaud%26aufirst%3DR.%26aulast%3DB%25C3%25A9couarn%26aufirst%3DY.%26aulast%3DAdenis%26aufirst%3DA.%26aulast%3DRaoul%26aufirst%3DJ.%2BL.%26aulast%3DGourgou-Bourgade%26aufirst%3DS.%26aulast%3Dde%2Bla%2BFouchardi%25C3%25A9re%26aufirst%3DC.%26aulast%3DBennouna%26aufirst%3DJ.%26aulast%3DBachet%26aufirst%3DJ.%2BB.%26aulast%3DKhemissa-Akouz%26aufirst%3DF.%26aulast%3DPere-Verge%26aufirst%3DD.%26aulast%3DDelbaldo%26aufirst%3DC.%26aulast%3DAssenat%26aufirst%3DE.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DMichel%26aufirst%3DP.%26aulast%3DMontoto-Grillot%26aufirst%3DC.%26aulast%3DDucreux%26aufirst%3DM.%26aulast%3DGrp%2BTumeurs%2BDigestives%26aufirst%3DU.%26aulast%3DIntergrp%26aufirst%3DP.%26atitle%3DFOLFIRINOX%2520versus%2520Gemcitabine%2520for%2520Metastatic%2520Pancreatic%2520Cancer%26jtitle%3DNew%2520England%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1817%26epage%3D1825%26doi%3D10.1056%2FNEJMoa1011923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haber, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span> <span> </span><span class="NLM_article-title">The evolving war on cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">19</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2011.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.cell.2011.03.026" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=19-24&author=D.+A.+Haberauthor=N.+S.+Grayauthor=J.+Baselga&title=The+evolving+war+on+cancer&doi=10.1016%2Fj.cell.2011.03.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DThe%2520evolving%2520war%2520on%2520cancer%26jtitle%3DCell%26date%3D2011%26volume%3D145%26spage%3D19%26epage%3D24%26doi%3D10.1016%2Fj.cell.2011.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Epigenetic polypharmacology: from combination therapy to multitargeted drugs</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">105</span>, <span class="refDoi">Â DOI: 10.1186/s13148-016-0271-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1186%2Fs13148-016-0271-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27752293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslOgsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=105&author=A.+R.+de%0ALeraauthor=A.+Ganesan&title=Epigenetic+polypharmacology%3A+from+combination+therapy+to+multitargeted+drugs&doi=10.1186%2Fs13148-016-0271-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic polypharmacology: from combination therapy to multitargeted drugs</span></div><div class="casAuthors">de Lera, Angel R.; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105/1-105/21</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The modern drug discovery process has largely focused its attention in the so-called magic bullets, single chem. entities that exhibit high selectivity and potency for a particular target.  This approach was based on the assumption that the deregulation of a protein was causally linked to a disease state, and the pharmacol. intervention through inhibition of the deregulated target was able to restore normal cell function.  However, the use of cocktails or multicomponent drugs to address several targets simultaneously is also popular to treat multifactorial diseases such as cancer and neurol. disorders.  We review the state of the art with such combinations that have an epigenetic target as one of their mechanisms of action.  Epigenetic drug discovery is a rapidly advancing field, and drugs targeting epigenetic enzymes are in the clinic for the treatment of hematol. cancers.  Approved and exptl. epigenetic drugs are undergoing clin. trials in combination with other therapeutic agents via fused or linked pharmacophores in order to benefit from synergistic effects of polypharmacol.  In addn., ligands are being discovered which, as single chem. entities, are able to modulate multiple epigenetic targets simultaneously (multitarget epigenetic drugs).  These multiple ligands should in principle have a lower risk of drug-drug interactions and drug resistance compared to cocktails or multicomponent drugs.  This new generation may rival the so-called magic bullets in the treatment of diseases that arise as a consequence of the deregulation of multiple signaling pathways provided the challenge of optimization of the activities shown by the pharmacophores with the different targets is addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphm-KIEGyYKrVg90H21EOLACvtfcHk0lhmyay75BMIYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslOgsbY%253D&md5=7cd89a93a22121cc9db2c7118e2e23f1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs13148-016-0271-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-016-0271-9%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%26aufirst%3DA.%2BR.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DEpigenetic%2520polypharmacology%253A%2520from%2520combination%2520therapy%2520to%2520multitargeted%2520drugs%26jtitle%3DClin.%2520Epigenet.%26date%3D2016%26volume%3D8%26spage%3D105%26doi%3D10.1186%2Fs13148-016-0271-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Multitarget drugs: an epigenetic epiphany</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1227</span>â <span class="NLM_lpage">1241</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201500394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fcmdc.201500394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=26891251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28Xislehu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1227-1241&author=A.+Ganesan&title=Multitarget+drugs%3A+an+epigenetic+epiphany&doi=10.1002%2Fcmdc.201500394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Drugs: an Epigenetic Epiphany</span></div><div class="casAuthors">Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1227-1241</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Epigenetics refers to changes in a biol. phenotype that are not due to an underlying change in genotype.  In eukaryotes, epigenetics involves a set of chem. modifications of the DNA and the histone proteins in nucleosomes.  These dynamic changes are carried out by enzymes and modulate protein-protein and protein-nucleic acid interactions to det. whether specific genes are expressed or silenced.  Both the epigenetic enzymes and recognition domains are currently important drug discovery targets, particularly for the treatment of cancer.  This review summarizes the progress of epigenetic targets that have reached a clin. stage: DNA methyltransferases, histone deacetylases, lysine methyltransferases, lysine demethylases, and bromodomains; this is followed by a comprehensive survey of multitarget drugs that have included an epigenetic target as one of their mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwdZM3u9Wbc7Vg90H21EOLACvtfcHk0lhmyay75BMIYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xislehu7w%253D&md5=736284dc3f05db0032c9a304884f980d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500394%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DMultitarget%2520drugs%253A%2520an%2520epigenetic%2520epiphany%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1227%26epage%3D1241%26doi%3D10.1002%2Fcmdc.201500394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anighoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastelli, G.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology: Challenges and opportunities in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7874</span>â <span class="NLM_lpage">7887</span>, <span class="refDoi">Â DOI: 10.1021/jm5006463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+Challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0lhmyay75BMIYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520Challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J.-U.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology â Foe or friend?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8955</span>â <span class="NLM_lpage">8971</span>, <span class="refDoi">Â DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology+%E2%80%93+Foe+or+friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0lhmyay75BMIYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology%2520%25E2%2580%2593%2520Foe%2520or%2520friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) anticancer prodrugs - hypotheses and facts</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12983</span>â <span class="NLM_lpage">12991</span>, <span class="refDoi">Â DOI: 10.1039/C6DT01414C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC6DT01414C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27214873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28XotlCruro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=12983-12991&author=D.+Gibson&title=Platinum%28IV%29+anticancer+prodrugs+-+hypotheses+and+facts&doi=10.1039%2FC6DT01414C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) anticancer prodrugs - hypotheses and facts</span></div><div class="casAuthors">Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12983-12991</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this manuscript we focus on Pt(IV) anticancer prodrugs.  We explore the main working hypotheses for the design of effective Pt(IV) prodrugs and note the exceptions to the common assumptions that are prevalent in the field.  Special attention was devoted to the emerging class of "dual action" Pt(IV) prodrugs, where bioactive ligands are conjugated to the axial positions of platinum in order to obtain orthogonal or complementary effects that will increase the efficacy of killing the cancer cells.  We discuss the rationale behind the design of the "dual action" prodrugs and the results of the pharmacol. studies obtained.  Simultaneous release of two bioactive moieties inside the cancer cells often triggers several processes that together det. the fate of the cell.  Pt(IV) complexes provide many opportunities for applying new concepts in targeting, synergistic cell killing and exploiting novel nanodelivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN31ie6PsEtLVg90H21EOLACvtfcHk0lgbXFWsUXejzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotlCruro%253D&md5=99fca9a3216d25087a0b565f8997c3ae</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2FC6DT01414C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT01414C%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DPlatinum%2528IV%2529%2520anticancer%2520prodrugs%2520-%2520hypotheses%2520and%2520facts%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26spage%3D12983%26epage%3D12991%26doi%3D10.1039%2FC6DT01414C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osella, D.</span></span> <span> </span><span class="NLM_article-title">Pros and cons of bifunctional platinum(IV) antitumor prodrugs: two are (not always) better than one</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">9813</span>â <span class="NLM_lpage">9820</span>, <span class="refDoi">Â DOI: 10.1039/c4dt00911h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2Fc4dt00911h" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=9813-9820&author=E.+Gabanoauthor=M.+Raveraauthor=D.+Osella&title=Pros+and+cons+of+bifunctional+platinum%28IV%29+antitumor+prodrugs%3A+two+are+%28not+always%29+better+than+one&doi=10.1039%2Fc4dt00911h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2Fc4dt00911h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4dt00911h%26sid%3Dliteratum%253Aachs%26aulast%3DGabano%26aufirst%3DE.%26aulast%3DRavera%26aufirst%3DM.%26aulast%3DOsella%26aufirst%3DD.%26atitle%3DPros%2520and%2520cons%2520of%2520bifunctional%2520platinum%2528IV%2529%2520antitumor%2520prodrugs%253A%2520two%2520are%2520%2528not%2520always%2529%2520better%2520than%2520one%26jtitle%3DDalton%2520Trans.%26date%3D2014%26volume%3D43%26spage%3D9813%26epage%3D9820%26doi%3D10.1039%2Fc4dt00911h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wexselblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">What do we know about the reduction of Pt(IV) pro-drugs?</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">220</span>â <span class="NLM_lpage">229</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2012.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2012.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=22877926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Klsr7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2012&pages=220-229&author=E.+Wexselblattauthor=D.+Gibson&title=What+do+we+know+about+the+reduction+of+Pt%28IV%29+pro-drugs%3F&doi=10.1016%2Fj.jinorgbio.2012.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">What do we know about the reduction of Pt(IV) pro-drugs?</span></div><div class="casAuthors">Wexselblatt, Ezequiel; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">220-229</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Platinum(IV) pro-drugs are an important class of mols. that might improve the pharmacol. properties of the platinum(II) anticancer agents that are currently used in the clinic.  Their axial ligands that are detached during cellular activation by reductive elimination can be used to confer favorable pharmacol. properties to the complexes allowing for potentially lower toxicity and improved efficacy.  This manuscript describes the various approaches taken to design and prep. Pt(IV) complexes that will be effective anticancer agents.  We review the working hypotheses guiding the researchers in the field while pointing out some more recent results that contradict some of the accepted paradigms in the hope of triggering some rethinking of the existing working hypotheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPyz4uDONRLrVg90H21EOLACvtfcHk0lgbXFWsUXejzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Klsr7L&md5=bc7eedfee3214769162e5e1131a569d5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2012.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2012.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DWhat%2520do%2520we%2520know%2520about%2520the%2520reduction%2520of%2520Pt%2528IV%2529%2520pro-drugs%253F%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D117%26spage%3D220%26epage%3D229%26doi%3D10.1016%2Fj.jinorgbio.2012.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hambley, T. W.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) antitumour compounds: their bioinorganic chemistry</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">49</span>â <span class="NLM_lpage">67</span>, <span class="refDoi">Â DOI: 10.1016/S0010-8545(02)00026-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2FS0010-8545%2802%2900026-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD38XntF2ktbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2002&pages=49-67&author=M.+D.+Hallauthor=T.+W.+Hambley&title=Platinum%28IV%29+antitumour+compounds%3A+their+bioinorganic+chemistry&doi=10.1016%2FS0010-8545%2802%2900026-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) antitumour compounds: their bioinorganic chemistry</span></div><div class="casAuthors">Hall, Matthew D.; Hambley, Trevor W.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">49-67</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  This article reviews the studies undertaken into Pt(IV) antitumor compds. since Barnett Rosenberg 1st noted the activity of Pt(IV) complexes.  The chem. and pharmacol. properties of the drugs are discussed and both the reactions with individual biomols., which have received attention and the characterization of biotransformation products from animal and clin. trials are reviewed.  The bioinorg. chem. of Pt(IV) complexes has not previously been reviewed, and the purpose here is to provide insight into the requirements for the antitumor activity of Pt(IV) complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkHxf962L07rVg90H21EOLACvtfcHk0lgbXFWsUXejzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntF2ktbs%253D&md5=200992ab1e4313bea2f5c9b3f60ac26f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2802%2900026-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252802%252900026-7%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DHambley%26aufirst%3DT.%2BW.%26atitle%3DPlatinum%2528IV%2529%2520antitumour%2520compounds%253A%2520their%2520bioinorganic%2520chemistry%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2002%26volume%3D232%26spage%3D49%26epage%3D67%26doi%3D10.1016%2FS0010-8545%2802%2900026-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doshi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonpavde, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, C. N.</span></span> <span> </span><span class="NLM_article-title">Clinical and pharmacokinetic evaluation of satraplatin</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1517/17425255.2012.636352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1517%2F17425255.2012.636352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=22098065" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=103-111&author=G.+Doshiauthor=G.+Sonpavdeauthor=C.+N.+Sternberg&title=Clinical+and+pharmacokinetic+evaluation+of+satraplatin&doi=10.1517%2F17425255.2012.636352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.636352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.636352%26sid%3Dliteratum%253Aachs%26aulast%3DDoshi%26aufirst%3DG.%26aulast%3DSonpavde%26aufirst%3DG.%26aulast%3DSternberg%26aufirst%3DC.%2BN.%26atitle%3DClinical%2520and%2520pharmacokinetic%2520evaluation%2520of%2520satraplatin%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2011%26volume%3D8%26spage%3D103%26epage%3D111%26doi%3D10.1517%2F17425255.2012.636352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">22199</span>â <span class="NLM_lpage">22204</span>, <span class="refDoi">Â DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (ÎÏm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0lgNnyWomsFS5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Conjugation of vitamin E analog Î±-TOS to Pt(IV) complexes for dual-targeting anticancer therapy</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2465</span>â <span class="NLM_lpage">2468</span>, <span class="refDoi">Â DOI: 10.1039/c3cc48740g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2Fc3cc48740g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=24452361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVygsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=2465-2468&author=K.+Suntharalingamauthor=Y.+Songauthor=S.+J.+Lippard&title=Conjugation+of+vitamin+E+analog+%CE%B1-TOS+to+Pt%28IV%29+complexes+for+dual-targeting+anticancer+therapy&doi=10.1039%2Fc3cc48740g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of vitamin E analog Î±-TOS to Pt(IV) complexes for dual-targeting anticancer therapy</span></div><div class="casAuthors">Suntharalingam, Kogularamanan; Song, Ying; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2465-2468</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report two platinum(IV) complexes conjugated with a vitamin E analog, Î±-tocopherol succinate (Î±-TOS).  One of the conjugates displays the activity of both cisplatin and Î±-TOS in cancer cells, causing damage to DNA and mitochondria simultaneously.  Accordingly, it serves as a promising dual-targeting anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruxZumJGIJpbVg90H21EOLACvtfcHk0lgNnyWomsFS5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVygsLY%253D&md5=dc381d990f2afa1e349752f4e81976ba</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2Fc3cc48740g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cc48740g%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DConjugation%2520of%2520vitamin%2520E%2520analog%2520%25CE%25B1-TOS%2520to%2520Pt%2528IV%2529%2520complexes%2520for%2520dual-targeting%2520anticancer%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D2465%26epage%3D2468%26doi%3D10.1039%2Fc3cc48740g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">133</span>â <span class="NLM_lpage">144</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2015.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.bcp.2015.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=25888926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvVyku7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=133-144&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=New+insights+into+the+molecular+and+epigenetic+effects+of+antitumor+Pt%28IV%29-valproic+acid+conjugates+in+human+ovarian+cancer+cells&doi=10.1016%2Fj.bcp.2015.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-144</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Substitutionally inert Pt(IV) prodrugs, combining bioactive axial ligands with Pt(IV) derivs. of antitumor Pt(II) compds., represent a new generation of anticancer drugs.  The rationale behind these prodrugs is to release, by reductive elimination inside the cancer cell, an active Pt(II) drug which binds nuclear DNA as well as bioactive ligands that may potentiate toxic effects of the Pt(II) drugs by an independent pathway.  Platinum prodrugs, such as Pt(IV) derivs. of cisplatin contg. axial valproic acid (VPA) ligands, destroy cancer cells with greater efficacy than conventional cisplatin.  These axial ligands were chosen because VPA inhibits histone deacetylase (HDAC) activity, thereby decondensing chromatin and subsequently increasing the accessibility of DNA within chromatin to DNA-binding agents.  We examd. the mechanism of cytotoxic activity of Pt(IV) derivs. of cisplatin with VPA axial ligands.  Particular attention was paid to the role of the VPA ligand in these Pt(IV) prodrugs in the mechanism underlying their toxic effects in human ovarian tumor cells.  We demonstrate that (i) treatment of the cells with these prodrugs resulted in enhanced histone H3 acetylation and decondensation of heterochromatin markedly more effectively than free VPA; (ii) of the total Pt inside the cells, a considerably higher fraction of Pt from the Pt(IV)-VPA conjugates is bound to DNA than from the conjugates with biol. inactive ligands.  The results indicate that the enhanced cytotoxicity of the Pt(IV)-VPA conjugates is a consequence of several processes involving enhanced cellular accumulation, downregulation of HDACs and yet other biochem. processes (not involving HDACs) which may potentiate antitumor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3LmsPWxK7QLVg90H21EOLACvtfcHk0lgNnyWomsFS5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvVyku7w%253D&md5=27a82b24b212af7c7cfd423ca43e3bf9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DNew%2520insights%2520into%2520the%2520molecular%2520and%2520epigenetic%2520effects%2520of%2520antitumor%2520Pt%2528IV%2529-valproic%2520acid%2520conjugates%2520in%2520human%2520ovarian%2520cancer%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D95%26spage%3D133%26epage%3D144%26doi%3D10.1016%2Fj.bcp.2015.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braude, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexselblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuchlikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2381</span>â <span class="NLM_lpage">2391</span>, <span class="refDoi">Â DOI: 10.1039/C5SC04205D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC5SC04205D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=29997781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVOlsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=2381-2391&author=R.+Raveendranauthor=J.+P.+Braudeauthor=E.+Wexselblattauthor=V.+Novohradskyauthor=O.+Stuchlikovaauthor=V.+Brabecauthor=V.+Gandinauthor=D.+Gibson&title=Pt%28IV%29+derivatives+of+cisplatin+and+oxaliplatin+with+phenylbutyrate+axial+ligands+are+potent+cytotoxic+agents+that+act+by+several+mechanisms+of+action&doi=10.1039%2FC5SC04205D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action</span></div><div class="casAuthors">Raveendran, Raji; Braude, Jeremy Phillip; Wexselblatt, Ezequiel; Novohradsky, Vojtech; Stuchlikova, Olga; Brabec, Viktor; Gandin, Valentina; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2381-2391</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Our study demonstrates that Pt(IV) deriv. of cisplatin, with two axial PhB ligands, ctc-[Pt(NH3)2(PhB)2Cl2], is a very potent cytotoxic agent against many different human cancer cell lines and is up to 100 fold more potent than cisplatin, and significantly more potent than the Pt(IV) derivs. of cisplatin with either two hydroxido, two acetato or two valproato ligands.  The high potency of this compd. (and some others) is due to several factors including enhanced internalization, probably driven by "synergistic accumulation" of both the Pt moiety and the phenylbutyrate, that correlates with enhanced DNA binding and cytotoxicity.  Ctc-[Pt(NH3)2(PhB)2Cl2] inhibits 60-70% HDAC activity in cancer cells, at levels below the IC50 values of PhB, suggesting synergism between Pt and PhB.  Mechanistically, ctc-[Pt(NH3)2(PhB)2Cl2] induces activation of caspases (3 and 9) triggering apoptotic signaling via the mitochondrial pathway.  Data also suggest that the antiproliferative effect of ctc-[Pt(NH3)2(PhB)2Cl2] may not depend of p53.  Pt(IV) derivs. of cisplatin with either two axial PhB or valproate ligands are more potent than their oxaliplatin analogs.  Ctc-[Pt(NH3)2(PhB)2Cl2] is significantly more potent than its valproate analog ctc-[Pt(NH3)2(VPA)2Cl2].  These compds. combine multiple effects such as efficient uptake of both Pt and PhB with DNA binding, HDAC inhibition and activation of caspases to effectively kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUvxQyimpaX7Vg90H21EOLACvtfcHk0lhzeDtu0dCAog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVOlsg%253D%253D&md5=0599753b615d64adcf6a4014defc1327</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2FC5SC04205D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC04205D%26sid%3Dliteratum%253Aachs%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DBraude%26aufirst%3DJ.%2BP.%26aulast%3DWexselblatt%26aufirst%3DE.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DStuchlikova%26aufirst%3DO.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DPt%2528IV%2529%2520derivatives%2520of%2520cisplatin%2520and%2520oxaliplatin%2520with%2520phenylbutyrate%2520axial%2520ligands%2520are%2520potent%2520cytotoxic%2520agents%2520that%2520act%2520by%2520several%2520mechanisms%2520of%2520action%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D2381%26epage%3D2391%26doi%3D10.1039%2FC5SC04205D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span> <span> </span><span class="NLM_article-title">A platinum(IV) anticancer prodrug targeting nucleotide excision repair to overcome cisplatin resistance</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">15564</span>â <span class="NLM_lpage">15568</span>, <span class="refDoi">Â DOI: 10.1002/anie.201608936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fanie.201608936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yju7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=15564-15568&author=Z.+Wangauthor=Z.+Xuauthor=G.+Zhu&title=A+platinum%28IV%29+anticancer+prodrug+targeting+nucleotide+excision+repair+to+overcome+cisplatin+resistance&doi=10.1002%2Fanie.201608936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance</span></div><div class="casAuthors">Wang, Zhigang; Xu, Zoufeng; Zhu, Guangyu</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">15564-15568</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA damage response plays a key role not only in maintaining genome integrity but also in mediating the antitumor efficacy of DNA-damaging antineoplastic drugs.  Herein, we report the rational design and evaluation of a PtIV anticancer prodrug inhibiting nucleotide excision repair (NER), one of the most pivotal processes after the formation of cisplatin-induced DNA damage that deactivates the drug and leads to drug resistance in the clinic.  This dual-action prodrug enters cells efficiently and causes DNA damage while simultaneously inhibiting NER to promote apoptotic response.  The prodrug is strongly active against the proliferation of cisplatin-resistant human cancer cells with an up to 88-fold increase in growth inhibition compared with cisplatin, and the prodrug is much more active than a mixt. of cisplatin and an NER inhibitor.  Our study highlights the importance of targeting downstream pathways after the formation of Pt-induced DNA damage as a novel strategy to conquer cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5lc5oE4qMXrVg90H21EOLACvtfcHk0lhzeDtu0dCAog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yju7fK&md5=551b6004833ce071b79c923cdf9483ca</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.201608936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201608936%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DG.%26atitle%3DA%2520platinum%2528IV%2529%2520anticancer%2520prodrug%2520targeting%2520nucleotide%2520excision%2520repair%2520to%2520overcome%2520cisplatin%2520resistance%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D15564%26epage%3D15568%26doi%3D10.1002%2Fanie.201608936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4686</span>â <span class="NLM_lpage">4700</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2017.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.bmc.2017.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28728896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFynsrbN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4686-4700&author=X.+Huangauthor=R.+Huangauthor=S.+Gouauthor=Z.+Wangauthor=Z.+Liaoauthor=H.+Wang&title=Platinum%28IV%29+complexes+conjugated+with+phenstatin+analogue+as+inhibitors+of+microtubule+polymerization+and+reverser+of+multidrug+resistance&doi=10.1016%2Fj.bmc.2017.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance</span></div><div class="casAuthors">Huang, Xiaochao; Huang, Rizhen; Gou, Shaohua; Wang, Zhimei; Liao, Zhixin; Wang, Hengshan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4686-4700</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pt(IV) complexes comprising a phenstatin analog, as dual-targeting Pt(IV) prodrug, were designed and synthesized.  They were found not only to carry the DNA binding platinum warhead into the tumor cells, but also to have a small mol. unit to inhibit tubulin polymn.  In vitro evaluation results revealed that Pt(IV) complexes showed better and more potent activity against the test human cancer cells including cisplatin resistant cell lines than their corresponding Pt(II) counterparts.  In addn., the Pt(IV) deriv. of cisplatin, complex 10, exhibited highly selective inhibition in human cancer cells and displayed no obvious toxicity to two human normal cell lines, resp.  Mechanism study suggested that complex I induced cell-cycle arrest at the G2/M phase and caused apoptotic cell death of human lung cancer NCI-H460 cells through the mitochondrial mediated pathway.  Moreover, complex I effectively inhibited the tumor growth in the NCI-H460 xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzt6XOfYO-rVg90H21EOLACvtfcHk0lhzeDtu0dCAog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFynsrbN&md5=953e8445ffd3733e53ff013356f002dd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DGou%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DPlatinum%2528IV%2529%2520complexes%2520conjugated%2520with%2520phenstatin%2520analogue%2520as%2520inhibitors%2520of%2520microtubule%2520polymerization%2520and%2520reverser%2520of%2520multidrug%2520resistance%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4686%26epage%3D4700%26doi%3D10.1016%2Fj.bmc.2017.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanellato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pracharova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3751</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-03864-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fs41598-017-03864-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28623355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BC1cnptFGisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=3751&author=V.+Novohradskyauthor=I.+Zanellatoauthor=C.+Marzanoauthor=J.+Pracharovaauthor=J.+Kasparkovaauthor=D.+Gibsonauthor=V.+Gandinauthor=D.+Osellaauthor=V.+Brabec&title=Epigenetic+and+antitumor+effects+of+platinum%28IV%29-octanoato+conjugates&doi=10.1038%2Fs41598-017-03864-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates</span></div><div class="casAuthors">Novohradsky Vojtech; Kasparkova Jana; Brabec Viktor; Zanellato Ilaria; Osella Domenico; Marzano Cristina; Gandin Valentina; Pracharova Jitka; Gibson Dan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3751</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We present the anticancer properties of cis, cis, trans-[Pt(IV)(NH3)2Cl2(OA)2] [Pt(IV)diOA] (OA = octanoato), Pt(IV) derivative of cisplatin containing two OA units appended to the axial positions of a six-coordinate Pt(IV) center.  Our results demonstrate that Pt(IV)diOA is a potent cytotoxic agent against many cancer cell lines (the IC50 values are approximately two orders of magnitude lower than those of clinically used cisplatin or Pt(IV) derivatives with biologically inactive axial ligands).  Importantly, Pt(IV)diOA overcomes resistance to cisplatin, is significantly more potent than its branched Pt(IV) valproato isomer and exhibits promising in vivo antitumor activity.  The potency of Pt(IV)diOA is a consequence of several factors including enhanced cellular accumulation correlating with enhanced DNA platination and cytotoxicity.  Pt(IV)diOA induces DNA hypermethylation and reduces mitochondrial membrane potential in cancer cells at levels markedly lower than the IC50 value of free OA suggesting the synergistic action of platinum and OA moieties.  Collectively, the remarkable antitumor effects of Pt(IV)diOA are a consequence of the enhanced cellular uptake which makes it possible to simultaneously accumulate high levels of both cisplatin and OA in cells.  The simultaneous dual action of cisplatin and OA by different mechanisms in tumor cells may result in a markedly enhanced and unique antitumor effects of Pt(IV) prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJFccvOyb6-YvKgEt20y1XfW6udTcc2ebofVPpe4bNWrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnptFGisQ%253D%253D&md5=de8c0401375343881d826185537f25ef</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-03864-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-03864-w%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZanellato%26aufirst%3DI.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DPracharova%26aufirst%3DJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DOsella%26aufirst%3DD.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DEpigenetic%2520and%2520antitumor%2520effects%2520of%2520platinum%2528IV%2529-octanoato%2520conjugates%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D3751%26doi%3D10.1038%2Fs41598-017-03864-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanellato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottone, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osella, D.</span></span> <span> </span><span class="NLM_article-title">An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">14174</span>â <span class="NLM_lpage">14185</span>, <span class="refDoi">Â DOI: 10.1039/C7DT02928D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7DT02928D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28984330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtL%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=14174-14185&author=E.+Gabanoauthor=M.+Raveraauthor=I.+Zanellatoauthor=S.+Tinelloauthor=A.+Gallinaauthor=B.+Rangoneauthor=V.+Gandinauthor=C.+Marzanoauthor=M.+G.+Bottoneauthor=D.+Osella&title=An+unsymmetric+cisplatin-based+Pt%28IV%29+derivative+containing+2-%282-propynyl%29octanoate%3A+a+very+efficient+multi-action+antitumor+prodrug+candidate&doi=10.1039%2FC7DT02928D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate</span></div><div class="casAuthors">Gabano, Elisabetta; Ravera, Mauro; Zanellato, Ilaria; Tinello, Stefano; Gallina, Andrea; Rangone, Beatrice; Gandin, Valentina; Marzano, Cristina; Bottone, Maria Grazia; Osella, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">14174-14185</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The design, synthesis, characterization and biol. properties of a Pt(IV) complex contg. the very active inhibitor of histone deacetylase (2-propynyl)octanoic acid, POA, as an axial ligand are reported here.  The title complex, namely (OC-6-44)-acetatodiamminedichlorido(2-(2-propynyl)octanoato)platinum(IV) (I), contg. POA in racemic or in enantiomeric forms, was one/two orders of magnitude more active than cisplatin, depending on the chemo-sensitivity of the cancer cell lines.  Moreover, I exhibited similar or even better antiproliferative activity than (OC-6-33)-diamminedichloridobis(2-propylpentanoato)platinum(IV), contg. two mols. of the well-known histone deacetylase inhibitor 2-propylpentanoic (valproic) acid.  The high potency of I is likely due to its high cellular accumulation and to the synergism between the DNA-damaging cisplatin and the histone deacetylase inhibitor POA, both released upon the intracellular redn. of I.  Prodrug I, after oral administration, caused an impressive redn. of the tumor mass (94%) in a model of solid tumor (murine Lewis lung carcinoma), compared to that of the control, whereas (i.p.) cisplatin induced a tumor regression of 75% only.  A good accumulation of I was obsd. in the tumor mass.  The time course of the body wt. attested that cisplatin induced elevated anorexia, whereas treatment with I did not induce significant body wt. loss throughout the therapeutic expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroh-E9hmmzn7Vg90H21EOLACvtfcHk0lhoEVN65zghWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtL%252FL&md5=75b8c007a4ba673f3a6055127d83da86</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC7DT02928D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT02928D%26sid%3Dliteratum%253Aachs%26aulast%3DGabano%26aufirst%3DE.%26aulast%3DRavera%26aufirst%3DM.%26aulast%3DZanellato%26aufirst%3DI.%26aulast%3DTinello%26aufirst%3DS.%26aulast%3DGallina%26aufirst%3DA.%26aulast%3DRangone%26aufirst%3DB.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DBottone%26aufirst%3DM.%2BG.%26aulast%3DOsella%26aufirst%3DD.%26atitle%3DAn%2520unsymmetric%2520cisplatin-based%2520Pt%2528IV%2529%2520derivative%2520containing%25202-%25282-propynyl%2529octanoate%253A%2520a%2520very%2520efficient%2520multi-action%2520antitumor%2520prodrug%2520candidate%26jtitle%3DDalton%2520Trans.%26date%3D2017%26volume%3D46%26spage%3D14174%26epage%3D14185%26doi%3D10.1039%2FC7DT02928D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro-Ranninger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiroga, A. G.</span></span> <span> </span><span class="NLM_article-title">Enhanced cytotoxicity and reactivity of a novel platinum(IV) family with DNA-targeting naphthalimide ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6175</span>â <span class="NLM_lpage">6183</span>, <span class="refDoi">Â DOI: 10.1021/acs.inorgchem.7b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1Gku7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=6175-6183&author=F.+Navasauthor=F.+Mendesauthor=I.+Santosauthor=C.+Navarro-Ranningerauthor=S.+Cabreraauthor=A.+G.+Quiroga&title=Enhanced+cytotoxicity+and+reactivity+of+a+novel+platinum%28IV%29+family+with+DNA-targeting+naphthalimide+ligands&doi=10.1021%2Facs.inorgchem.7b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands</span></div><div class="casAuthors">Navas, Francisco; Mendes, Filipa; Santos, Isabel; Navarro-Ranninger, Carmen; Cabrera, Silvia; Quiroga, Adoracion G.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6175-6183</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pt(IV) complexes are known as prodrugs that can potentially overcome cisplatin limitations by slowing down its reactivity and, once reduced, act as the corresponding Pt(II) drugs.  We report a new approach toward trans Pt(IV) complexes, conceived to afford nonconventional active trans Pt(II) complexes with dual-targeting properties.  The redn. of the complexes has been studied in the presence of ascorbic acid and glutathione, showing that different species are formed in the process.  The interaction with DNA after redn. has been also studied and correlated to the formation of Pt(II) species.  The cytotoxicity profile of the Pt(IV) complexes corroborated the rationale behind this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcPCxn9jf7ULVg90H21EOLACvtfcHk0lhoEVN65zghWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1Gku7k%253D&md5=d0fa3ece9345eff99f7a0e67ddc5f880</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b00136%26sid%3Dliteratum%253Aachs%26aulast%3DNavas%26aufirst%3DF.%26aulast%3DMendes%26aufirst%3DF.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DNavarro-Ranninger%26aufirst%3DC.%26aulast%3DCabrera%26aufirst%3DS.%26aulast%3DQuiroga%26aufirst%3DA.%2BG.%26atitle%3DEnhanced%2520cytotoxicity%2520and%2520reactivity%2520of%2520a%2520novel%2520platinum%2528IV%2529%2520family%2520with%2520DNA-targeting%2520naphthalimide%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D6175%26epage%3D6183%26doi%3D10.1021%2Facs.inorgchem.7b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKeon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devocelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. M.</span></span> <span> </span><span class="NLM_article-title">Platinum(IV) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11318</span>â <span class="NLM_lpage">11321</span>, <span class="refDoi">Â DOI: 10.1039/C7CC04764A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7CC04764A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28967013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGgu7bK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=11318-11321&author=A.+M.+McKeonauthor=J.+Noonanauthor=M.+Devocelleauthor=B.+M.+Murphyauthor=D.+M.+Griffith&title=Platinum%28IV%29+oxaliplatin-peptide+conjugates+targeting+memHsp70%2B+phenotype+in+colorectal+cancer+cells&doi=10.1039%2FC7CC04764A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum(IV) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells</span></div><div class="casAuthors">McKeon, A. M.; Noonan, J.; Devocelle, M.; Murphy, B. M.; Griffith, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">82</span>),
    <span class="NLM_cas:pages">11318-11321</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Novel Pt(IV) tumor penetrating peptide (TPP) conjugates are reported.  They are the first example of metallodrugs to target a membrane bound heat shock protein 70 pos. (memHSP70+) phenotype in cancer cells.  The conjugates exhibit superior cytotoxicity as compared to oxaliplatin alone in Pt resistant colorectal cancer cells with relatively high memHSP70+ expression.  Substitution of TPP in Pt(IV) peptide conjugates with scrambled peptide (ScP) essentially abolishes the obsd. cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUaQamhAZ9WbVg90H21EOLACvtfcHk0li7S4kyOst2bA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGgu7bK&md5=fa61de39ad4f01159ec86c6f5e9aca55</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC7CC04764A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC04764A%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeon%26aufirst%3DA.%2BM.%26aulast%3DNoonan%26aufirst%3DJ.%26aulast%3DDevocelle%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DB.%2BM.%26aulast%3DGriffith%26aufirst%3DD.%2BM.%26atitle%3DPlatinum%2528IV%2529%2520oxaliplatin-peptide%2520conjugates%2520targeting%2520memHsp70%252B%2520phenotype%2520in%2520colorectal%2520cancer%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D11318%26epage%3D11321%26doi%3D10.1039%2FC7CC04764A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almotairy, A. R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erxleben, A.</span></span> <span> </span><span class="NLM_article-title">Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2017.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2017.09.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2017&pages=1-7&author=A.+R.+Z.+Almotairyauthor=V.+Gandinauthor=L.+Morrisonauthor=C.+Marzanoauthor=D.+Montagnerauthor=A.+Erxleben&title=Antitumor+platinum%28IV%29+derivatives+of+carboplatin+and+the+histone+deacetylase+inhibitor+4-phenylbutyric+acid&doi=10.1016%2Fj.jinorgbio.2017.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DAlmotairy%26aufirst%3DA.%2BR.%2BZ.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DMorrison%26aufirst%3DL.%26aulast%3DMarzano%26aufirst%3DC.%26aulast%3DMontagner%26aufirst%3DD.%26aulast%3DErxleben%26aufirst%3DA.%26atitle%3DAntitumor%2520platinum%2528IV%2529%2520derivatives%2520of%2520carboplatin%2520and%2520the%2520histone%2520deacetylase%2520inhibitor%25204-phenylbutyric%2520acid%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D177%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.jinorgbio.2017.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braude, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">A quadruple-action platinum(IV) prodrug with anticancer activity against KRAS mutated cancer cell lines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11539</span>â <span class="NLM_lpage">11544</span>, <span class="refDoi">Â DOI: 10.1002/anie.201706739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fanie.201706739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11539-11544&author=E.+Petruzzellaauthor=J.+P.+Braudeauthor=J.+R.+Aldrich-Wrightauthor=V.+Gandinauthor=D.+Gibson&title=A+quadruple-action+platinum%28IV%29+prodrug+with+anticancer+activity+against+KRAS+mutated+cancer+cell+lines&doi=10.1002%2Fanie.201706739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines</span></div><div class="casAuthors">Petruzzella, Emanuele; Braude, Jeremy Phillip; Aldrich-Wright, Janice R.; Gandin, Valentina; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11539-11544</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We developed a novel PtIV prodrug that simultaneously releases four different bioactive moieties inside the cancer cell.  Its cytotoxicity against monolayer cultures (2D) and spheroid (3D) cancer cells is significantly better than cisplatin.  It is 200-450-fold more potent than cisplatin against KRAS mutated pancreatic and colon cancers and is 40-fold more selective towards KRAS mutated cells compared to non-cancerous.  This is important since RAS proteins play a role in regulating cell differentiation, proliferation, and survival and KRAS is mutated in 90 % of pancreatic adenocarcinomas, 45 % of colorectal cancers, and 35 % of lung adenocarcinomas.  The selectivity index, detd. by dividing the IC50 value in non-cancerous cells by that of a cancerous cell line, is two-fold better than cisplatin, attesting to preferential cytotoxicity towards neoplastic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQHgQHWGMgbVg90H21EOLACvtfcHk0li7S4kyOst2bA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ&md5=4a9c4fcc8d6006775b09c9e4c246d175</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706739%26sid%3Dliteratum%253Aachs%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DBraude%26aufirst%3DJ.%2BP.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DA%2520quadruple-action%2520platinum%2528IV%2529%2520prodrug%2520with%2520anticancer%2520activity%2520against%2520KRAS%2520mutated%2520cancer%2520cell%2520lines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11539%26epage%3D11544%26doi%3D10.1002%2Fanie.201706739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarski, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GrÃ¼nert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span> <span> </span><span class="NLM_article-title">Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">488</span>â <span class="NLM_lpage">495</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.200600211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fcmdc.200600211" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=488-495&author=D.+M.+Fisherauthor=P.+J.+Bednarskiauthor=R.+Gr%C3%BCnertauthor=P.+Turnerauthor=R.+R.+Fentonauthor=J.+R.+Aldrich-Wright&title=Chiral+platinum%28II%29+metallointercalators+with+potent+in+vitro+cytotoxic+activity&doi=10.1002%2Fcmdc.200600211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600211%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BM.%26aulast%3DBednarski%26aufirst%3DP.%2BJ.%26aulast%3DGr%25C3%25BCnert%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DP.%26aulast%3DFenton%26aufirst%3DR.%2BR.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26atitle%3DChiral%2520platinum%2528II%2529%2520metallointercalators%2520with%2520potent%2520in%2520vitro%2520cytotoxic%2520activity%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D488%26epage%3D495%26doi%3D10.1002%2Fcmdc.200600211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Multi-action Pt(IV) anticancer agents; do we understand how they work?</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">77</span>â <span class="NLM_lpage">84</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2018.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2018.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=30471522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ymu7bL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2019&pages=77-84&author=D.+Gibson&title=Multi-action+Pt%28IV%29+anticancer+agents%3B+do+we+understand+how+they+work%3F&doi=10.1016%2Fj.jinorgbio.2018.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-action Pt(IV) anticancer agents; do we understand how they work?</span></div><div class="casAuthors">Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Pt(IV) complexes act as prodrugs that are activated inside cancer cells releasing cytotoxic Pt(II) drugs such as cisplatin as well as two axial ligands.  These ligands can be used to confer favorable pharmacol. properties to the prodrug.  They can be innocent spectators, targeting agents or bioactive moieties.  When the ligands are bioactive moieties such as enzyme inhibitors or antiproliferative agents, the prodrug attacks several cellular targets at the same time acting as a multi-action prodrug.  These compds. are very potent and often overcome resistance to cisplatin.  Despite solid rationalization and careful design, often there is no correlation between the ability of the bioactive ligand to inhibit the target enzyme and the cytotoxicity.  This might be because most bioactive ligands affect several cellular functions and not only the ones they were designed to inhibit.  Thus, even "dual action" prodrugs might in reality be multi-action prodrugs.  This class of multi-action Pt(IV) prodrugs seems to have great potential in the attempts to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKUt_0wXsE5bVg90H21EOLACvtfcHk0lhIBkkw9scSLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ymu7bL&md5=a199a637a9b7064be424d40a295d9a34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2018.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2018.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DMulti-action%2520Pt%2528IV%2529%2520anticancer%2520agents%253B%2520do%2520we%2520understand%2520how%2520they%2520work%253F%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2019%26volume%3D191%26spage%3D77%26epage%3D84%26doi%3D10.1016%2Fj.jinorgbio.2018.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kidani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukagoshi, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anti-tumor activities of platinum(II) complexes of 1,2-diaminocyclohexane isomers and their related derivatives</span>. <i>J. Clin. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">197</span>â <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaE2sXktVShu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1977&pages=197-209&author=Y.+Kidaniauthor=K.+Inagakiauthor=R.+Saitoauthor=S.+Tsukagoshi&title=Synthesis+and+anti-tumor+activities+of+platinum%28II%29+complexes+of+1%2C2-diaminocyclohexane+isomers+and+their+related+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anti-tumor activities of platinum(II) complexes of 1,2-diaminocyclohexane isomers and their related derivatives</span></div><div class="casAuthors">Kidani, Y.; Inagaki, K.; Saito, R.; Tsukagoshi, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hematology and Oncology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-209</span>CODEN:
                <span class="NLM_cas:coden">JCHODP</span>;
        ISSN:<span class="NLM_cas:issn">0162-9360</span>.
    </div><div class="casAbstract">Pt(II) complexes with cis- [1436-59-5], d-trans [21436-03-3], and l-trans-1,2-diaminocyclohexane [20439-47-8] were prepd. and tested for antitumor activity.  The Pt(II) complexes included the Cl, oxalate, malonate, and methylmalonate salts and the uracil complexes.  The l-trans-1,2-diaminocyclohexane complexes showed the greatest neoplasm inhibiting activity.  In contrast, complexes of Cu and Ni with 1,2-diaminocyclohexane were inactive.  The conformational difference obsd. in this study may give very important information in the study of the mechanism of Pt complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpylOJGUQa6c7Vg90H21EOLACvtfcHk0lhIBkkw9scSLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVShu7Y%253D&md5=dded18668af28b91b6de3fdc05c1d1c5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKidani%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DTsukagoshi%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520anti-tumor%2520activities%2520of%2520platinum%2528II%2529%2520complexes%2520of%25201%252C2-diaminocyclohexane%2520isomers%2520and%2520their%2520related%2520derivatives%26jtitle%3DJ.%2520Clin.%2520Hematol.%2520Oncol.%26date%3D1977%26volume%3D7%26spage%3D197%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kidani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukagoshi, S.</span></span> <span> </span><span class="NLM_article-title">Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers and their related complexes</span>. <i>Gann</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">921</span>â <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1976&pages=921-922&author=Y.+Kidaniauthor=K.+Inagakiauthor=S.+Tsukagoshi&title=Examination+of+antitumor+activities+of+platinum+complexes+of+1%2C2-diaminocyclohexane+isomers+and+their+related+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKidani%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DK.%26aulast%3DTsukagoshi%26aufirst%3DS.%26atitle%3DExamination%2520of%2520antitumor%2520activities%2520of%2520platinum%2520complexes%2520of%25201%252C2-diaminocyclohexane%2520isomers%2520and%2520their%2520related%2520complexes%26jtitle%3DGann%26date%3D1976%26volume%3D67%26spage%3D921%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnesano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannunzio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coluccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natile, G.</span></span> <span> </span><span class="NLM_article-title">Effect of chirality in platinum drugs</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">286</span>â <span class="NLM_lpage">297</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2014.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ccr.2014.07.016" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2015&pages=286-297&author=F.+Arnesanoauthor=A.+Pannunzioauthor=M.+Colucciaauthor=G.+Natile&title=Effect+of+chirality+in+platinum+drugs&doi=10.1016%2Fj.ccr.2014.07.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DArnesano%26aufirst%3DF.%26aulast%3DPannunzio%26aufirst%3DA.%26aulast%3DColuccia%26aufirst%3DM.%26aulast%3DNatile%26aufirst%3DG.%26atitle%3DEffect%2520of%2520chirality%2520in%2520platinum%2520drugs%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D284%26spage%3D286%26epage%3D297%26doi%3D10.1016%2Fj.ccr.2014.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pages, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakoff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeschele, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span> <span> </span><span class="NLM_article-title">Combining the platinum(II) drug candidate kiteplatin with 1,10-phenanthroline analogues</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2156</span>â <span class="NLM_lpage">2163</span>, <span class="refDoi">Â DOI: 10.1039/C7DT04108J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7DT04108J" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=2156-2163&author=B.+J.+Pagesauthor=J.+Sakoffauthor=J.+Gilbertauthor=Y.+Zhangauthor=S.+M.+Kellyauthor=J.+D.+Hoescheleauthor=J.+R.+Aldrich-Wright&title=Combining+the+platinum%28II%29+drug+candidate+kiteplatin+with+1%2C10-phenanthroline+analogues&doi=10.1039%2FC7DT04108J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC7DT04108J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT04108J%26sid%3Dliteratum%253Aachs%26aulast%3DPages%26aufirst%3DB.%2BJ.%26aulast%3DSakoff%26aufirst%3DJ.%26aulast%3DGilbert%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DS.%2BM.%26aulast%3DHoeschele%26aufirst%3DJ.%2BD.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26atitle%3DCombining%2520the%2520platinum%2528II%2529%2520drug%2520candidate%2520kiteplatin%2520with%25201%252C10-phenanthroline%2520analogues%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26spage%3D2156%26epage%3D2163%26doi%3D10.1039%2FC7DT04108J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovejoy, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagpacan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacomini, K. M.</span></span> <span> </span><span class="NLM_article-title">Organic cation transporters are determinants of oxaliplatin cytotoxicity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">8847</span>â <span class="NLM_lpage">8857</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-06-0769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1158%2F0008-5472.CAN-06-0769" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8847-8857&author=S.+Zhangauthor=K.+S.+Lovejoyauthor=J.+E.+Shimaauthor=L.+L.+Lagpacanauthor=Y.+Shuauthor=A.+Lapukauthor=Y.+Chenauthor=T.+Komoriauthor=J.+W.+Grayauthor=X.+Chenauthor=S.+J.+Lippardauthor=K.+M.+Giacomini&title=Organic+cation+transporters+are+determinants+of+oxaliplatin+cytotoxicity&doi=10.1158%2F0008-5472.CAN-06-0769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-0769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-0769%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLovejoy%26aufirst%3DK.%2BS.%26aulast%3DShima%26aufirst%3DJ.%2BE.%26aulast%3DLagpacan%26aufirst%3DL.%2BL.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DLapuk%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKomori%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26atitle%3DOrganic%2520cation%2520transporters%2520are%2520determinants%2520of%2520oxaliplatin%2520cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8847%26epage%3D8857%26doi%3D10.1158%2F0008-5472.CAN-06-0769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¶schl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varbanov, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">264</span>â <span class="NLM_lpage">274</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2016.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27055943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BC28fotFartw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=264-274&author=S.+G%C3%B6schlauthor=H.+P.+Varbanovauthor=S.+Theinerauthor=M.+A.+Jakupecauthor=M.+Galanskiauthor=B.+K.+Keppler&title=The+role+of+the+equatorial+ligands+for+the+redox+behavior%2C+mode+of+cellular+accumulation+and+cytotoxicity+of+platinum%28IV%29+prodrugs&doi=10.1016%2Fj.jinorgbio.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs</span></div><div class="casAuthors">Goschl Simone; Galanski Markus; Varbanov Hristo P; Theiner Sarah; Keppler Bernhard K; Jakupec Michael A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of inorganic biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">264-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current study aims to elucidate the possible reasons for the significantly different pharmacological behavior of platinum(IV) complexes with cisplatin-, carboplatin- or nedaplatin-like cores and how this difference can be related to their main physicochemical properties.  Chlorido-containing complexes are reduced fast (within hours) by ascorbate and are able to unwind plasmid DNA in the presence of ascorbate, while their tri- and tetracarboxylato analogs are generally inert under the same conditions.  Comparison of the lipophilicity, cellular accumulation and cytotoxicity of the investigated platinum compounds revealed the necessity to define new structure-property/activity relationships (SPRs and SARs).  The higher activity and improved accumulation of platinum(IV) complexes bearing Cl(-) in equatorial position cannot only be attributed to passive diffusion facilitated by their lipophilicity.  Therefore, further platinum accumulation experiments under conditions where active/facilitated transport mechanisms are suppressed were performed.  Under hypothermic conditions (4Â°C), accumulation of dichloridoplatinum(IV) complexes is reduced down to 10% of the amount determined at 37Â°C.  These findings suggest the involvement of active and/or facilitated transport in cellular uptake of platinum(IV) complexes with a cisplatin-like core.  Studies with ATP depletion mediated by oligomycin and low glucose partially confirmed these observations, but their feasibility was severely limited in the adherent cell culture setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLmoZWYt2uxdHxxy173TfNfW6udTcc2eYnADGAncGIJ7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fotFartw%253D%253D&md5=bde61949f69036e84c95aa4b53c26b79</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6schl%26aufirst%3DS.%26aulast%3DVarbanov%26aufirst%3DH.%2BP.%26aulast%3DTheiner%26aufirst%3DS.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DGalanski%26aufirst%3DM.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DThe%2520role%2520of%2520the%2520equatorial%2520ligands%2520for%2520the%2520redox%2520behavior%252C%2520mode%2520of%2520cellular%2520accumulation%2520and%2520cytotoxicity%2520of%2520platinum%2528IV%2529%2520prodrugs%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D160%26spage%3D264%26epage%3D274%26doi%3D10.1016%2Fj.jinorgbio.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5777</span>â <span class="NLM_lpage">5783</span>, <span class="refDoi">Â DOI: 10.1021/ic200607j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic200607j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=5777-5783&author=Z.+Liuauthor=L.+Salassaauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Contrasting+reactivity+and+cancer+cell+cytotoxicity+of+isoelectronic+organometallic+iridium%28III%29+complexes&doi=10.1021%2Fic200607j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span></div><div class="casAuthors">Liu, Zhe; Salassa, Luca; Habtemariam, Abraha; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5777-5783</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iridium(III) half-sandwich neutral cyclometalated 2-phenylpyridine (Hphpy) complex [Cp*Ir(phpy)Cl] (2, Cp* = Î·5-C5Me5) undergo substitution of the chloro ligand for nucleobases, exhibiting a promising cytotoxicity against human ovarian cancer cells.  Replacing the N,N-chelating ligand 2,2'-bipyridine (bpy) in the IrIII Î·5-pentamethylcyclopentadienyl complex [Cp*Ir(bpy)Cl]+ (1) with the C,N-chelating ligand Hphpy to give 2 switches on cytotoxicity toward A2780 human ovarian cancer cells (IC50 values of >100 Î¼M for 1 and 10.8 Î¼M for 2).  Ir-Cl hydrolysis is rapid for both complexes (hydrolysis equil. reached in <5 min at 278 K).  Complex 2 forms adducts with both 9-ethylguanine (9-EtG) and 9-methyladenine (9-MeA), but preferentially with 9-EtG when in competition (ca. 85% of total Ir after 24 h).  The x-ray crystal structure of [(Î·5-C5Me5)Ir(phpy)(9-EtG-N7)]NO3Â·1.5CH2Cl2 (3) confirms N7 binding to guanine.  Two-dimensional NMR spectra show that complex 2 binds to adenine mainly through N1, consistent with d. functional theory (DFT) calcns.  DFT calcns. indicate an interaction between the nitrogen of the NH2 group (9-MeA) and carbons from phpy in the adenine adduct of complex 2.  Calcns. show that the most stable geometry of the adduct [Cp*Ir(phpy)(9-EtG-ÎºN7)]+ (3b) has the C6 of 9-EtG orientated toward the pyridine ring of phpy, and for [Cp*Ir(phpy)(9-MeA-ÎºN1)]+ (4(N1)a), the NH2 group of 9-EtA is adjacent to the Ph ring side of phpy.  Complex 2 is more hydrophobic than complex 1, with log P values of 1.57 and -0.95, resp.  The strong nucleobase binding and high hydrophobicity of complex 2 probably contribute to its promising anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqMjGMrbypdbVg90H21EOLACvtfcHk0ljCH-sRFi9yDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D&md5=b60e6409afb934203732b78ce3169b6e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fic200607j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic200607j%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DContrasting%2520reactivity%2520and%2520cancer%2520cell%2520cytotoxicity%2520of%2520isoelectronic%2520organometallic%2520iridium%2528III%2529%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D2011%26volume%3D50%26spage%3D5777%26epage%3D5783%26doi%3D10.1021%2Fic200607j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">72</span>â <span class="NLM_lpage">79</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=25063910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Khu7rL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2014&pages=72-79&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=Antitumor+platinum%28IV%29+derivatives+of+oxaliplatin+with+axial+valproato+ligands&doi=10.1016%2Fj.jinorgbio.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-79</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We report new anticancer prodrugs, platinum(IV) derivs. of oxaliplatin conjugated with valproic acid (VPA), a well-known drug having histone deacetylase inhibitory activity.  Like most platinum(IV) derivs., the cytotoxicity of the conjugates was lower in cell culture than that of oxaliplatin, but greater than those of its Pt(IV) deriv. contg. biol. inactive axial ligands in several cancer cell lines.  Notably, these conjugates display activity in both cisplatin sensitive- and resistant tumor cells capable of both markedly enhanced accumulation in tumor cells and acting in a dual threat manner, concurrently targeting histone deacetylase and genomic DNA.  These results demonstrate the dual targeting strategy to be a valuable route to pursue in the design of platinum agents which may be more effective in cancer types that are typically resistant to therapy by conventional cisplatin.  Moreover, platinum(IV) derivs. contg. VPA axial ligands seem to be promising dual-targeting candidates for addnl. preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUyC3cksfQ2rVg90H21EOLACvtfcHk0ljCH-sRFi9yDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Khu7rL&md5=9bb753b45976997c1ab2b0416d1fd89a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DAntitumor%2520platinum%2528IV%2529%2520derivatives%2520of%2520oxaliplatin%2520with%2520axial%2520valproato%2520ligands%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D140%26spage%3D72%26epage%3D79%26doi%3D10.1016%2Fj.jinorgbio.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abassi, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirstein, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaylord, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinstein, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Kinetic cell-based morphological screening: Prediction of mechanism of compound action and off-target effects</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">712</span>â <span class="NLM_lpage">723</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2009.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.chembiol.2009.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=19635408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=712-723&author=Y.+A.+Abassiauthor=B.+Xiauthor=W.+F.+Zhangauthor=P.+F.+Yeauthor=S.+L.+Kirsteinauthor=M.+R.+Gaylordauthor=S.+C.+Feinsteinauthor=X.+B.+Wangauthor=X.+Xu&title=Kinetic+cell-based+morphological+screening%3A+Prediction+of+mechanism+of+compound+action+and+off-target+effects&doi=10.1016%2Fj.chembiol.2009.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects</span></div><div class="casAuthors">Abassi, Yama A.; Xi, Biao; Zhang, Wenfu; Ye, Peifang; Kirstein, Shelli L.; Gaylord, Michelle R.; Feinstein, Stuart C.; Wang, Xiaobo; Xu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">712-723</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: We describe a cell-based kinetic profiling approach using impedance readout for monitoring the effect of small mol. compds.  This noninvasive readout allows continuous sampling of cellular responses to biol. active compds. and the ensuing kinetic profile provides information regarding the temporal interaction of compds. with cells.  The utility of this approach was tested by screening a library contg. FDA approved drugs, exptl. compds., and nature compds.  Compds. with similar activity produced similar impedance-based time-dependent cell response profiles (TCRPs).  The compds. were clustered based on TCRP similarity.  We identified novel mechanisms for existing drugs, confirmed previously reported calcium modulating activity for COX-2 inhibitor celecoxib, and identified an addnl. mechanism for the exptl. compd. monastrol.  We also identified and characterized a new antimitotic agent.  Our findings indicate that the TCRP approach provides predictive mechanistic information for small mol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA6tm5nSc0P7Vg90H21EOLACvtfcHk0lgyNS7kzttiCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLs%253D&md5=aee918ffcbd38ac87a6239062dae3771</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DAbassi%26aufirst%3DY.%2BA.%26aulast%3DXi%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DW.%2BF.%26aulast%3DYe%26aufirst%3DP.%2BF.%26aulast%3DKirstein%26aufirst%3DS.%2BL.%26aulast%3DGaylord%26aufirst%3DM.%2BR.%26aulast%3DFeinstein%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BB.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DKinetic%2520cell-based%2520morphological%2520screening%253A%2520Prediction%2520of%2520mechanism%2520of%2520compound%2520action%2520and%2520off-target%2520effects%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D712%26epage%3D723%26doi%3D10.1016%2Fj.chembiol.2009.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1491</span>â <span class="NLM_lpage">1501</span>, <span class="refDoi">Â DOI: 10.1039/C4MT00112E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC4MT00112E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=24828756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1491-1501&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=A.+Kisovaauthor=H.+Kostrhunovaauthor=Z.+Liuauthor=P.+J.+Sadlerauthor=J.+Kasparkovaauthor=V.+Brabec&title=A+dual-targeting%2C+apoptosis-inducing+organometallic+half-sandwich+iridium+anticancer+complex&doi=10.1039%2FC4MT00112E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Kisova, Anna; Kostrhunova, Hana; Liu, Zhe; Sadler, Peter J.; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1491-1501</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cellular mechanism of action of an iridium(III) half-sandwich complex [(Î·5-C5Me4C6H4C6H5)Ir(phen)Cl]PF6 (phen = phenanthroline) (1) is reported.  Complex 1 was used to treat several cell lines, including cisplatin-sensitive, cisplatin-resistant (with intrinsic and acquired resistance) carcinoma cells with wild type p53 status as well as the cells with no intact p53 gene, and nontumorigenic cells.  Complex 1 preferentially kills cancer cells over nontumorigenic cells and exhibits no cross-resistance with cisplatin.  It appears to retain significant activity in human tumor cell lines that are refractory or poorly responsive to cisplatin, and in contrast to cisplatin it displays a high activity in human tumor cell lines that are characterized by both wild type and mutant p53 gene.  The mechanism of cell killing was established through detailed cell-based assays.  Complex 1 exhibits dual effects in killing cancer cells causing nuclear DNA damage and mitochondrial dysfunction involving ROS prodn. simultaneously.  Flow cytometric studies and impedance-based monitoring of cellular responses to 1 demonstrated that 1 acts more quickly than cisplatin to induce cell death and that 1 is a more effective apoptosis inducer than cisplatin in particular in early stages of treatment, when the apoptotic effects predominate over necrosis.  Overall, our findings confirm that 1 and its iridium derivs. represent promising candidates for further pre-clin. studies and new addns. to the growing family of nonplatinum metal-based anticancer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rhP03baUXLVg90H21EOLACvtfcHk0lgyNS7kzttiCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK&md5=5180cef5e67873d2336bb4cf2b24f95a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FC4MT00112E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00112E%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DKisova%26aufirst%3DA.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DA%2520dual-targeting%252C%2520apoptosis-inducing%2520organometallic%2520half-sandwich%2520iridium%2520anticancer%2520complex%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26spage%3D1491%26epage%3D1501%26doi%3D10.1039%2FC4MT00112E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irelan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abassi, Y. A.</span></span> <span> </span><span class="NLM_article-title">Screening and identification of small molecule compounds perturbing mitosis using time-dependent cellular response profiles</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">6495</span>â <span class="NLM_lpage">6503</span>, <span class="refDoi">Â DOI: 10.1021/ac1007877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac1007877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2010&pages=6495-6503&author=N.+Keauthor=B.+Xiauthor=P.+Yeauthor=W.+Xuauthor=M.+Zhengauthor=L.+Maoauthor=M.+J.+Wuauthor=J.+Zhuauthor=J.+Wuauthor=W.+Zhangauthor=J.+Zhangauthor=J.+Irelanauthor=X.+Wangauthor=X.+Xuauthor=Y.+A.+Abassi&title=Screening+and+identification+of+small+molecule+compounds+perturbing+mitosis+using+time-dependent+cellular+response+profiles&doi=10.1021%2Fac1007877"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fac1007877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac1007877%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DIrelan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DAbassi%26aufirst%3DY.%2BA.%26atitle%3DScreening%2520and%2520identification%2520of%2520small%2520molecule%2520compounds%2520perturbing%2520mitosis%2520using%2520time-dependent%2520cellular%2520response%2520profiles%26jtitle%3DAnal.%2520Chem.%26date%3D2010%26volume%3D82%26spage%3D6495%26epage%3D6503%26doi%3D10.1021%2Fac1007877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic platinum coordination compounds. DNA binding agents</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">2</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2017.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ccr.2017.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVyksb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2017&pages=2-31&author=V.+Brabecauthor=O.+Hrabinaauthor=J.+Kasparkova&title=Cytotoxic+platinum+coordination+compounds.+DNA+binding+agents&doi=10.1016%2Fj.ccr.2017.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic platinum coordination compounds. DNA binding agents</span></div><div class="casAuthors">Brabec, Viktor; Hrabina, Ondrej; Kasparkova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2-31</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Despite the widespread use of antineoplastic platinum drugs, a no. of accompanying disadvantages exist.  In connection with attempts to circumvent these problems, new platinum compds. have been prepd. and mechanisms underlying their biol. activity have been extensively investigated.  These mechanistic investigations involve research focused on understanding interactions of platinum agents with DNA since DNA binding and recognition of DNA modified by these metallodrugs are the important processes responsible for their anticancer properties.  In this review, we discuss how various classes of platinum(II) complexes, which can interact with DNA by coordination, intercalation and other noncovalent modes of binding or by a combination of these DNA binding modes, can alter the cellular response induced by conventional platinum drugs.  We describe that these alterations can be achieved by changing: (i) the nature and structure of the DNA lesion induced; (ii) conformational alterations induced in DNA by these lesions; and (iii) various cellular signaling pathways initiated by platinum-DNA damage.  We anticipate that summarization of the results on DNA binding of cytotoxic platinum compds. may help to shed light on their potency and will make it possible to create new strategies to design rationally new anticancer platinum compds. and/or combine platinum drugs with other cytotoxic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon1KJpzvhkYrVg90H21EOLACvtfcHk0lirmcxG6jrc_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVyksb8%253D&md5=f2b5a9076242507a8742327d05651a33</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2017.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2017.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DHrabina%26aufirst%3DO.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DCytotoxic%2520platinum%2520coordination%2520compounds.%2520DNA%2520binding%2520agents%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2017%26volume%3D351%26spage%3D2%26epage%3D31%26doi%3D10.1016%2Fj.ccr.2017.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harper, B. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman-Ezra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirota, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Probing the interactions of cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and its PtIVDerivatives with human serum</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">510</span>â <span class="NLM_lpage">519</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201700092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fcmdc.201700092" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=510-519&author=B.+W.+J.+Harperauthor=A.+Friedman-Ezraauthor=R.+Sirotaauthor=E.+Petruzzellaauthor=J.+R.+Aldrich-Wrightauthor=D.+Gibson&title=Probing+the+interactions+of+cytotoxic+%5BPt%281S%2C2S-DACH%29%285%2C6-dimethyl-1%2C10-phenanthroline%29%5D+and+its+PtIVDerivatives+with+human+serum&doi=10.1002%2Fcmdc.201700092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700092%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DB.%2BW.%2BJ.%26aulast%3DFriedman-Ezra%26aufirst%3DA.%26aulast%3DSirota%26aufirst%3DR.%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DProbing%2520the%2520interactions%2520of%2520cytotoxic%2520%255BPt%25281S%252C2S-DACH%2529%25285%252C6-dimethyl-1%252C10-phenanthroline%2529%255D%2520and%2520its%2520PtIVDerivatives%2520with%2520human%2520serum%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D510%26epage%3D519%26doi%3D10.1002%2Fcmdc.201700092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2793</span>â <span class="NLM_lpage">2800</span>, <span class="refDoi">Â DOI: 10.1021/mp200597r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200597r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=2793-2800&author=J.+Yangauthor=X.+Sunauthor=W.+Maoauthor=M.+Suiauthor=J.+Tangauthor=Y.+Shen&title=Conjugate+of+Pt%28IV%29-histone+deacetylase+inhibitor+as+a+prodrug+for+cancer+chemotherapy&doi=10.1021%2Fmp200597r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugate of Pt(IV)-Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy</span></div><div class="casAuthors">Yang, Jun; Sun, Xuanrong; Mao, Weiwei; Sui, Meihua; Tang, Jianbin; Shen, Youqing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2793-2800</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Platinum(IV) prodrug diaminedichlorodihydroxyplatinum (ACHP) conjugated with a histone deacetylase (HDAC) inhibitor valproic acid (VA), VAAP, exhibited strong synergistic cytotoxicity, about 50-100 times more cytotoxic than ACHP or its simple mixt. with VA, against various human carcinoma cell lines.  VAAP could be quickly absorbed in the cell membrane and diffused into the cytosol.  VAAP loaded in polyethylene glycol-polycaprolactone micelles (PEG-PCL) was taken up via endocytosis.  The cytosolic VAAP was intracellular reduced to Pt(II) and released VA eliciting a HDAC inhibitory effect and subsequently induced cell cycle arrest at the S phase in 24 h and cell apoptosis in a time-dependent manner.  The in vivo antitumor expt. on A549-xenograft tumor model showed that VAAP dispersed in Tween 80 or loaded in PEG-PCL nanoparticles had long blood circulation times and thereby high accumulation in tumors and exerted a significant in vivo inhibitory effect on tumor growth with low systemic toxicity.  Therefore, this novel conjugate is very promising for cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeW1MFD6bedbVg90H21EOLACvtfcHk0lirmcxG6jrc_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrK&md5=838e90dcb852b4dddeb424832f46ab15</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fmp200597r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200597r%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DSui%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DConjugate%2520of%2520Pt%2528IV%2529-histone%2520deacetylase%2520inhibitor%2520as%2520a%2520prodrug%2520for%2520cancer%2520chemotherapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D2793%26epage%3D2800%26doi%3D10.1021%2Fmp200597r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blajeski, A.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottke, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S. H.</span></span> <span> </span><span class="NLM_article-title">G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1172/JCI13275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1172%2FJCI13275" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=91-99&author=A.%0AL.+Blajeskiauthor=V.+A.+Phanauthor=T.+J.+Kottkeauthor=S.+H.+Kaufmann&title=G%281%29+and+G%282%29+cell-cycle+arrest+following+microtubule+depolymerization+in+human+breast+cancer+cells&doi=10.1172%2FJCI13275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1172%2FJCI13275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI13275%26sid%3Dliteratum%253Aachs%26aulast%3DBlajeski%26aufirst%3DA.%2BL.%26aulast%3DPhan%26aufirst%3DV.%2BA.%26aulast%3DKottke%26aufirst%3DT.%2BJ.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DG%25281%2529%2520and%2520G%25282%2529%2520cell-cycle%2520arrest%2520following%2520microtubule%2520depolymerization%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D110%26spage%3D91%26epage%3D99%26doi%3D10.1172%2FJCI13275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. H.</span></span> <span> </span><span class="NLM_article-title">Mycotoxin citrinin induced cell cycle G2/M arrest and numerical chromosomal aberration associated with disruption of microtubule formation in human cells</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">84</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.1093/toxsci/kfq309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1093%2Ftoxsci%2Fkfq309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=20929984" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=84-92&author=C.+H.+Changauthor=F.+Y.+Yuauthor=T.+S.+Wuauthor=L.+T.+Wangauthor=B.+H.+Liu&title=Mycotoxin+citrinin+induced+cell+cycle+G2%2FM+arrest+and+numerical+chromosomal+aberration+associated+with+disruption+of+microtubule+formation+in+human+cells&doi=10.1093%2Ftoxsci%2Fkfq309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq309%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DYu%26aufirst%3DF.%2BY.%26aulast%3DWu%26aufirst%3DT.%2BS.%26aulast%3DWang%26aufirst%3DL.%2BT.%26aulast%3DLiu%26aufirst%3DB.%2BH.%26atitle%3DMycotoxin%2520citrinin%2520induced%2520cell%2520cycle%2520G2%252FM%2520arrest%2520and%2520numerical%2520chromosomal%2520aberration%2520associated%2520with%2520disruption%2520of%2520microtubule%2520formation%2520in%2520human%2520cells%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D119%26spage%3D84%26epage%3D92%26doi%3D10.1093%2Ftoxsci%2Fkfq309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Oliveira Niero, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado-Santelli, G. M.</span></span> <span> </span><span class="NLM_article-title">Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi">Â DOI: 10.1186/1756-9966-32-31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1186%2F1756-9966-32-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=23701745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2qurvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=31&author=E.+L.+de%0AOliveira+Nieroauthor=G.+M.+Machado-Santelli&title=Cinnamic+acid+induces+apoptotic+cell+death+and+cytoskeleton+disruption+in+human+melanoma+cells&doi=10.1186%2F1756-9966-32-31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells</span></div><div class="casAuthors">de Oliveira Niero, Evandro Luis; Machado-Santelli, Glaucia Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Anticancer activities of cinnamic acid derivs. include induction of apoptosis by irreversible DNA damage leading to cell death.  The present work aimed to compare the cytotoxic and genotoxic potential of cinnamic acid in human melanoma cell line (HT-144) and human melanocyte cell line derived from blue nevus (NGM).  Viability assay showed that the IC50 for HT-144 cells was 2.4 mM, while NGM cells were more resistant to the treatment.  The growth inhibition was probably assocd. with DNA damage leading to DNA synthesis inhibition, as shown by BrdU incorporation assay, induction of nuclear aberrations and then apoptosis.  The frequency of cell death caused by cinnamic acid was higher in HT-144 cells.  Activated-caspase 3 staining showed apoptosis after 24 h of treatment with cinnamic acid 3.2 mM in HT-144 cells, but not in NGM.  We obsd. microtubules disorganization after cinnamic acid exposure, but this event and cell death seem to be independent according to M30 and tubulin labeling.  The frequency of micronucleated HT-144 cells was higher after treatment with cinnamic acid (0.4 and 3.2 mM) when compared to the controls.  Cinnamic acid 3.2 mM also increased the frequency of micronucleated NGM cells indicating genotoxic activity of the compd., but the effects were milder.  Binucleation and multinucleation counting showed similar results.  We conclude that cinnamic acid has effective antiproliferative activity against melanoma cells.  However, the increased frequency of micronucleation in NGM cells warrants the possibility of genotoxicity and needs further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTLjZZfx2E77Vg90H21EOLACvtfcHk0lgBA01yjGv6oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2qurvK&md5=a37503718007e3602fd2987f656f18eb</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-32-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-32-31%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BOliveira%2BNiero%26aufirst%3DE.%2BL.%26aulast%3DMachado-Santelli%26aufirst%3DG.%2BM.%26atitle%3DCinnamic%2520acid%2520induces%2520apoptotic%2520cell%2520death%2520and%2520cytoskeleton%2520disruption%2520in%2520human%2520melanoma%2520cells%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D32%26spage%3D31%26doi%3D10.1186%2F1756-9966-32-31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, M.</span></span> <span> </span><span class="NLM_article-title">Cucurbitacins: elucidation of their interactions with the cytoskeleton</span>. <i>PeerJ</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e3357</span> <span class="refDoi">Â DOI: 10.7717/peerj.3357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.7717%2Fpeerj.3357" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&author=X.+Wangauthor=M.+Tanakaauthor=H.+S.+Peixotoauthor=M.+Wink&title=Cucurbitacins%3A+elucidation+of+their+interactions+with+the+cytoskeleton&doi=10.7717%2Fpeerj.3357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.7717%2Fpeerj.3357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7717%252Fpeerj.3357%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DPeixoto%26aufirst%3DH.%2BS.%26aulast%3DWink%26aufirst%3DM.%26atitle%3DCucurbitacins%253A%2520elucidation%2520of%2520their%2520interactions%2520with%2520the%2520cytoskeleton%26jtitle%3DPeerJ%26date%3D2017%26volume%3D5%26doi%3D10.7717%2Fpeerj.3357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wawruszak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luszczki, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabarska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumbarewicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmoszynska-Graniczka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepulak, A.</span></span> <span> </span><span class="NLM_article-title">Assessment of interactions between cisplatin and two histone deacetylase inhibitors in MCF7, T47D and MDA-MB-231 human breast cancer cell lines â An isobolographic analysis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0143013</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0143013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1371%2Fjournal.pone.0143013" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=A.+Wawruszakauthor=J.+J.+Luszczkiauthor=A.+Grabarskaauthor=E.+Gumbarewiczauthor=M.+Dmoszynska-Graniczkaauthor=K.+Polbergauthor=A.+Stepulak&title=Assessment+of+interactions+between+cisplatin+and+two+histone+deacetylase+inhibitors+in+MCF7%2C+T47D+and+MDA-MB-231+human+breast+cancer+cell+lines+%E2%80%93+An+isobolographic+analysis&doi=10.1371%2Fjournal.pone.0143013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0143013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0143013%26sid%3Dliteratum%253Aachs%26aulast%3DWawruszak%26aufirst%3DA.%26aulast%3DLuszczki%26aufirst%3DJ.%2BJ.%26aulast%3DGrabarska%26aufirst%3DA.%26aulast%3DGumbarewicz%26aufirst%3DE.%26aulast%3DDmoszynska-Graniczka%26aufirst%3DM.%26aulast%3DPolberg%26aufirst%3DK.%26aulast%3DStepulak%26aufirst%3DA.%26atitle%3DAssessment%2520of%2520interactions%2520between%2520cisplatin%2520and%2520two%2520histone%2520deacetylase%2520inhibitors%2520in%2520MCF7%252C%2520T47D%2520and%2520MDA-MB-231%2520human%2520breast%2520cancer%2520cell%2520lines%2520%25E2%2580%2593%2520An%2520isobolographic%2520analysis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0143013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauzi, A. Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omar, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, A. L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alitheen, N. B.</span></span> <span> </span><span class="NLM_article-title">Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro</span>. <i>Chin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">46</span>, <span class="refDoi">Â DOI: 10.1186/s13020-016-0118-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1186%2Fs13020-016-0118-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=27891174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVaqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=46&author=A.+Z.+M.+Pauziauthor=S.+K.+Yeapauthor=N.+Abuauthor=K.+L.+Limauthor=A.+R.+Omarauthor=S.+A.+Azizauthor=A.+L.+T.+Chowauthor=T.+Subramaniauthor=S.+G.+Tanauthor=N.+B.+Alitheen&title=Combination+of+cisplatin+and+bromelain+exerts+synergistic+cytotoxic+effects+against+breast+cancer+cell+line+MDA-MB-231+in+vitro&doi=10.1186%2Fs13020-016-0118-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro</span></div><div class="casAuthors">Pauzi, Ahmad Zaim Mat; Yeap, Swee Keong; Abu, Nadiah; Lim, Kian Lam; Omar, Abdul Rahman; Abdul Aziz, Suraini; Chow, Adam Leow Thean; Subramani, Tamilselvan; Tan, Soon Guan; Alitheen, Noorjahan Banu</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">46/1-46/11</span>CODEN:
                <span class="NLM_cas:coden">CMHEBK</span>;
        ISSN:<span class="NLM_cas:issn">1749-8546</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Bromelain, which is a cysteine endopeptidase commonly found in pineapple stems, has been investigated as a potential anti-cancer agent for the treatment of breast cancer.  However, information pertaining to the effects of combining bromelain with existing chemotherapeutic drugs remains scarce.  This study aimed to investigate the possible synergistic cytotoxic effects of using bromelain in combination with cisplatin on MDA-MB-231 human breast cancer cells.  Method: MDA-MB-231 cells were treated with different concns. (0.24-9.5 Î¼M) of bromelain or cisplatin alone, as well as four different combinations of these two agents to assess their individual and combination effects after 24 and 48 h.  Cell viability was analyzed using an MTT assay.  The induction of apoptosis was assessed using cell cycle anal. and an Annexin V-FITC assay.  The role of the mitochondrial membrane potential in the apoptotic process was assessed using a JC-1 staining assay.  Apoptotic protein levels were assessed by western blot anal. and proteome profiling using an antibody array kit.  Results: Single-agent treatment with cisplatin or bromelain led to dose- and time-dependent decreases in the viability of the MDA-MB-231 cells at 24 and 48 h.  Furthermore, most of the combinations evaluated in this study displayed synergistic effects against MDA-MB-231 cells at 48 h, with combination 1 (bromelain 2 Î¼M + cisplatin 1.5 Î¼M) exhibiting the greatest synergistic effect (P = 0.000).  The results of subsequent assays indicated that combination 1 treatment induced apoptosis via mitochondria-mediated pathway.  Combination 1 also resulted in significant decreases in the levels of several apoptotic proteins such as Bcl-x and HSP70, compared with bromelain (P = 0.002 and 0.000, resp.) or cisplatin (P = 0.000 and 0.001, resp.) single treatment.  Notably, MDA-MB-231 cells treated with combination 1 showed increased levels of the pro-apoptotic proteins Bax compared with those treated with bromelain (P = 0.000) or cisplatin single treatment (P = 0.043).  Conclusion: Bromelain in combination with cisplatin synergistically enhanced the induction of apoptosis in MDA-MB-231 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyeb8iXrNGTrVg90H21EOLACvtfcHk0lgBA01yjGv6oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVaqsw%253D%253D&md5=bcfb97c62e39f4799ca1e3682f3edc12</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2Fs13020-016-0118-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13020-016-0118-5%26sid%3Dliteratum%253Aachs%26aulast%3DPauzi%26aufirst%3DA.%2BZ.%2BM.%26aulast%3DYeap%26aufirst%3DS.%2BK.%26aulast%3DAbu%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DK.%2BL.%26aulast%3DOmar%26aufirst%3DA.%2BR.%26aulast%3DAziz%26aufirst%3DS.%2BA.%26aulast%3DChow%26aufirst%3DA.%2BL.%2BT.%26aulast%3DSubramani%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DS.%2BG.%26aulast%3DAlitheen%26aufirst%3DN.%2BB.%26atitle%3DCombination%2520of%2520cisplatin%2520and%2520bromelain%2520exerts%2520synergistic%2520cytotoxic%2520effects%2520against%2520breast%2520cancer%2520cell%2520line%2520MDA-MB-231%2520in%2520vitro%26jtitle%3DChin.%2520Med.%26date%3D2016%26volume%3D11%26spage%3D46%26doi%3D10.1186%2Fs13020-016-0118-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, C. T.</span></span> <span> </span><span class="NLM_article-title">Multi-target therapeutics: when the whole is greater than the sum of the parts</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">34</span>â <span class="NLM_lpage">42</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+therapeutics%3A+when+the+whole+is+greater+than+the+sum+of+the+parts&doi=10.1016%2Fj.drudis.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2ea1Q8wqYb_cmbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520therapeutics%253A%2520when%2520the%2520whole%2520is%2520greater%2520than%2520the%2520sum%2520of%2520the%2520parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42%26doi%3D10.1016%2Fj.drudis.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DoldÃ¡n-Martelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ­guez, D. G.</span></span> <span> </span><span class="NLM_article-title">Synergistic interaction between selective drugs in cell populations models</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0117558</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0117558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1371%2Fjournal.pone.0117558" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=V.+Dold%C3%A1n-Martelliauthor=D.+G.+M%C3%ADguez&title=Synergistic+interaction+between+selective+drugs+in+cell+populations+models&doi=10.1371%2Fjournal.pone.0117558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0117558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0117558%26sid%3Dliteratum%253Aachs%26aulast%3DDold%25C3%25A1n-Martelli%26aufirst%3DV.%26aulast%3DM%25C3%25ADguez%26aufirst%3DD.%2BG.%26atitle%3DSynergistic%2520interaction%2520between%2520selective%2520drugs%2520in%2520cell%2520populations%2520models%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0117558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Analysis of combined drug effects: a new look at a very old problem</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">450</span>â <span class="NLM_lpage">454</span>, <span class="refDoi">Â DOI: 10.1016/0165-6147(83)90490-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2F0165-6147%2883%2990490-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=450-454&author=T.-C.+Chouauthor=P.+Talalay&title=Analysis+of+combined+drug+effects%3A+a+new+look+at+a+very+old+problem&doi=10.1016%2F0165-6147%2883%2990490-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of combined drug effects:  a new look at a very old problem</span></div><div class="casAuthors">Chou, Ting Chao; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">450-4</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A simple, general and novel method for the quant. anal. of combined drug effects is presented.  The procedure dets. if the drug combinations are additive, synergistic or antagonistic, regardless of whether the dose-effect curves are hyperbolic (first order) or sigmoidal (higher order), or whether the effects of the drugs are totally independent or not.  The proposed method (median-effect plot) suffers from fewer restrictions and is more widely applicable than the isobologram or the fractional product method.  It provides insight into the nature of the dose-effect relationship with relatively few measurements.  The procedure is illustrated by analyzing the combined lethal effects of 2 insecticides on house-flies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObQzLgU9z07Vg90H21EOLACvtfcHk0lg014AzLDrSEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D&md5=af5698ed81a74924a1a296dacc8ce691</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2883%2990490-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252883%252990490-X%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.-C.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DAnalysis%2520of%2520combined%2520drug%2520effects%253A%2520a%2520new%2520look%2520at%2520a%2520very%2520old%2520problem%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1983%26volume%3D4%26spage%3D450%26epage%3D454%26doi%3D10.1016%2F0165-6147%2883%2990490-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Quantitative-analysis of dose-effect relationships - the combined effects of multiple-drugs or enzyme-inhibitors</span>. <i>Adv. Enzyme Regul.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">55</span>, <span class="refDoi">Â DOI: 10.1016/0065-2571(84)90007-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2F0065-2571%2884%2990007-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=6382953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaL2cXktlaksLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1984&pages=27-55&author=T.+C.+Chouauthor=P.+Talalay&title=Quantitative-analysis+of+dose-effect+relationships+-+the+combined+effects+of+multiple-drugs+or+enzyme-inhibitors&doi=10.1016%2F0065-2571%2884%2990007-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of dose-effect relationships:  the combined effects of multiple drugs or enzyme inhibitors</span></div><div class="casAuthors">Chou, Ting Chao; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzyme Regulation</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-55</span>CODEN:
                <span class="NLM_cas:coden">AEZRA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-2571</span>.
    </div><div class="casAbstract">A simplified exptl. design method for the anal. of multiple drug effects and for detg. summation, synergism, and antagonism is described.  The method is not limited by: whether the dose-effect relations are hyperbolic or sigmoidal, whether the effects are mutually exclusive or nonexclusive, whether the ligand interactions are competitive, noncompetitive, or uncompetitive, or whether the drugs are agonists or antagonists.  The method is independent of the no. of drugs involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX4wNupCqgpbVg90H21EOLACvtfcHk0lg014AzLDrSEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktlaksLk%253D&md5=055a2711b52dde49389c3f526352333d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2F0065-2571%2884%2990007-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0065-2571%252884%252990007-4%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DQuantitative-analysis%2520of%2520dose-effect%2520relationships%2520-%2520the%2520combined%2520effects%2520of%2520multiple-drugs%2520or%2520enzyme-inhibitors%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D1984%26volume%3D22%26spage%3D27%26epage%3D55%26doi%3D10.1016%2F0065-2571%2884%2990007-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risinger, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooberry, S. L.</span></span> <span> </span><span class="NLM_article-title">Microtubule dynamics as a target in oncology</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">255</span>â <span class="NLM_lpage">261</span>, <span class="refDoi">Â DOI: 10.1016/j.ctrv.2008.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ctrv.2008.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=19117686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVantrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=255-261&author=A.+L.+Risingerauthor=F.+J.+Gilesauthor=S.+L.+Mooberry&title=Microtubule+dynamics+as+a+target+in+oncology&doi=10.1016%2Fj.ctrv.2008.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule dynamics as a target in oncology</span></div><div class="casAuthors">Risinger, April L.; Giles, Francis J.; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Drugs that affect microtubule dynamics, including the taxanes and vinca alkaloids, have been a mainstay in the treatment of leukemias and solid tumors for decades.  New, more effective microtubule-targeting agents continue to enter into clin. trials and some, including the epothilone ixapebilone, have been approved for use.  In contrast, several other drugs of this class with promising preclin. data were later shown to be ineffective or intolerable in animal models or clin. trials.  In this review, we discuss the mol. mechanisms as well as preclin. and clin. results for a variety of microtubule-targeting agents in various stages of development.  We also offer a frank discussion of which microtubule-targeting agents are amenable to further development based on their availability, efficacy and toxic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2wR_5ls3DLVg90H21EOLACvtfcHk0lhUSE3-2TJgkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVantrg%253D&md5=2d18cb599b5c35f1e0bc0292c183826f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2008.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2008.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DMicrotubule%2520dynamics%2520as%2520a%2520target%2520in%2520oncology%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2009%26volume%3D35%26spage%3D255%26epage%3D261%26doi%3D10.1016%2Fj.ctrv.2008.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gernert, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettles, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span> <span> </span><span class="NLM_article-title">Drugs that target dynamic microtubules: A new molecular perspective</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">443</span>â <span class="NLM_lpage">481</span>, <span class="refDoi">Â DOI: 10.1002/med.20242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fmed.20242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=21381049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=443-481&author=R.+A.+Stantonauthor=K.+M.+Gernertauthor=J.+H.+Nettlesauthor=R.+Aneja&title=Drugs+that+target+dynamic+microtubules%3A+A+new+molecular+perspective&doi=10.1002%2Fmed.20242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs that target dynamic microtubules: A new molecular perspective</span></div><div class="casAuthors">Stanton, Richard A.; Gernert, Kim M.; Nettles, James H.; Aneja, Ritu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-481</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle app.  As such, there is a wide variety of compds. currently in clin. use and in development that act as antimitotic agents by altering microtubule dynamics.  Although these diverse mols. are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research.  In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biol. function relative to the mol. vectors of microtubule assembly or disassembly.  These "biol. vectors" can thus be used as a spatiotemporal context to describe mol. mechanisms by which microtubule-targeting drugs work. Â© 2011 Wiley Periodicals, Inc.  Med Res Rev, 31, No. 3, 443-481, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6_lcUQbXYrVg90H21EOLACvtfcHk0lhUSE3-2TJgkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D&md5=acce5b9cc89581a7dab0236072b68c72</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fmed.20242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20242%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DGernert%26aufirst%3DK.%2BM.%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DAneja%26aufirst%3DR.%26atitle%3DDrugs%2520that%2520target%2520dynamic%2520microtubules%253A%2520A%2520new%2520molecular%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2011%26volume%3D31%26spage%3D443%26epage%3D481%26doi%3D10.1002%2Fmed.20242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minton, A. P.</span></span> <span> </span><span class="NLM_article-title">Turbidity as a probe of tubulin polymerization kinetics: A theoretical and experimental re-examination</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">198</span>â <span class="NLM_lpage">213</span>, <span class="refDoi">Â DOI: 10.1016/j.ab.2005.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ab.2005.07.011" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2005&pages=198-213&author=D.+Hallauthor=A.+P.+Minton&title=Turbidity+as+a+probe+of+tubulin+polymerization+kinetics%3A+A+theoretical+and+experimental+re-examination&doi=10.1016%2Fj.ab.2005.07.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2005.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2005.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DD.%26aulast%3DMinton%26aufirst%3DA.%2BP.%26atitle%3DTurbidity%2520as%2520a%2520probe%2520of%2520tubulin%2520polymerization%2520kinetics%253A%2520A%2520theoretical%2520and%2520experimental%2520re-examination%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D345%26spage%3D198%26epage%3D213%26doi%3D10.1016%2Fj.ab.2005.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span> <span> </span><span class="NLM_article-title">Taxol-induced polymerization of purified tubulin - Mechanism of action</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">10435</span>â <span class="NLM_lpage">10441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1981&pages=10435-10441&author=N.+Kumar&title=Taxol-induced+polymerization+of+purified+tubulin+-+Mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26atitle%3DTaxol-induced%2520polymerization%2520of%2520purified%2520tubulin%2520-%2520Mechanism%2520of%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1981%26volume%3D256%26spage%3D10435%26epage%3D10441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farshori, P. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goode, D.</span></span> <span> </span><span class="NLM_article-title">Effects of the microtubule depolymerizing and stabilizing agents Nocodazole and taxol on glucose-induced insulin secretion from hamster islet tumor (HIT) cells</span>. <i>J. Submicrosc. Cytol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">137</span>â <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=7912644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1Whs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1994&pages=137-146&author=P.+Q.+Farshoriauthor=D.+Goode&title=Effects+of+the+microtubule+depolymerizing+and+stabilizing+agents+Nocodazole+and+taxol+on+glucose-induced+insulin+secretion+from+hamster+islet+tumor+%28HIT%29+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the microtubule-depolymerizing and -stabilizing agents nocodazole and taxol on glucose-induced insulin secretion from hamster islet tumor (HIT) cells</span></div><div class="casAuthors">Farshori, P.Q.; Goode, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Submicroscopic Cytology and Pathology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-46</span>CODEN:
                <span class="NLM_cas:coden">JSCPEE</span>;
        ISSN:<span class="NLM_cas:issn">1122-9497</span>.
    </div><div class="casAbstract">HIT cells retain much of the capacity of normal Î²-cells to act as glucose sensors.  When stimulated with glucose or glucose plus forskolin, HIT cells released much more insulin than unstimulated cells.  Ultrastructural anal. revealed that the secretory product of these cells was stored in membrane-bound granules that assocd. with microtubules under certain circumstances.  Immunofluorescence studies using insulin antibody confirmed the presence of insulin in granular structures in these cells.  The microtubule inhibitor nocodazole reduced the no. of polymd. microtubules and inhibited the sustained phase of insulin secretion by HIT cells.  Thus, the structural integrity of microtubules is important for the sustained phase of the insulin secretion to occur.  The microtubule-stabilizing drug taxol did not decrease insulin secretion.  Since taxol blocks microtubule depolymn., microtubule polymn.-depolymn. alone does not appear to be responsible for insulin granule transport.  The increased use of these drugs in cancer research and therapy makes it important to understand their effects on insulin secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHKTYgtaKlorVg90H21EOLACvtfcHk0lhUSE3-2TJgkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1Whs7k%253D&md5=43b38fc01de7aeadf6b9fcd1ef003805</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarshori%26aufirst%3DP.%2BQ.%26aulast%3DGoode%26aufirst%3DD.%26atitle%3DEffects%2520of%2520the%2520microtubule%2520depolymerizing%2520and%2520stabilizing%2520agents%2520Nocodazole%2520and%2520taxol%2520on%2520glucose-induced%2520insulin%2520secretion%2520from%2520hamster%2520islet%2520tumor%2520%2528HIT%2529%2520cells%26jtitle%3DJ.%2520Submicrosc.%2520Cytol.%2520Pathol.%26date%3D1994%26volume%3D26%26spage%3D137%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaskin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, C. R.</span></span> <span> </span><span class="NLM_article-title">Microtubule assembly in the absence of added nucleotides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">765</span>â <span class="NLM_lpage">768</span>, <span class="refDoi">Â DOI: 10.1073/pnas.70.3.765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.70.3.765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=4514990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=765-768&author=M.+L.+Shelanskiauthor=F.+Gaskinauthor=C.+R.+Cantor&title=Microtubule+assembly+in+the+absence+of+added+nucleotides&doi=10.1073%2Fpnas.70.3.765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule assembly in the absence of added nucleotides</span></div><div class="casAuthors">Shelanski, Michael L.; Gaskin, Felicia; Cantor, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">765-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Microtubule assembly was enhanced by the addn. of M sucrose or 4 M glycerol to the reassembly mixt.  Tubulin was purified from guinea pig brain readily and in good yield by tycles of assembly in glycerol-contg. solns  The tubules assembled in glycerol and sucrose were more stable than tubules formed in the absence of these compds.  Assembly occurred in glycerol or sucrose in he absence of ATP or GT but was greatly accelerated by their presence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVpPUVyzxhcbVg90H21EOLACvtfcHk0liYA-fMDb8d0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D&md5=c0eb0f728884f0a0eba421d633c9031b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.70.3.765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.70.3.765%26sid%3Dliteratum%253Aachs%26aulast%3DShelanski%26aufirst%3DM.%2BL.%26aulast%3DGaskin%26aufirst%3DF.%26aulast%3DCantor%26aufirst%3DC.%2BR.%26atitle%3DMicrotubule%2520assembly%2520in%2520the%2520absence%2520of%2520added%2520nucleotides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1973%26volume%3D70%26spage%3D765%26epage%3D768%26doi%3D10.1073%2Fpnas.70.3.765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timasheff, S. N.</span></span> <span> </span><span class="NLM_article-title">In vitro reconstitution of calf brain microtubules: effects of solution variables</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1754</span>â <span class="NLM_lpage">1764</span>, <span class="refDoi">Â DOI: 10.1021/bi00627a037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00627a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaE2sXhvVCkuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1977&pages=1754-1764&author=J.+C.+Leeauthor=S.+N.+Timasheff&title=In+vitro+reconstitution+of+calf+brain+microtubules%3A+effects+of+solution+variables&doi=10.1021%2Fbi00627a037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro reconstitution of calf brain microtubules:  effects of solution variables</span></div><div class="casAuthors">Lee, James C.; Timasheff, Serge N.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1754-64</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The effects of soln. variables on the in vitro reconstitution of calf brain tubulin were investigated at pH 7.0.  Reconstitution of microtubules was successful in a variety of buffer systems.  Microtubule formation was promoted by Mg2+ and GTP, but inhibited by Ca2+.  The dependence of the apparent assocn. const. for microtubule formation on ligand concn. was analyzed.  The formation of a tubulin-tubulin contact involves the binding of 1 addnl. Mg2+/tubulin dimer.  Microtubule formation is also accompanied by the apparent binding of 1 addnl. proton and the release of H2O mols., as suggested by thermodyn. parameters.  The reaction is entropy driven with an apparent heat capacity change, ÎCp, of -1500 cal/degree-mol.  The enhancement of tubulin reassembly by glycerol is most likely due to nonspecific protein-solvent general thermodyn. interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMRSO63LMZTrVg90H21EOLACvtfcHk0liYA-fMDb8d0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhvVCkuro%253D&md5=0764be20538284d0834b08ca054e751e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fbi00627a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00627a037%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTimasheff%26aufirst%3DS.%2BN.%26atitle%3DIn%2520vitro%2520reconstitution%2520of%2520calf%2520brain%2520microtubules%253A%2520effects%2520of%2520solution%2520variables%26jtitle%3DBiochemistry%26date%3D1977%26volume%3D16%26spage%3D1754%26epage%3D1764%26doi%3D10.1021%2Fbi00627a037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savarin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curmi, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PastrÃ©, D.</span></span> <span> </span><span class="NLM_article-title">Rapid assembly and collective behavior of microtubule bundles in the presence of polyamines</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">205</span>â <span class="NLM_lpage">216</span>, <span class="refDoi">Â DOI: 10.1016/j.bpj.2011.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.bpj.2011.05.022" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2011&pages=205-216&author=L.+Hamonauthor=P.+Savarinauthor=P.+A.+Curmiauthor=D.+Pastr%C3%A9&title=Rapid+assembly+and+collective+behavior+of+microtubule+bundles+in+the+presence+of+polyamines&doi=10.1016%2Fj.bpj.2011.05.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2011.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2011.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DL.%26aulast%3DSavarin%26aufirst%3DP.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DPastr%25C3%25A9%26aufirst%3DD.%26atitle%3DRapid%2520assembly%2520and%2520collective%2520behavior%2520of%2520microtubule%2520bundles%2520in%2520the%2520presence%2520of%2520polyamines%26jtitle%3DBiophys.%2520J.%26date%3D2011%26volume%3D101%26spage%3D205%26epage%3D216%26doi%3D10.1016%2Fj.bpj.2011.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieder, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodjakov, A.</span></span> <span> </span><span class="NLM_article-title">Mitosis through the microscope: Advances in seeing inside live dividing cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1126/science.1082177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1126%2Fscience.1082177" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=91-96&author=C.+L.+Riederauthor=A.+Khodjakov&title=Mitosis+through+the+microscope%3A+Advances+in+seeing+inside+live+dividing+cells&doi=10.1126%2Fscience.1082177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1082177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1082177%26sid%3Dliteratum%253Aachs%26aulast%3DRieder%26aufirst%3DC.%2BL.%26aulast%3DKhodjakov%26aufirst%3DA.%26atitle%3DMitosis%2520through%2520the%2520microscope%253A%2520Advances%2520in%2520seeing%2520inside%2520live%2520dividing%2520cells%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D91%26epage%3D96%26doi%3D10.1126%2Fscience.1082177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Whole cell microtubule analysis by flow cytometry</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>420</i></span>,  <span class="NLM_fpage">26</span>â <span class="NLM_lpage">32</span>, <span class="refDoi">Â DOI: 10.1016/j.ab.2011.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.ab.2011.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=21893022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKitbnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2012&pages=26-32&author=K.+C.+Morrisonauthor=P.+J.+Hergenrother&title=Whole+cell+microtubule+analysis+by+flow+cytometry&doi=10.1016%2Fj.ab.2011.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Whole cell microtubule analysis by flow cytometry</span></div><div class="casAuthors">Morrison, Karen C.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-32</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Perturbation of the tubulin/microtubule dynamic in cells is perhaps the single most important mode of action of anticancer drugs.  Std. methods for identifying and evaluating compds. for their ability to alter tubulin polymn. are low throughput, labor intensive, expensive, or make their assessment in vitro.  Here the authors report a method to rapidly quantify the extent of tubulin polymn. in whole cells using flow cytometry, and the authors use this technique to evaluate compds. that stabilize and destabilize microtubule formation.  This facile method is useful for conveniently, quant., and cost-effectively comparing small mols. that perturb tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZgQAWuTSkLVg90H21EOLACvtfcHk0liYA-fMDb8d0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKitbnM&md5=e4c4be8f87985c5eb9ce4a87d82e3fb6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2011.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2011.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DK.%2BC.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DWhole%2520cell%2520microtubule%2520analysis%2520by%2520flow%2520cytometry%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D420%26spage%3D26%26epage%3D32%26doi%3D10.1016%2Fj.ab.2011.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDIQQ)]Cl</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">437</span>â <span class="NLM_lpage">443</span>, <span class="refDoi">Â DOI: 10.1039/C3MT00364G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC3MT00364G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=24514456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsFGgu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=437-443&author=K.+Suntharalingamauthor=J.+J.+Wilsonauthor=W.+Linauthor=S.+J.+Lippard&title=A+dual-targeting%2C+p53-independent%2C+apoptosis-inducing+platinum%28II%29+anticancer+complex%2C+%5BPt%28BDIQQ%29%5DCl&doi=10.1039%2FC3MT00364G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeting, p53-independent, apoptosis-inducing platinum(ii) anticancer complex, [Pt(BDIQQ)]Cl</span></div><div class="casAuthors">Suntharalingam, Kogularamanan; Wilson, Justin J.; Lin, Wei; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-443</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The therapeutic index and cellular mechanism of action of [Pt(BDIQQ)]Cl, a monocationic, square-planar platinum(ii) complex, are reported. [Pt(BDIQQ)]Cl was used to treat several cell lines, including wild type and cisplatin-resistant ovarian carcinoma cells (A2780 and A2780CP70) and non-proliferating lung carcinoma cells (A549). [Pt(BDIQQ)]Cl selectively kills cancer cells over healthy cells and exhibits no cross-resistance with cisplatin.  The mechanism of cell killing was established through detailed cell-based assays. [Pt(BDIQQ)]Cl exhibits dual-threat capabilities, targeting nuclear DNA and mitochondria simultaneously. [Pt(BDIQQ)]Cl induces DNA damage, leading to p53 enrichment, mitochondrial membrane potential depolarisation, and caspase-mediated apoptosis. [Pt(BDIQQ)]Cl also accumulates in the mitochondria, resulting in direct mitochondrial damage.  Flow cytometric studies demonstrated that [Pt(BDIQQ)]Cl has no significant effect on cell cycle progression.  Remarkably, p53-status is a not a determinant of [Pt(BDIQQ)]Cl activity.  In p53-null cells, [Pt(BDIQQ)]Cl induces cell death through mitochondrial dysfunction.  Cancers with p53-null status could therefore be targeted using [Pt(BDIQQ)]Cl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPCsuBh2qa3rVg90H21EOLACvtfcHk0ljZsg6H2X5iSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsFGgu78%253D&md5=552e3f54dba546369f777d9c06f396a3</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1039%2FC3MT00364G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MT00364G%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DJ.%2BJ.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DA%2520dual-targeting%252C%2520p53-independent%252C%2520apoptosis-inducing%2520platinum%2528II%2529%2520anticancer%2520complex%252C%2520%255BPt%2528BDIQQ%2529%255DCl%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26spage%3D437%26epage%3D443%26doi%3D10.1039%2FC3MT00364G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemann, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Necroptosis-inducing rhenium(V) oxo complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2967</span>â <span class="NLM_lpage">2974</span>, <span class="refDoi">Â DOI: 10.1021/ja511978y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja511978y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2msbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=2967-2974&author=K.+Suntharalingamauthor=S.+G.+Awuahauthor=P.+M.+Brunoauthor=T.+C.+Johnstoneauthor=F.+Wangauthor=W.+Linauthor=Y.-R.+Zhengauthor=J.+E.+Pageauthor=M.+T.+Hemannauthor=S.+J.+Lippard&title=Necroptosis-inducing+rhenium%28V%29+oxo+complexes&doi=10.1021%2Fja511978y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis-Inducing Rhenium(V) Oxo Complexes</span></div><div class="casAuthors">Suntharalingam, Kogularamanan; Awuah, Samuel G.; Bruno, Peter M.; Johnstone, Timothy C.; Wang, Fang; Lin, Wei; Zheng, Yao-Rong; Page, Julia E.; Hemann, Michael T.; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2967-2974</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rhenium(V) oxo complexes of general formula [ReO(OMe)(NÌN)Cl2], where NÌN = 4,7-diphenyl-1,10-phenanthroline, 1, or 3,4,7,8-tetramethyl-1,10-phenanthroline, 2, effectively kill cancer cells by triggering necroptosis, a non-apoptotic form of cell death.  Both complexes evoke necrosome (RIP1-RIP3)-dependent intracellular reactive oxygen species (ROS) prodn. and propidium iodide uptake.  The complexes also induce mitochondrial membrane potential depletion, a possible downstream effect of ROS prodn.  Apparently, 1 and 2 are the first rhenium complexes to evoke cellular events consistent with programmed necrosis in cancer cells.  Furthermore, 1 and 2 display low acute toxicity in C57BL/6 mice and reasonable stability in fresh human blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrocO9cnc07Vg90H21EOLACvtfcHk0ljZsg6H2X5iSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2msbc%253D&md5=902f2e791f1f6eb4ea93a1f68dcf5fae</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja511978y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja511978y%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DK.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26aulast%3DBruno%26aufirst%3DP.%2BM.%26aulast%3DJohnstone%26aufirst%3DT.%2BC.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DY.-R.%26aulast%3DPage%26aufirst%3DJ.%2BE.%26aulast%3DHemann%26aufirst%3DM.%2BT.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DNecroptosis-inducing%2520rhenium%2528V%2529%2520oxo%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D2967%26epage%3D2974%26doi%3D10.1021%2Fja511978y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zajac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">89</span>â <span class="NLM_lpage">97</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2015.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2015.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=26780576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2016&pages=89-97&author=J.+Zajacauthor=H.+Kostrhunovaauthor=V.+Novohradskyauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=Potentiation+of+mitochondrial+dysfunction+in+tumor+cells+by+conjugates+of+metabolic+modulator+dichloroacetate+with+a+Pt%28IV%29+derivative+of+oxaliplatin&doi=10.1016%2Fj.jinorgbio.2015.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span></div><div class="casAuthors">Zajac, Juraj; Kostrhunova, Hana; Novohradsky, Vojtech; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mol. and cellular mechanisms of enhanced toxic effects in tumor cells of the Pt(IV) derivs. of antitumor oxaliplatin contg. axial dichloroacetate (DCA) ligands were investigated.  DCA ligands were chosen because DCA has shown great potential as an apoptosis sensitizer and anticancer agent reverting the Wartburg effect.  In addn., DCA reverses mitochondrial changes in a wide range of cancers, promoting tumor cell apoptosis in a mitochondrial-dependent pathway.  We demonstrate that (i) the transformation of oxaliplatin to its Pt(IV) derivs. contg. axial DCA ligands markedly enhances toxicity in cancer cells and helps overcome inherent and acquired resistance to cisplatin and oxaliplatin; (ii) a significant fraction of the intact mols. of DCA conjugates with Pt(IV) deriv. of oxaliplatin accumulates in cancer cells where it releases free DCA; (iii) mechanism of biol. action of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands is connected with the effects of DCA released in cancer cells from the Pt(IV) prodrugs on mitochondria and metab. of glucose; (iv) treatments with the Pt(IV) derivs. of oxaliplatin contg. DCA ligands activate an autophagic response in human colorectal cancer cells; (v) the toxic effects in cancer cells of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands can be potentiated if cells are treated with these prodrugs in combination with 5-fluorouracil.  These properties of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands provide opportunities for further development of new platinum-based agents with the capability of killing cancer cells resistant to conventional antitumor platinum drugs used in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2vp2jhBrirVg90H21EOLACvtfcHk0ljZsg6H2X5iSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D&md5=3b66039a74fa4741e11698a76d2ef394</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZajac%26aufirst%3DJ.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DPotentiation%2520of%2520mitochondrial%2520dysfunction%2520in%2520tumor%2520cells%2520by%2520conjugates%2520of%2520metabolic%2520modulator%2520dichloroacetate%2520with%2520a%2520Pt%2528IV%2529%2520derivative%2520of%2520oxaliplatin%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D156%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.jinorgbio.2015.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harper, B. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirota, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccioli, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and in vitro and in vivo anticancer activity of Pt(IV) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)]</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7005</span>â <span class="NLM_lpage">7019</span>, <span class="refDoi">Â DOI: 10.1039/C7DT01054K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1039%2FC7DT01054K" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7005-7019&author=B.+W.+J.+Harperauthor=E.+Petruzzellaauthor=R.+Sirotaauthor=F.+F.+Faccioliauthor=J.+R.+Aldrich-Wrightauthor=V.+Gandinauthor=D.+Gibson&title=Synthesis%2C+characterization+and+in+vitro+and+in+vivo+anticancer+activity+of+Pt%28IV%29+derivatives+of+%5BPt%281S%2C2S-DACH%29%285%2C6-dimethyl-1%2C10-phenanthroline%29%5D&doi=10.1039%2FC7DT01054K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2FC7DT01054K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT01054K%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DB.%2BW.%2BJ.%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DSirota%26aufirst%3DR.%26aulast%3DFaccioli%26aufirst%3DF.%2BF.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%2520of%2520Pt%2528IV%2529%2520derivatives%2520of%2520%255BPt%25281S%252C2S-DACH%2529%25285%252C6-dimethyl-1%252C10-phenanthroline%2529%255D%26jtitle%3DDalton%2520Trans.%26date%3D2017%26volume%3D46%26spage%3D7005%26epage%3D7019%26doi%3D10.1039%2FC7DT01054K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yellol, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuchlikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yellol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Organoruthenium complexes with C N ligands are highly potent cytotoxic agents that act by a new mechanism of action</span>. <i>Chem. â Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">15294</span>â <span class="NLM_lpage">15299</span>, <span class="refDoi">Â DOI: 10.1002/chem.201703581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1002%2Fchem.201703581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28922506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=15294-15299&author=V.+Novohradskyauthor=J.+Yellolauthor=O.+Stuchlikovaauthor=M.+D.+Santanaauthor=H.+Kostrhunovaauthor=G.+Yellolauthor=J.+Kasparkovaauthor=D.+Bautistaauthor=J.+Ruizauthor=V.+Brabec&title=Organoruthenium+complexes+with+C+N+ligands+are+highly+potent+cytotoxic+agents+that+act+by+a+new+mechanism+of+action&doi=10.1002%2Fchem.201703581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Organoruthenium Complexes with C-N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action</span></div><div class="casAuthors">Novohradsky, Vojtech; Yellol, Jyoti; Stuchlikova, Olga; Santana, Maria Dolores; Kostrhunova, Hana; Yellol, Gorakh; Kasparkova, Jana; Bautista, Delia; Ruiz, Jose; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">15294-15299</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The study demonstrates that four novel kinetically inert C,N-cyclometalated RuII complexes of the type [Ru(C-N)(N-N)2][PF6] contg. a handle for functionalization on the C-N ligand are very potent cytotoxic agents against several different human cancer cell lines and are up to 400-fold more potent than clin. used cisplatin.  In addn., the investigated ruthenium complexes are less cytotoxic in noncancerous cells, and exhibit higher selectivity for cancer cells than conventional platinum anticancer drugs.  The high potency of the investigated ruthenium compds. can be attributed to several factors, including enhanced internalization and their capability to change mitochondrial transmembrane potential in cells.  The new ruthenium complexes also interfere with protein synthesis with a markedly higher potency than conventional inhibitors of DNA translation.  Notably, the latter mechanism has not been hitherto described for other cytotoxic Ru compds. and cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo_fKsxB7IHbVg90H21EOLACvtfcHk0li0FUWR8c3uBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrjL&md5=624b39cf521b7f44e73007c117e65b9e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703581%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DYellol%26aufirst%3DJ.%26aulast%3DStuchlikova%26aufirst%3DO.%26aulast%3DSantana%26aufirst%3DM.%2BD.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DYellol%26aufirst%3DG.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBautista%26aufirst%3DD.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DOrganoruthenium%2520complexes%2520with%2520C%2520N%2520ligands%2520are%2520highly%2520potent%2520cytotoxic%2520agents%2520that%2520act%2520by%2520a%2520new%2520mechanism%2520of%2520action%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D15294%26epage%3D15299%26doi%3D10.1002%2Fchem.201703581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julsing, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Methylation of DNA repair genes and the efficacy of DNA targeted anticancer treatment</span>. <i>Oncol. Discov.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi">Â DOI: 10.7243/2052-6199-2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.7243%2F2052-6199-2-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=3&author=J.+R.+Julsingauthor=G.+J.+Peters&title=Methylation+of+DNA+repair+genes+and+the+efficacy+of+DNA+targeted+anticancer+treatment&doi=10.7243%2F2052-6199-2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.7243%2F2052-6199-2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7243%252F2052-6199-2-3%26sid%3Dliteratum%253Aachs%26aulast%3DJulsing%26aufirst%3DJ.%2BR.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DMethylation%2520of%2520DNA%2520repair%2520genes%2520and%2520the%2520efficacy%2520of%2520DNA%2520targeted%2520anticancer%2520treatment%26jtitle%3DOncol.%2520Discov.%26date%3D2014%26volume%3D2%26spage%3D3%26doi%3D10.7243%2F2052-6199-2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llewellyn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, J.</span></span> <span> </span><span class="NLM_article-title">BRAF, KRAS and PIK3CA mutation and sensitivity to trastuzumab in breast cancer cell line model</span>. <i>Asian Pac. J. Cancer Prev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2209</span>â <span class="NLM_lpage">2213</span>, <span class="refDoi">Â DOI: 10.22034/APJCP.2017.18.8.2209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.22034%2FAPJCP.2017.18.8.2209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=28843257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BC1cbhvVOmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2209-2213&author=S.+Patraauthor=V.+Youngauthor=L.+Llewellynauthor=J.+N.+Senapatiauthor=J.+Mathew&title=BRAF%2C+KRAS+and+PIK3CA+mutation+and+sensitivity+to+trastuzumab+in+breast+cancer+cell+line+model&doi=10.22034%2FAPJCP.2017.18.8.2209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model</span></div><div class="casAuthors">Patra Satyajit; Young Vanesa; Llewellyn Leslie; Senapati Jitendra N; Mathew Jesil</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2209-2213</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Studies show that approximately 20% of all breast cancer patients have a breast tumor that tests positive for Human Epidermal Growth Factor Receptor 2, otherwise known as the HER2 gene.  As such, treatments for breast cancer usually include drugs that target HER2.  The drug Trastuzumab is a recombinant antibody that has been approved by the FDA for the treatment of these HER2 positive breast cancers.  However, researchers have found that mutations in associated genes, PIK3CA and KRAS, can cause the tumor to become resistant to Trastuzumab.  The purpose of this article is to evaluate the sensitivity of the cancer cell lines to the drug Trastuzumab and investigate how this sensitivity is compromised by the PIK3CA, KRAS and BRAF gene mutations.  Trastuzumab responsiveness was evaluated in breast cancer cell lines by treating the lines with an optimal concentration of the drug followed by a proliferation assay of the cell lines in the presence of monoclonal antibodies.  We determined the optimum concentration of Trastuzumab to be 7 Î¼g/well.  The BRAF and KRAS mutated cell line, MDA-MB-231, showed the least sensitivity after being treated with trastuzumab when compared to the sensitivity of the PIK3CA mutated cell lines, MCF-7 and MDA-MB-361, and the KRAS/ BRAF/ PIK3CA cell line, MDA-MB-453.  Clinical observations show that mutations in BRAF and KRAS genes in breast cancer cells do lower the responsiveness of Trastuzumab drug treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJq-HpTS29KN-cVm4E2RlLfW6udTcc2eaHBKpMp-f5T7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbhvVOmsA%253D%253D&md5=dbc566be6c367b4e44c1987912a87bbf</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.22034%2FAPJCP.2017.18.8.2209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.22034%252FAPJCP.2017.18.8.2209%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DV.%26aulast%3DLlewellyn%26aufirst%3DL.%26aulast%3DSenapati%26aufirst%3DJ.%2BN.%26aulast%3DMathew%26aufirst%3DJ.%26atitle%3DBRAF%252C%2520KRAS%2520and%2520PIK3CA%2520mutation%2520and%2520sensitivity%2520to%2520trastuzumab%2520in%2520breast%2520cancer%2520cell%2520line%2520model%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev.%26date%3D2017%26volume%3D18%26spage%3D2209%26epage%3D2213%26doi%3D10.22034%2FAPJCP.2017.18.8.2209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Downward, J.</span></span> <span> </span><span class="NLM_article-title">Targeting RAS signalling pathways in cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi">Â DOI: 10.1038/nrc969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fnrc969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=12509763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD38XpvVertbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=11&author=J.+Downward&title=Targeting+RAS+signalling+pathways+in+cancer+therapy&doi=10.1038%2Fnrc969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RAS signalling pathways in cancer therapy</span></div><div class="casAuthors">Downward, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-22</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The RAS proteins control signaling pathways that are key regulators of several aspects of normal cell growth and malignant transformation.  They are aberrant in most human tumors due to activating mutations in the RAS genes themselves or to alterations in upstream or downstream signaling components.  Rational therapies that target the RAS pathways might inhibit tumor growth, survival and spread.  Several of these new therapeutic agents are showing promise in the clinic and many more are being developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwKF9JX2sXtbVg90H21EOLACvtfcHk0liyhKFY3S15Ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpvVertbo%253D&md5=85ea9312480c3ca01f2a94faae7b84e7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnrc969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc969%26sid%3Dliteratum%253Aachs%26aulast%3DDownward%26aufirst%3DJ.%26atitle%3DTargeting%2520RAS%2520signalling%2520pathways%2520in%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D11%26doi%3D10.1038%2Fnrc969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gloushankova, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyubimova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tint, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feder, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiliev, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelfand, I. M.</span></span> <span> </span><span class="NLM_article-title">Role of the microtubular system in morphological organization of normal and oncogene-transfected epithelial cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">8597</span>â <span class="NLM_lpage">8601</span>, <span class="refDoi">Â DOI: 10.1073/pnas.91.18.8597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.91.18.8597" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8597-8601&author=N.+A.+Gloushankovaauthor=A.+V.+Lyubimovaauthor=I.+S.+Tintauthor=H.+H.+Federauthor=J.+M.+Vasilievauthor=I.+M.+Gelfand&title=Role+of+the+microtubular+system+in+morphological+organization+of+normal+and+oncogene-transfected+epithelial+cells&doi=10.1073%2Fpnas.91.18.8597"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8597%26sid%3Dliteratum%253Aachs%26aulast%3DGloushankova%26aufirst%3DN.%2BA.%26aulast%3DLyubimova%26aufirst%3DA.%2BV.%26aulast%3DTint%26aufirst%3DI.%2BS.%26aulast%3DFeder%26aufirst%3DH.%2BH.%26aulast%3DVasiliev%26aufirst%3DJ.%2BM.%26aulast%3DGelfand%26aufirst%3DI.%2BM.%26atitle%3DRole%2520of%2520the%2520microtubular%2520system%2520in%2520morphological%2520organization%2520of%2520normal%2520and%2520oncogene-transfected%2520epithelial%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D8597%26epage%3D8601%26doi%3D10.1073%2Fpnas.91.18.8597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, L.</span></span> <span> </span><span class="NLM_article-title">The Ras-related GTPase Rac1 binds tubulin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">3756</span>â <span class="NLM_lpage">3762</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.7.3756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1074%2Fjbc.271.7.3756" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=3756-3762&author=A.+Bestauthor=S.+Ahmedauthor=R.+Kozmaauthor=L.+Lim&title=The+Ras-related+GTPase+Rac1+binds+tubulin&doi=10.1074%2Fjbc.271.7.3756"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.7.3756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.7.3756%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DKozma%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DL.%26atitle%3DThe%2520Ras-related%2520GTPase%2520Rac1%2520binds%2520tubulin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D3756%26epage%3D3762%26doi%3D10.1074%2Fjbc.271.7.3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yvon, A.-M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span> <span> </span><span class="NLM_article-title">Taxol suppresses dynamics of individual microtubules in living human tumor cells</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">947</span>â <span class="NLM_lpage">959</span>, <span class="refDoi">Â DOI: 10.1091/mbc.10.4.947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1091%2Fmbc.10.4.947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10198049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADyaK1MXisVGks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=947-959&author=A.-M.+C.+Yvonauthor=P.+Wadsworthauthor=M.+A.+Jordan&title=Taxol+suppresses+dynamics+of+individual+microtubules+in+living+human+tumor+cells&doi=10.1091%2Fmbc.10.4.947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Taxol suppresses dynamics of individual microtubules in living human tumor cells</span></div><div class="casAuthors">Yvon, Anne-Marie C.; Wadsworth, Patricia; Jordan, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">947-959</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Microtubules are intrinsically dynamic polymers, and their dynamics play a crucial role in mitotic spindle assembly, the mitotic checkpoint, and chromosome movement.  The authors hypothesized that, in living cells, suppression of microtubule dynamics is responsible for the ability of taxol to inhibit mitotic progression and cell proliferation.  Using quant. fluorescence video microscopy, the authors examd. the effects of taxol (30-100 nM) on the dynamics of individual microtubules in 2 living human tumor cell lines: Caov-3 ovarian adenocarcinoma cells and A-498 kidney carcinoma cells.  Taxol accumulated more in Caov-3 cells than in A-498 cells.  At equivalent intracellular taxol concns., dynamic instability was inhibited similarly in the 2 cell lines.  Microtubule shortening rates were inhibited in Caov-3 cells and in A-498 cells by 32 and 26%, growing rates were inhibited by 24 and 18%, and dynamicity was inhibited by 31 and 63%, resp.  All mitotic spindles were abnormal, and many interphase cells became multinucleate (Caov-3, 30%; A-498, 58%).  Taxol blocked cell cycle progress at the metaphase/anaphase transition and inhibited cell proliferation.  The results indicate that suppression of microtubule dynamics by taxol deleteriously affects the ability of cancer cells to properly assemble a mitotic spindle, pass the metaphase/anaphase checkpoint, and produce progeny.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJFjcttggzWLVg90H21EOLACvtfcHk0liyhKFY3S15Ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVGks70%253D&md5=9419edf05d76d4abc3ef10235c79fbc5</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1091%2Fmbc.10.4.947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.10.4.947%26sid%3Dliteratum%253Aachs%26aulast%3DYvon%26aufirst%3DA.-M.%2BC.%26aulast%3DWadsworth%26aufirst%3DP.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DTaxol%2520suppresses%2520dynamics%2520of%2520individual%2520microtubules%2520in%2520living%2520human%2520tumor%2520cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1999%26volume%3D10%26spage%3D947%26epage%3D959%26doi%3D10.1091%2Fmbc.10.4.947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">32242</span>â <span class="NLM_lpage">32250</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M110.160820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1074%2Fjbc.M110.160820" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32242-32250&author=H.+Yangauthor=A.+Gangulyauthor=F.+Cabral&title=Inhibition+of+cell+migration+and+cell+division+correlates+with+distinct+effects+of+microtubule+inhibiting+drugs&doi=10.1074%2Fjbc.M110.160820"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.160820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.160820%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DCabral%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520cell%2520migration%2520and%2520cell%2520division%2520correlates%2520with%2520distinct%2520effects%2520of%2520microtubule%2520inhibiting%2520drugs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32242%26epage%3D32250%26doi%3D10.1074%2Fjbc.M110.160820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, L.</span></span> <span> </span><span class="NLM_article-title">Microtubules as a target for anticancer drugs</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">253</span>â <span class="NLM_lpage">265</span>, <span class="refDoi">Â DOI: 10.1038/nrc1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+target+for+anticancer+drugs&doi=10.1038%2Fnrc1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0lgQb0czbs3HGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520target%2520for%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265%26doi%3D10.1038%2Fnrc1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sackett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span> <span> </span><span class="NLM_article-title">Tubulin/microtubules: Still a promising target for new chemotherapeutic agents</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">182</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.1093/jnci/92.3.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1093%2Fjnci%2F92.3.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10655426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A280%3ADC%252BD3c7it1GjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=182-183&author=P.+Giannakakouauthor=D.+Sackettauthor=T.+Fojo&title=Tubulin%2Fmicrotubules%3A+Still+a+promising+target+for+new+chemotherapeutic+agents&doi=10.1093%2Fjnci%2F92.3.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin/microtubules: still a promising target for new chemotherapeutic agents</span></div><div class="casAuthors">Giannakakou P; Sackett D; Fojo T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-3</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlgIiZscAk1srRqEXsZufAfW6udTcc2eax2QzWrQvlM7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7it1GjsQ%253D%253D&md5=dfad57d5c9ba54ecd5f43589ec175af6</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.3.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.3.182%26sid%3Dliteratum%253Aachs%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DSackett%26aufirst%3DD.%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DTubulin%252Fmicrotubules%253A%2520Still%2520a%2520promising%2520target%2520for%2520new%2520chemotherapeutic%2520agents%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D182%26epage%3D183%26doi%3D10.1093%2Fjnci%2F92.3.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prota, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bargsten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liniger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, M. O.</span></span> <span> </span><span class="NLM_article-title">A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">13817</span>â <span class="NLM_lpage">13821</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1408124111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1073%2Fpnas.1408124111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=25114240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCju7vM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=13817-13821&author=A.+E.+Protaauthor=K.+Bargstenauthor=J.+F.+Diazauthor=M.+Marshauthor=C.+Cuevasauthor=M.+Linigerauthor=C.+Neuhausauthor=J.+M.+Andreuauthor=K.+H.+Altmannauthor=M.+O.+Steinmetz&title=A+new+tubulin-binding+site+and+pharmacophore+for+microtubule-destabilizing+anticancer+drugs&doi=10.1073%2Fpnas.1408124111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs</span></div><div class="casAuthors">Prota, Andrea E.; Bargsten, Katja; Diaz, J. Fernando; Marsh, May; Cuevas, Carmen; Liniger, Marc; Neuhaus, Christian; Andreu, Jose M.; Altmann, Karl-Heinz; Steinmetz, Michel O.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13817-13821</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The recent success of antibody-drug conjugates (ADCs) in the treatment of cancer has led to a revived interest in microtubule-destabilizing agents.  Here, we detd. the high-resoln. crystal structure of the complex between tubulin and maytansine, which is part of an ADC that is approved by the US Food and Drug Administration (FDA) for the treatment of advanced breast cancer.  We found that the drug binds to a site on Î²-tubulin that is distinct from the vinca domain and that blocks the formation of longitudinal tubulin interactions in microtubules.  We also solved crystal structures of tubulin in complex with both a variant of rhizoxin and the phase 1 drug PM060184.  Consistent with biochem. and mutagenesis data, we found that the two compds. bound to the same site as maytansine and that the structures revealed a common pharmacophore for the three ligands.  Our results delineate a distinct mol. mechanism of action for the inhibition of microtubule assembly by clin. relevant agents.  They further provide a structural basis for the rational design of potent microtubule-destabilizing agents, thus opening opportunities for the development of next-generation ADCs for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4icqk698gLVg90H21EOLACvtfcHk0lgQb0czbs3HGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCju7vM&md5=798cae320e427ff76c2099387d9e6ba4</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1408124111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1408124111%26sid%3Dliteratum%253Aachs%26aulast%3DProta%26aufirst%3DA.%2BE.%26aulast%3DBargsten%26aufirst%3DK.%26aulast%3DDiaz%26aufirst%3DJ.%2BF.%26aulast%3DMarsh%26aufirst%3DM.%26aulast%3DCuevas%26aufirst%3DC.%26aulast%3DLiniger%26aufirst%3DM.%26aulast%3DNeuhaus%26aufirst%3DC.%26aulast%3DAndreu%26aufirst%3DJ.%2BM.%26aulast%3DAltmann%26aufirst%3DK.%2BH.%26aulast%3DSteinmetz%26aufirst%3DM.%2BO.%26atitle%3DA%2520new%2520tubulin-binding%2520site%2520and%2520pharmacophore%2520for%2520microtubule-destabilizing%2520anticancer%2520drugs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D13817%26epage%3D13821%26doi%3D10.1073%2Fpnas.1408124111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerikan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruss, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kigoshi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiebel, E.</span></span> <span> </span><span class="NLM_article-title">The Î³-tubulin-specific inhibitor gatastatin reveals temporal requirements of microtubule nucleation during the cell cycle</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8722</span>, <span class="refDoi">Â DOI: 10.1038/ncomms9722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1038%2Fncomms9722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=26503935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCns7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8722&author=T.+Chinenauthor=P.+Liuauthor=S.+Shiodaauthor=J.+Pagelauthor=B.+Cerikanauthor=T.+C.+Linauthor=O.+Grussauthor=Y.+Hayashiauthor=H.+Takenoauthor=T.+Shimaauthor=Y.+Okadaauthor=I.+Hayakawaauthor=Y.+Hayashiauthor=H.+Kigoshiauthor=T.+Usuiauthor=E.+Schiebel&title=The+%CE%B3-tubulin-specific+inhibitor+gatastatin+reveals+temporal+requirements+of+microtubule+nucleation+during+the+cell+cycle&doi=10.1038%2Fncomms9722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The Î³-tubulin-specific inhibitor gatastatin reveals temporal requirements of microtubule nucleation during the cell cycle</span></div><div class="casAuthors">Chinen, Takumi; Liu, Peng; Shioda, Shuya; Pagel, Judith; Cerikan, Berati; Lin, Tien-chen; Gruss, Oliver; Hayashi, Yoshiki; Takeno, Haruka; Shima, Tomohiro; Okada, Yasushi; Hayakawa, Ichiro; Hayashi, Yoshio; Kigoshi, Hideo; Usui, Takeo; Schiebel, Elmar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8722</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibitors of microtubule (MT) assembly or dynamics that target Î±/Î²-tubulin are widely exploited in cancer therapy and biol. research.  However, specific inhibitors of the MT nucleator Î³-tubulin that would allow testing temporal functions of Î³-tubulin during the cell cycle are yet to be identified.  By evolving Î²-tubulin-binding drugs we now find that the glaziovianin A deriv. gatastatin is a Î³-tubulin-specific inhibitor.  Gatastatin decreased interphase MT dynamics of human cells without affecting MT no.  Gatastatin inhibited assembly of the mitotic spindle in prometaphase.  Addn. of gatastatin to preformed metaphase spindles altered MT dynamics, reduced the no. of growing MTs and shortened spindle length.  Furthermore, gatastatin prolonged anaphase duration by affecting anaphase spindle structure, indicating the continuous requirement of MT nucleation during mitosis.  Thus, gatastatin facilitates the dissection of the role of Î³-tubulin during the cell cycle and reveals the sustained role of Î³-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrffZKKt6KhELVg90H21EOLACvtfcHk0lh5aJOyieSTgw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCns7fK&md5=2b9dd9c0e362bea8ae1b1473debaff9e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms9722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9722%26sid%3Dliteratum%253Aachs%26aulast%3DChinen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DShioda%26aufirst%3DS.%26aulast%3DPagel%26aufirst%3DJ.%26aulast%3DCerikan%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DT.%2BC.%26aulast%3DGruss%26aufirst%3DO.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DTakeno%26aufirst%3DH.%26aulast%3DShima%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DI.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKigoshi%26aufirst%3DH.%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DSchiebel%26aufirst%3DE.%26atitle%3DThe%2520%25CE%25B3-tubulin-specific%2520inhibitor%2520gatastatin%2520reveals%2520temporal%2520requirements%2520of%2520microtubule%2520nucleation%2520during%2520the%2520cell%2520cycle%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8722%26doi%3D10.1038%2Fncomms9722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheate, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikac, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span> <span> </span><span class="NLM_article-title">The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1049</span>â <span class="NLM_lpage">1058</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2007.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;key=10.1016%2Fj.jinorgbio.2007.04.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1049-1058&author=S.+Kempauthor=N.+J.+Wheateauthor=D.+P.+Buckauthor=M.+Nikacauthor=J.+G.+Collinsauthor=J.+R.+Aldrich-Wright&title=The+effect+of+ancillary+ligand+chirality+and+phenanthroline+functional+group+substitution+on+the+cytotoxicity+of+platinum%28II%29-based+metallointercalators&doi=10.1016%2Fj.jinorgbio.2007.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2007.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2007.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DS.%26aulast%3DWheate%26aufirst%3DN.%2BJ.%26aulast%3DBuck%26aufirst%3DD.%2BP.%26aulast%3DNikac%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DJ.%2BG.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520effect%2520of%2520ancillary%2520ligand%2520chirality%2520and%2520phenanthroline%2520functional%2520group%2520substitution%2520on%2520the%2520cytotoxicity%2520of%2520platinum%2528II%2529-based%2520metallointercalators%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2007%26volume%3D101%26spage%3D1049%26epage%3D1058%26doi%3D10.1016%2Fj.jinorgbio.2007.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i49"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00489">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16874"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00489">10.1021/acs.jmedchem.9b00489</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">DNA platination in MDA-MB-231 cells treated with the investigated compounds, DNA binding of Pt(IV) complexes derived from <b>5</b> and <b>1</b> in the presence or absence of sodium ascorbate, cell-cycle profiles of MDA-MB-231 cells treated with the investigated platinum complex <b>5</b> and its Pt(IV) derivatives, effects of <b>5</b> and its Pt(IV) derivatives on the organization of the structural network (cytoskeleton) within the cellâs cytoplasm, and mitochondrial membrane hypopolarization of MDA-MB-231 cells treated with the investigated platinum complexes (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Cytotoxicity data of the complexes (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_001.pdf">jm9b00489_si_001.pdf (850.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00489/suppl_file/jm9b00489_si_002.csv">jm9b00489_si_002.csv (1.29 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00489&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00489%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00489" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a8d29ce1a3c40","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
